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ABSTRACT
Three approaches to the synthesis of 2-oxabicyclo 
[3 . 3 .1]nonanes are described. The first route involved 
the attempted cyclisation of 4-ethoxycyclohexanones via 
an internal enolate alkylation process. A 3-oxygen effect 
was postulated as the reason for failure of these 
cyclisations. The second route utilised the same internal 
enolate alkylation process, but using 4-chloroacetoxy- 
cyclohexanone, but this failed as the substrate was 
too reactive under the conditions, giving a mixture of 
products. The third route involved the attempted 







The synthesis of a range of 3-oxabicyclo[3.3.1 ]nonanes 
are described, which were synthesised by the reaction 
of either the morpholine or pyrrolidine enamine of tetra- 
hydropyran-4-one with acrolein. Under anhydrous 
conditions the products were 6-morpholino or 6-pyrrolidinyl 
3-oxabicyclo[3.3.1]nonan-9-ones but under aqueous conditions, 
exo and endo 6-hydroxy 3-oxabicyclo[3.3.1 ]nonan-9-ones 
were obtained. These structures were assigned on the 
basis of detailed spectroscopic analysis.
The synthesis of the trimethylsilyl and t-butyldimethyl 
silyl enol ethers of 3-oxabicyclo[3.3.1]nonan-6-one are 
described and were obtained in good yield.
The ^ C n m r  spectra of various 3-oxabicyclo C3 . 3 .1] 
nonanes were compared and their conformation were assigned 
by comparison with data from bicycloC3.3.1]nonanes.
The trimethylsilyl and t-butyldimethylsilyl enol 
ethers of 3-oxabicyclo[3.3.1]nonan-6-one were ozonolysed 
to give the bifunctional products 5-(2-formylmethyl)- 
3-tetrahydropyran carboxylic acid and 5-(2-formylmethyl)- 
3-tetrahydropyranmethyl t-butyldimethylsiloxycarbonyl 
respectively in good yields. 5-( 2-Formylmethyl)-3-tetra- 
hydropyran carboxylic acid was found to be a very useful 
synthetic relay compound.
A number of Wittig reactions were attempted in order 
to elaborate the side chains. The Wittig reaction of
5-( 2-formylmethyl)-3-tetrahydropyran carboxylic acid 
with n-hexylphosphonium bromide to give 5-(cis-2-octenyl)- 
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1. Introduct ion
1.1 Background
Lipoxygenases are iron containing dioxygenases, that 
characteristically incorporate two atoms of molecular 
oxygen into a substrate. The lipoxygenases give rise to 
a number of primary metabolites from arachidonic acid (1 ), 





The lipoxygenases family of enzymes catalyse the 
oxidation of a cis,cis,l,4 pentadiene unit within arachi­
donic acid to a trans-2,cis-4 dien-5-hydroperoxy moiety^, 
which are then converted to a hydroxy compound (hydroxy- 
eicosatetrenoic acid (HETE'S)) by a reductase enzyme, 
probably by glutathione in the presence of glutathione 
peroxidase (see Scheme 1) .
Theories on the mechanism of lipoxygenases are based 
on what is known about the process of fatty acid auto­
oxidation which occurs spontaneously in the presence of 
oxygen, light and metal ions. This process is initiated 
by abstraction of a hydrogen radical from the methylene 
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Scheme 1 MODE OF ACTION OF LIPOXYGENASE
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in formation of an activated form of the pentadiene which 
is susceptible to attack by molecular oxygen across either 
of the double bonds. The resulting hydroperoxides each 
contain one cis and one trans double bond separated by a 
carbon-carbon single bond. Arachidonic acid contains 
three overlapping cis,cis,1,4 pentadiene moieties and 
autooxidation gives rise to a mixture of six different 
hydroperoxides. As the process is non-enzymic each of the 
hydroperoxides is a mixture of stereoisomers containing 
the R and S enantiomers. Lipoxygenase-catalysed 
hydroperoxidation, on the other hand, is characterized not 
only by positional specificity, but also by specific 
formation of one enantiomer. Also, a lot of information
has been obtained from the model for the cyclooxygenase
2e n z yme.
H
Mechanism lipoxygenase (Scheme 2)
3 4Lands and Hemler ' suggested electron transfer as 
a mechanism of generating radical intermediates without 
cleavage of the hydroperoxide 0-0 bond. Thus the 
initiating event would be a hydroperoxide of Fe^+ to Fe^+
- 4 -
with the concomitant generation of the hydroperoxide 
radical leading to free radical chain reaction with the 
substrate. The ability of iron to transfer or accept 
an electron is of critical importance to lipoxygenase 
activity.
RH +  ROOH
>  ROO
ROOHROOH
HELMER AND LANDS (1980)
An important characteristic of the lipoxygenase 
enzyme is the fact that it is activated by its own product 
(the hydroperoxide).^
Several animal lipoxygenases have been isolated and 
characterised by their positional specificity, and the 
position(s) of oxygenation commonly identified relative 
to the carboxy group of the substrate.
12-HPTE(12-hydroperoxyeicosatetrenoic acid)(2) was 





Prior to this lipoxygenase had only been found in 
plant tissues. The enzyme is widespread and has been 
identified in peas, potatoes, flaxseed and algae7 . The 
positional specificity depending on source or origin.
The birth of mammalian lipoxygenase derived products 
came with the recognition of "slow reacting substances"
g
as biological factors in 1938 by Feldberg and Kellaway . 
They found that during perfusion of guinea pig or cat 
lungs, treatment with cobra venom led to the appearance 
of what they called "slow reacting substance" (SRS) in 
the effluent, so called SRS because it had the ability to 
produce a slow and prolonged contraction of smooth muscle 
preparations.
9
Kellaway and Trethewie then discovered a pharma­
cologically similar substance in the effluent of 
immunologically sensitized guinea pig lungs treated with 
a specific antigen in vitro. Some time later Brocklehurst 
at Eli Lilly laboratories1^'11 demonstrated that in an 
anaphylatic event materials are generated which showed 
biological activity similar to Feldberg and Kellaway's SRS.
- 6 -
He was not able to ascertain whether the anaphylatic
material and the previously described SRS were the same
or different substances, so he modified the acronym to
SRS-A to indicate the former. It is now known that these
substances are indeed the same.
A major milestone was the discovery that arachidonic
acid (A.A.) is the starting point for the synthesis of
12SRS. Parker and Kakschik came to this conclusion as 
13did Bach , who showed, for example, that labelled 
arachidonic acid becomes incorporated into SRS.
The development that initiated the greatest advance
• i
was the discovery in 1979 by Murphy, Hammarstrom and 
14Samuelsson that the long known very elusive "slow
reacting substance of anaphylaxis" (SRS-A) was in fact a
product of the mammalian lipoxygenase pathway of the
arachidonic acid metabolism. Although SRS activity had
been recognised as early as 1938, purification had not
been possible until 1976. A considerable help was the use
of reverse phase high performance liquid chromatography in
15the isolation procedure. Evidence from hydrogenation,
oxidation experiments, and some physiochemical properties,
led Brocklehurst to suggest SRS-A was an unsaturated fatty 
16acid. The U.V. spectrum of SRS-A has a characteristic 
Mp OH1 at 280nm. This was attributed to a triple conjugated
max
17chromophore after the inspection of U.V. spectra of
18certain well-characterised hydroxylated lipids.
- 7 -
1.1.1 Structure Determination and Biosynthesis
The structures were determined by classical
analytical techniques coupled with total synthesis.
Reductive desulphurization of SRS with Raney nickel gave
5-hydroxyarachidonic acid indicating a 5-hydroxy function
14and confirmed the presence of a thio ether linkage.
Positions of the double bonds were determined in two ways.
Firstly, reductive ozonylsis led to hexan-l-ol demon-
14strating retention of the A double bond of the 
14precursor. The position of the t n e n e  system was
located enzymatically by hydroperoxidation with soya bean 
19lipoxygenase. This enzyme was specific for oxygenating
of fatty acids containing a cis,cis 1,4 diene system
20with concomitant isomerisation of the double bond.
The observed shift of 30nm in the U.V. spectrum of the 
product suggested that oxygenation and isomerisation of 
a Z-alkene unit at had occurred to bring it into
conjugation with a pre-existing triene unit. This 
indicated the presence of a second cis double bond at 
and additional double bonds at and .
In parallel studies, other research groups were 
investigating the metabolism of arachidonic acid in 
rabbit peritoneal polymorphonuclear leukocytes (PMNL). 
Borgeat incubated arachidonic acid with PMNL and charac-
terised the major metabolite, 5(S)-hydrc^icosa-6,8,11,14-
2
tetrenoic acid (5-HETE(3)). The formation of the 
metabolite was not inhibited by indomethacin thereby 
indicating prostaglandin synthetase enzymes were not
- 8 -
involved. A novel lipoxygenase type reaction was invoked
with enzymatic reduction of the first formed hydroperoxide
yielding the observed product. Subsequently the same
research group isolated another metabolite, 5(S), 12(R)-
dihydroxy-6,8,10,14-eicosatetrenoic acid (4). The geometry
around the double bonds was ambiguous from spectroscopic 
22data, but was later shown to be 6 Z ,8 E ,10E,14Z by
23chemical synthesis by Corey et al. It was subsequently
24named leukotriene B„ (LTB.). A number of minor metabo-4 4
25lites were also characterised, two 5,6-dihydroxy 7,9
11,14 eicosatetrenoic acids (epimers at C^) and two
geometric isomers of leukotriene .
A note on nomenclature is in order here: leukotrienes
A-F are referred to as LTX. where LT refers to the leuko-4
triene and X denotes the specific leukotriene: LTA^ is
the triene 5(S), 6(S )-epoxide(5) and LTB^(4) the enzymatic
hydrolysis product of LTA^(5). LTC^(7), (8), E ^ (9 ) and
(10) refer to the peptidoleukotrienes which adorn the
fatty acid chain through a cysteinyl sulphide linkage at
Cg. The subscript "4" refers to the total number of
double bonds in the C£q chain.
The structural similarities of the metabolites of
arachidonic acid derived from PMNL suggested a common
18
biosynthetic pathway. Samuelsson did some 0 labelling
studies where it could be demonstrated that the oxygen
of the hydroxy group at C-5 originated from atmospheric
C>2 , whereas the oxygen of the hydroxy group at C-12
2 6was derived from water. From these observations,
- 9 -
Samuelsson and Borgeat postulated that the leukocytes
generated an unstable intermediate which could undergo
attack by water, alcohols and other nucleophiles. The
intermediate was shown to be very labile at low pH with
a short half-life (approx 3 min at pH 7.4 at 37°).
Studies showed that LTB^ was produced enzymatically,
whereas the other metabolites present were the result
of non-enzymatic hydrolysis. From these results
Samuelsson proposed the intermediate 5(S), 6(S)-epoxide
(LTA^); the structure was confirmed by Corey et al's
27synthesis of this intermediate. This epoxide could
be transferred by neutrophils into leukotriene B ^ .
From the following results, Samuelsson proposed that
the transformation of arachidonic acid in PMNL occurs
according to Scheme 3.
It was becoming apparent from a number of sources
that the slow reacting substances were in fact related
to the newly discovered leukotrienes. They were both
12 21metabolites of arachidonic acid. ' The biosynthesis
22 29of 5-HPTE and that of SRS-A was not inhibited by
indomethacin and the calcium ionophore A23187 stimulated
the production of both S R S ^  and leukotrienes^ from
arachidonic acid.
It soon became evident that SRS was a conjugate
of LTA^(5) and a cysteine containing moiety. Incubation
of mouse mastocytoma cells with arachidonic acid, cysteine
and ionophore A23187 gave, as the major component, SRS
14
having a U.V. spectrum characteristic of a leukotriene. 
























with a cysteinyl containing substituent. Determination
of the substituent by amino acid analysis showed that
it was glutathione ( -glut amy leys teinylglycine ) residue.
Reaction of enatiomerically pure LTA^ with gluthione
yielded a product whose chemical, physical and biological
properties closely resembled SRS isolated from mouse
32mastocytoma cells. This was the first published 
structural determination of a slow reacting substance,
5(S )-hydroxy-6(R )-S-glutathionyleicosa-7E,9E,11Z,14Z- 
tetrenoic acid (LTC^(7)). In addition to LTC^, small 
amounts of another substance were present, this was 
found to be the 11-E isomer of LTC^(ll),^ the bio­
synthetic pathway for this is not known.
Two groups of workers also established the structure 
of the slow reacting substance released by rat basophil 
leukaemia cells (RBL-1).34'3 5 '36 RBL-1-SRS, was given
the trivial name leukotriene D„ and was shown to be4
5(S )-hydroxy-6(R )-cysteinylglycinyleicosa-7E,9E,11Z,14Z-
tetrenoic acid (8). It was also shown that 'l>-glutamyltrans
peptidase catalysed the conversion of LTC^ into LTD^
indicating that LTC^ was an intermediate in the bio-
3 6synthesis of LTD^. The 6-cysteinyl conjugate was
37 .identified in SRS-A released from rat peritoneum, its
structure and stereochemistry was confirmed by chemical 
3 8synthesis and was found to be 5(S )-hydroxy-6(R )- 
cysteinyleicosa 7E,9E,11Z,14Z tetrenoic acid (9) and 
was assigned the name leukotriene E^ (9). LTF^ (10) 
has been synthesised chemically, but as of yet has not 
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The biosynthetic pathway of leukotrienes
and E is shown in Scheme 4, also the structure of
leukotriene F. .4
Evidence for this proposed scheme comes from the
following:- Biosynthesis of LTC^ from LTA^ has been 
40observed, as has the enzymatic removal of the
32’^-glutamyl residue from LTC^ to form LTD^ . L T E 4  has
been formed from LTD^ using an aminopeptidase component
of a particular arylsulphatase.^^
Leukotrienes are transformed via a metabolic cascade;
therefore it was not surprising that the relative amounts
of LTC^, LTD^ and LTE^ found were dependent on the source
of stimulus and type of c e l l . ^
Samuelsson proposed that the single defined compounds
be known as the relevant leukotriene, and that SRS
describes biologically derived material, where the ratios
of leukotrienes are unknown.
Leukotriene formation is not restricted to products
derived from 5-HPETE. Arachidonic acid can produce six
different monhydroxylated metabolites via a lipoxygenase
pathway. See Scheme 5.
Indeed, two isomers of 14 ,15-dihydroxyeicosa-5,8,10,
12-tetrenoic acid (14-15-LTB^) (17) and two isomers of
8,15-dihydroxy-eicosa-5,9,11,13-tetrenoic acid (8-15-LTB^)
(16)were isolated from incubation of arachidonic acid with
43human leukocytes, (Scheme 6) which are believed to arise
from the intermediate 14,15-LTA^(15)• Another important
44 45pathway yields 12-HPETE in platelets and lymphocytes. '
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Scheme 5: HYDROXY EICOSATETRENOIC ACIDS (HETEs)
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Scheme 6 : PROPOSED PATHWAY OF 15-LIPOXYGENASE
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Recently, arachidonic acid has been shown to give a
new class of oxidative metabolites the so called lipoxins.
The lipoxins were first reported by Samuelsson and co- 
4 6 4 7workers, ' who incubated 15-HPETE(14 ) with purified
human leukocytes, which gave rise to lipoxins A and B,
two isomeric conjugated trihydroxytetraenes. Their




















Leukotrienes are potent mediators of allergic, 
inflammatory and other pathologic events. Their 
biological action may be divided into two groups: 
those involving contraction of smooth muscle (as 
exhibited by the sulphidopeptide leukotrienes) and those 
involving chemotaxis as exhibited by dihydroxy acids 
(such as LTB^ and its isomers).
LTA
DIHYDROXY ACIDS
LTB. AND ISOMERS 4
Chemotaxis 
Chemokinesis 
Aggregation of PMNS 
Exudation of plasma 
Contraction of guinea 
pig parenchyma
S-LINKAGE AND AMINO ACID 
RESIDUES AT C.
LTC., LTD., LTE.4 4 4
Contraction of smooth muscle 
Bronchoconstrietion 
Vascoconstrietion 
Exudation of plasma 
Stimulation of phospholipase 
(guinea pig lung)
Summary of leukotriene actions
Various inflammatory cells including leukocytes, 49,50
51,52 . 53,54 , . 55,56eosinophils, macrophages, and mast cells
in several species including humans, produce leukotrienes
from either added AA or from endogenous AA in the presence
of specific stimulants such as the chemotactic peptide,
5 7 58F-met-leu-Phe, platelet-activating factor (PAF),
- 19 -
59phorbol myristyl acetate (PMA) and IgE directed 
antigens.^ ^  Leukotrienes then produce a physio­
logical response by interacting with specific, high 
affinity receptors.
Leukotrienes are produced by cells (PMNs and
macrophages) that are present in large numbers at
6 2inflammatory sites. If stimulated with the calcium
ionophore A-23187, PMNs produce LTB^, which has potent
chemokinetic activity and is also an aggregating agent
6 3for neutrophils. is one of the most important
chemotactic factors known.
The role of LTB^ as an inflammatory mediator is 
supported by studies showing high amounts of LTB^ in
64the skin chamber fluid of involved skin from psoriatics
and in gouty e f f u s i o n s . L e u k o t r i e n e s  may also be
involved in the modulation of pain in inflammatory
conditions. However, the mechanism of action of response
is not fully understood.
Leukotrienes and may also be important
mediators of inflammatory processes. LTD^ and LTE^
influence vasopermeability in guinea pig skin and their
activities are potentiated by the presence of
prostagladin vasodilators.^ Also, LTC^ and LTD^
increase neutrophil adherence and may also affect release
reactions of macrophages.^
Samples of tissue from inflamed sites contain high 
6 8levels of LTB^ and also have increased ability to 
synthesise 5-lipoxygenase products compared with normal
- 20 -
tissue. Synovial fluids from rheumatoid arthritic
or gouty patients also contain large numbers of
62 65neutrophils and elevated levels of LTB^ . '
In the normal immune response, antibodies are
produced which neutralise antigens present without any
ill effect in the host. In hypersensitivity something
evidently goes wrong with the normal immune response.
The combination of antigen with antibody triggers a
poorly controlled excessive response and this causes
the release of various mediators which tend to exacerbate
the situation. These mediators serve as the immediate
cause of pathological change. The extreme form of
hypersensitivity is called anaphylaxis and is derived
69from the Greek words meaning "against protection".
The major mediators released can be subdivided into 
two groups: (1) Preformed mediators (already present
in the mast cell granules before stimulation and released 
within seconds, which include histamine) and (2) newly 
synthesised mediators (not detected before stimulation, 
but rapidly synthesised, and then released a few minutes 
after antigenic challenge); these include the leukotrienes 
and "platelet activating factor". In addition, it is 
probable that prostagladins are also released in such 
reactions.
The physiological actions of the primary metabolite
12-HPETE and the corresponding alcohol 12-HETE is unclear,
although 12-HPETE is believed to stimulate leukotriene
70biosynthesis in human blood leukocytes. Consequently, 
it has been concluded that leukocyte lipoxygenase products
- 21 -
of arachidonic acid have the capacity to amplify the
cellular component of inflammatory reactions.7 "^ HPETE
and HETE have additionally been implicated as possible
Endogenous regulators of prostacylin (PG^) biosynthesis
thus perhaps serving a physiological role in the
72regulation of vascular tone.
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1.2.2 Interactions between the lipoxygenases
There are a number of interactions between the 
various dioxygenases involved in the metabolism of AA 
and many of these may be biologically significant.
As well as the inhibitory effect of 15-HPETE on P G ^  
synthesis,^ it has been suggested that generation of 
hydroperoxy and hydroxy acids may be important in 
biochemically regulating the synthesis of leukotrienes.
- 22 -
It seems likely that C-15 and C-12 lipoxygenases exert,
respectively, inhibitory and stimulating influences
74 75on the synthesis of leukotrienes in leukocytes. '
The finding that 12-HPETE has a stimulating effect on
the activity of 5-lipoxygenase brings additional support
7 fi
to the hypothetical role of 15-HETE. The biological 
significance of the 5 S ,12S-DiHETE's remains unclear; 
it might be regarded as a product reflecting the 
stimulating interaction of 12-HPETE with the C-5 
lipoxygenase. Due to these interactions, when 
considering the biochemical mechanisms involved in 
allergy and inflammation it is important to ascertain 
the biological importance of the inhibitory and 
stimulating effect of hydroxy and hydroperoxy acids 
in leukotriene synthesis.
One of the most important areas of development 
is to ascertain what are the crucial differences between 
the normal and diseased state immune response. A 
successful resolution of this problem would help the 
treatment of a large number of human diseases including 
asthma, allergy and other forms of hypersensitivity 




There are a number of points of intersection in 
the arachidonic acid cascade, where inhibition may 
prove clinically useful in the treatment of asthmatic 
and inflammatory conditions. The point of intersection 
in our case is the lipoxygenase catalysed addition of 
oxygen to arachidonic acid giving the HPETE's and we 
are particularly interested in the 5- and 12-positions 
and the design of transition state surrogates as enzyme 
inhibitors.
1.3.2 Transition state surrogates as enzyme inhibitors
An organic reaction between two types of molecules
proceeds through a high energy activated complex known
as a transition state. In enzymes, from mathematical
analysis of equilibrium constants, the transition state
is considered to bind to the enzyme at least 1 0 ^  times
more tightly than the substrate. A transition state
surrogate is a stable compound that structurally resembles
77
the unstable transition state of the enzymatic reaction. 
There are a certain number of factors needed for the 
design of transition state surrogates: they require a 
knowledge of mechanism. Bond-breaking and bond-making 
mechanism should be similar. It is not possible to 
design a stable compound which mimics transition state 
closely since transition state is unstable. Why design
- 24 -
transition state surrogates? A transition state 
surrogate of a substrate reaction would be expected 
to be sufficiently tightly bound to be an excellent 
reversible inhibitor. As it binds more strongly to 
the enzyme than substrate, it should be more useful 
in therapy than the classical type (which only resembles 
the substrate). Its action is less likely to be reversed 
by build up of substrate.
1.3.3 Transition state surrogates for 5- and 12- 
lipoxygenase
The proposed mechanism for the conversion of
arachidonic acid into 5-HPETE is as follows and is based
on the analogous first stage of the cyclooxygenase 
2
reaction. Arachidonic acid is initially bound to the
lipoxygenase via the carboxyl group, and folds on to
the enzyme hydrophobic surface, possibly involving
a change of conformation to form a hydrophobic 'pocket'.
The pro-R-hydrogen at C-7 is abstracted homolytically
(as a free radical) from the bottom side of the folded
substrate. This is immediately followed by topside
allylic addition of molecular oxygen to form the (R)-
5-peroxy radical. There is considerable evidence to
2
support a mechanism of this type. (Same applies for 
the conversion of arachidonic acid into 12-HPETE. )
Proper orbital overlap required co-planarity of 
atoms 4,5,6,7 and 8. To further weaken the C^-H bond, 
the double bonds between atoms 5-6 and 8-9 probably
- 25 -
•0-0-M OOH
Scheme 10: Mechanism for conversion of arachidonic
acid into 5-HPETE
lie in the same plane. These requirements taken together
provide two hypothetical conformations of the product,
7 85-HPETE, in the 5-lipoxygenase active site.
OOH




Scheme 11; Proposed conformations of 5-HPETE in the 
active site of 5-lipoxygenase
From these free radical processes one can envisage 
the transformation in terms of a cyclic ene reaction 
involving free radicals containing a six-membered
- 26 -
transition state. The proposed transition state contains 
oxygens in the 2 and 3 positions and from this were 
derived compounds such as the cyclic ethers (22 and 23) 
which depending on the association constant of the enzyme 
may act as transition state surrogates. Our objective 
was to synthesise transition state surrogates for 
critical enzymatic steps in the synthesis of leukotrienes 
and 12-HETE in order that transition state requirements 
for these processes may accurately be defined.
Scheme 12: Proposed cyclic ene reaction
1.3.4 Retrosynthetic Analysis
Retrosynthetic analysis shows that the target 
surrogates are accessible from the (2)-3-oxabicyclo 
[3.3.1]non-6-enes (25 and 28) and the corresponding 
enol ethers (26 and 29), all of which are unknown. It 
was envisaged that the (2)-(3)-oxabicyclo[3.3.1]nonenes 
would be ozonylsed and then selective Wittig reactions 
would be performed to elaborate the side chains. This 
















Scheme 13: RETROSYNTHETIC ANALYSIS
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1.3.5 Review of lipoxygenase inhibitors
The discovery of the leukotrienes and the elucidation 
of the biosynthesis of these mediators of inflammatory 
and allergic disorders has presented synthetic chemists 
with the opportunity of preparing analogues of the bio­
chemical intermediates that may act as inhibitors of 
the enzyme. This review is going to be concerned only 
with inhibitors that bear some structural resemblance 
to AA or HETE's , i.e. substrate analogues.
A variety of substituted arachidonic acids have 
been identified as selective inhibitors of the lipoxy­
genase enzyme. Via this pathway, the biosynthesis of 
leukotrienes is initiated by stereospecific proton 
abstraction from C-7 of AA. AA analogues have been 
designed to function as inhibitors by blockade of proton 
abstraction from C-7, C-10 and C-13. This has been
done in a number of ways by insertion of a gem-
.. . 78,79,80 _ . .78 .. . . _ _dimethyl. Perchonock et al synthesised 7,7-
dimethyleicosa-5(Z ), 8(Z), 11(Z )-trienoic acid (30)






biochemically reactive positions 7 and 10 have been 
blocked by a gem-dimethyl. This choice of trienes rather 
than the tetraenes was based on the assumption that, 
lacking the 14,15-double bond, they would not be 
suitable as substrates for the cyclooxygenase pathway 
of the AA metabolism. The effect of compounds (30) 
and (31) on AA metabolism in RBL-1 cells was that (30) 
inhibited the formation of 5-lipoxygenase products 5- 
HETE and 5,12-di-HETE by 50%, as well as the cyclo­
oxygenase product PGD^ by 30-40%. Compound (31) was 
more selective for the 5-lipoxygenase pathway, inhibiting 
the formation of 5-HETE and 5,12-di-HETE by 40% at 100pm, 
while having little inhibitory activity on the formation 
of PGD2 .
7 8Using similar reasoning to Perchonock et al ,
that a gem dimethyl group would prevent proton
79
abstraction at C-7, F Scheinman et al undertook the 
synthesis of 7,7-dimethyl-eicosa-5(Z ), 8(Z)-dienoic acid 




By omitting olefinic linkages at carbons 11-12 
and 14-15, it was anticipated that they would not be 
in competition with arachidonic acid for binding to 
the active site of 12-lipoxygenase or cyclooxygenase 
and would thus be selective inhibitors of 5-lipoxygenase.
Acid (32) at 50ym inhibited 5-lipoxygenase from RBL-1
81 82 cells and human PNN leukocytes by 4 3% and 26%
respectively. Ester (33) was more active, giving inhibi­
tion of 74% and 50% at 50ym. Both compounds were
selective in their actions.
8 0Pfister and Murthy synthesised 7,7-Me2~AA (34) 
and 10,10-Me2-AA (35). These were chosen as potential 
inhibitors as (34) could block the formation of 5-HPETE 
from AA (a double bond shift from 5-6 to the 6-7 position 
is unlikely because C-7 in (34) is tetrasubstituted) 
whereas (35) might inhibit the conversion of 5-HPETE 
to LTA^ as there are no abstractable protons at C-10.
The biological data for these compounds was somewhat 
contradictory. However, it is somewhat difficult to 
compare inhibitors as in many cases testing methods 




8 3Prostaglandins (1984) by Cohen, Weber, Banner et al. 
who investigated the biological activity of these 
dimethyl AA's in great detail found that although these 
compounds did indeed block the ionophore-induced 
production of SRS-A from rat peritoneal cells, their 
mechanism of action does not appear to involve the 
inhibition of 5-lipoxygenase even in those compounds 
that were designed to block initial proton abstraction 
at the C-7 position. The actual mode of inhibition 
is not fully understood.
Another way designed to prevent proton abstraction 
was by the use of cyclopropane derivatives. The cyclo­
propane group has been inserted at various points and 
consequently has had quite different effects on activity.
= A = /
C5H11
C02H
J L / s H "
c o 2h
7-EAA (36) 7,13-DEAA (37)
CO2H / = > / = CO2H
10-EAA (38) 7,10-DEAA (39)
CO2H






i.e. in between a net of double bonds where only two 
of the analogues showed minor biological activity, these 
were 7,13 DEAA (37) and 7,10,13-TEAA (40).
8 6Also, by replacement of a double bond, as in
5,6-methano-AA (41), however this was inactive.
CO .H
(41)
8 7K.C. Nicolaou et al prepared 5,6-methanoleukotriene 
A^ (42) and 4 of these derivatives inhibited 5-lipoxygenase 
activity in cloned mastocytoma cells.
, ) nCOR
(42)
n=2,3 or 4, M=3,4 or 5, R=OM (where M is a 
pharmaceutically acceptable cation).
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84Toda et al also prepared similar compounds (43)
(43) n=1, 3 or 4
The n=3 compound selectively inhibited 5-lipoxygenase 
activity without inhibiting the cyclooxygenase and
12-lipoxygenase pathways in guinea pig and rabbit
« , « . 84platelets.
Raf. N. Misra prepared methylene cyclopropane
8 8analogues of arachidonic acid. It was hoped that (44) 
and (45) would act as conformationally-restricted analogues
’= V = :V''' (CH2)nC02H 
CsH,,
44) n=l,2 ( 45 ) n = l,2
of AA which specify the orientation about the 5,6-double 
bond of the C1-C4 carboxyl side chain relative to the 
aliphatic position of the molecule. He postulated that 
the methylene cyclopropane analogue best able to mimic 
the reactive conformation of the natural substance would 




Acetylene analogues of AA have been synthesised 
with the aim of inhibiting lipoxygenase. These analogues 
contain triple bonds in the place of double bonds, so 
that hydrogen abstraction and subsequent peroxidation 
cannot occur.
CO.H CO.H
The 5-6, 8-9, 11-12 or 14-15-dehydroarachidonic
acid (46, 47, 48, 49) selectively block peroxidation
^  c i i ic • 4. • i 89,90,91in the 5, 11 or 15 positions respectively.
Another solution to this problem was the 5,6-benzo-AA 
84(50) , where the double bond shift from the 5-6 to
the 6-7 position would involve deconjugation of the 
benzene ring which is unlikely to occur.
- 35 -
(50)
5,6-benzo-AA (50) was shown to inhibit the formation
84of 5-HETE and LTB. from intact human PMN's .4
An irreversible inhibition of the LT pathway was
observed with the allenic 4,5-dehydro-AA (51) in RBL 
92cells. It was found to have the same inhibitory 
activity as eicosa-5,8,11,14-tetraynoic acid (ETYNA) (52) 
toward the formation of LTB ^  and was twice as potent as
93ETYNA toward the formation of 5-HETE using intact PMN1s .
(52)
(51)
Sipio created his quaternary centre at C-7 by use
of the spiro-trienes (53) and (54) and he hoped that
94these would be inhibitors of L.T. biosynthesis.
- 36 -
(53)
Spiro-triene (53) was found to selectively inhibit 
5-lipoxygenase from RBL-1 cells (IC5Q=120ym) while having 
a negligible effect on prostaglandin synthetase. Compound 
(54) was also a selective inhibitor of 5-lipoxygenase 
(IC50=6ym).
Other approaches to the synthesis of lipoxygenase 
inhibitors have involved the introduction of hetero­
atoms into key positions. The secoleukotriene (55)
causes a decrease in the formation of LTB^ in human 
95PMN's.
A number of thiaarachidonic acids have also been 
synthesised. These are the 7-thia (56), 10-thia (57) 
and 13-thia-AA (58).96,97
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The 7-thia AA (56) was found to be an oxygen and 
time dependent irreversible inhibitor of the 5- 
lipoxygenase of rat basophilic cells?^ The 13-thia AA 
(58) was found to be a time and dependent irreversible 
inhibitor of soya bean 15-lipoxygenase enzyme whereas 
10-thia AA (57) was found to serve as a good substrate.
The reason for the activity of 7-thia AA has been 
rationalised as follows: Although it contains no
abstractable proton, the high-electron donating character 
of the divinyl sulphide unit can allow direct electron 
transfer to Fe(III) thereby activating (57) to react 
with oxygen even in the absence of an abstractable proton. 
Covalent coupling of enzyme and inhibitor as shown in
- 38 -






Scheme 14 Mode of inhibition of 7-thia AA
5-hydroxamyl (59) and 5-hydroxamylmethyl-6,8
11,14-eicosatetrenoic acid (60) were also found to be
9 8inhibitors of 5-lipoxygenase. They were synthesised
to act as iron chelators (as hydroxamic acids are known
99to be iron chelators ) and provide additional binding 
compared to that of the substrate, arachidonic acid.
Corey and coworkers/^ have prepared a number 
of acid derivatives of AA and a number of them have 




(60) r=c h 2c o n h o h






The arachidonamide (61) was found to be a competitive
Ok
inhibitor. All three hydro^mates (62), (63) and (64) 
were found to be powerful inhibitors of 5-lipoxygenase.
The hypothesis for their high potency is that the hydroxa, 
mate function in (62), (63) and (64) might be well 
positioned to coordinate with the catalytically crucial 
metal ion. They also found that the full eicosanoid 
chain is not required for strong inhibition as the 





The phenolic arachidonamide (65) was found to be 
considerably less potent than the hydroxmates (62,63,64).
From the review it can be seen that a number of 
methods have been used in the attempt to make lipoxygenase 
inhibitors. The blockade of proton abstraction from 
C-7, C-10 and C-13 by the use of various groups: gem
dimethyl, cyclopropane, benzene and spiro derivatives 
of arachidonic acid. The use of acetylenic and allenic 
derivatives so that hydrogen abstraction and subsequent 
peroxidation cannot occur. Blocking the critical carbon 
atoms to prevent hydrogen removal is more likely to 
give inhibitors that are merely competitive fatty acid 
analogues. Binding covalently seems more likely to 
have greater biological consequences than would the 
general competitive hydrophobic binding of a fatty acid 
to the enzyme.
The introduction of heteroatoms such as oxygen and 
sulphur into key positions, where in the case of sulphur 
they act as electron donors and the lone pair allows 
direct electron transfer. Also, by the use of hydrox**
CONHOH
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mates which act as iron chelators (to coordinate with 
the catalytically crucial metal atom).
The design and synthesis of lipoxygenase inhibitors 
has been a rapidly expanding field, which has resulted 
in greater understanding of the mechanisms evolved.
With this greater understanding hopefully in the future 
it should be possible to design rational inhibitors 
for any of the lipoxygenases and therefore have selective 





Bicyclo[3.3.11nonane itself may exist in any of 
the following three conformations: double(or twin)-
chair (cc), chair-boat (cb) and double-boat (bb). All 
these are subject to some destabilising interactions 
of non-bonded atoms. It has been shown that the double­






In oxoanalogues of the type (68) the double-chair 
conformation is destabilised relative to the boat-chair 
conformation, however they were still shown experimentally 
to be double chairs.
68 69
With the use of molecular mechanics it has been 
computed that introduction of an oxygen in the 2-position 
causes a destabilization of the c-c with respect to 
the b-c conformation.1^  In 2-oxabicyclo C3.3.11nonane
(69) the c-c and the b-c are computed to be about equally
4- • j 103s trained.
2.2 Synthesis
(2)-3-oxabicyclo [ 3.3.11nonanes are a class of 
compounds that have been synthesised mainly for conforma­
tional or spectroscopic studies. Conversely they have 
also been synthesised in conjunction with other ring 
systems to give highly functionalised derivatives.
None of the compounds required in this project are known. 
Syntheses of bicycloC3.3.11nonanes previously described 
in the literature have come in five types inherent to
- 44 -
the basic ring structure: 1) annulation of cyclohexane
derivatives; 2) annulation of cyclooctane derivatives;
3) ring cleavage of adamantane derivatives; 4) skeletal 
isomerization reactions and 5) syntheses starting from 
other bicycloC3.3.llnonanes. The majority of (2 ) — 3 — 
oxabicyclo[3.3.1Inonanes have been synthesised either 
via cyclohexane derivatives or from other (2)— 3 — 
oxabicyclo[3.3.1Inonanes.
2.2.1 Syntheses of 2-oxabicycloC3.3.1Inonanes
This series is known, although most of the compounds 
are poly-substituted or are in the form of a lactone 
(i.e. 2-oxabicyclo[3.3.1 ]nonan-3-one). Syntheses in this 
area have concentrated on two types of approach: 1)
cyclisation of a suitably substituted cyclohexane and 
2) iodolactionization of a suitably substituted cyclohexene.
Using the first approach 2-oxabicyclo[3.3.1 Inonane
104(69) has been synthesised. Starting from 3-hydroxyphenyl
acetic acid (70) which was hydrogenated in an alkaline 
medium with Rh/C as a catalyst to give a cis/trans mixture 
of the corresponding cyclohexane derivative (71). After 
esterification with diazomethane and reduction with 
LAH a cis/trans mixture of 3-hydroxycyclohexyl-ethanol 
(72) was obtained. Reaction with 1 equivalent of methane- 
sulphonylchloride afforded the monomesylate (73) which 
was cyclised in an extremely low yield (4%) to 2- 
oxabicycloC3.3.1Inonane (69) vith the use of NaH in 
DMSO. (Scheme 15) The very low yield can be attributed 
to two factors: 1) only the cis isomer can react and
- 45 -





H2 ,Rh/C; NaOH-H20 
1 atm, 60°





2-oxabicyclo[3.3.1]nonan-3-one (76) has been
synthesised by the second type of approach through
iodolactionization^^ of 3-cyclohexene-l-acetic acid
followed by reductive removal of iodine from the
iodolactone (75 )1 ^ 5 with tributylstannane. (Scheme
This synthetic method has been used for a wide
















2.2.2. Syntheses of 3-oxabicyclo [3.3.1Inonanes
There have been three main approaches to the 
syntheses of 3-oxabicycloC3.3.llnonanes: 1) Reactions
of cyclohexene using Prins type reactions; 2) Cyclisation 
of suitably substituted 1,3 cyclohexane derivatives and,
3) from the pyrrolidine enamine of tetrahydro(4H)pyran- 
4-one.
A number of 3-oxabicycloC3.3.1]nonanes have been
isolated as minor products from the mineral acid-catalyzed
reaction (Prins reaction) of cyclohexene with formaldehyde
109in acetic acid as solvent. Compounds (77) and (78)
were isolated as minor products from the reaction mixture.
Other derivatives have been synthesised via this 
type of approach. When 1-phenylcyclohexene was subjected
to the Prins reaction, two diastereoisomeric products 
(79) and (80) were obtained
HO'
(79) (80
Many Russian workers have developed similar schemes
and have obtained complementary results.^ ^ ^ ^ ^  One
group of workers used HC1 and obtained 9-chloro-3-
112oxabicycloC3.3.1 Inonane (82).
Various derivatives have been obtained using the
114procedure of Haggis and Owen. Cyclohexane cis-1,3-
dicarboxylic acid (83) was converted to the methanol 






afforded the mesylates (85) which gave the desired 3- 
















One group cyclised the dimethanol compound (84)
115direct by distillation from alumina to obtain the
desired compound in 15% yield.
Cyclisation of suitable 1,3 cyclohexane derivatives
has proved very popular, ^ ^  although the method of
cyclisation prevents the use of epimerisable groups
as complex mixtures are obtained with the use of KOH.
To overcome this problem Peters et a l ^ ^  developed an
alternative approach when they were synthesising 7-alkyl-
3-oxabicyclo[3.3.1]nonane for mass spectroscopic studies.
7-endo-methyl- and 7-endoisopropyl-3-oxabicyclo[3.3.ll
nonanes (92,96) were synthesised starting from tetrahydro
(4H)pyran-4-one (86). a ,a '-Annelation of the pyrrolidine
enamine (87) with methyl B,B1 dibromoisobutyrate afforded
methyl 3-oxa-9-oxobicycloT3.3.13nonane-7-endo carboxylate
(88). After protection of the 9-oxo function as the
dimethyl acetal, reduction with LAH and acid hydrolysis
gave the 7-endo-methanol compound (90). The 9-oxo-function
was removed by a Huang-Minlon reduction (91). Tosylation
of the resulting methanol compound and subsequent
reduction with LAH gave 7-endo-methyl-3-oxobicycloC3.3.1]
nonane (92). Reaction of (88) with MeMgBr resulted
in the corresponding dimethyl-carbinol (89). Treatment
with 4N H 2 SO^-dioxane (1:1) caused hydrolysis of the
acetal and dehydration to yield 7-isopropyl-9-oxo-3-
oxabicyclo[3.3.1]non-6-ene (93). This was hydrogenated
selectively to give 9-hydroxy-7-endo-isopropyl-3- 










(ii) a) (BrCH2 )2CHC02Me 
b) H +
(iii) a) LAH 
b) H +
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(vi) a) TsCl 
b) LAH
(v i i ) H +-H20 
(viii) H 2 ;Pd/C 
(ix) CrO-j
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9-hydroxy function (95), a Huang-Minlon reduction 
afforded the desired 7-endo-isopropyl-3-oxabicycloC3.3.1] 
nonane (96). (Scheme 18)
Most of the synthetic routes to (2)-3-oxabicyclo
[3.3.1]nonanes have been developed for conformation 
or spectroscopic studies and so consequently yield has 
not been too important and in most cases (2)-3-oxabicyclo
[3.3.1]nonanes have been obtained in painfully low yields. 
One of the aims of this project was to develop high 
yielding synthetic routes to 2-3-oxabicycloC3.3.1^nonanes, 




3. Approaches to the synthesis of 2-oxabicyclo[3.3.1] 
nonanes
3 . 1 Synthetic strategy
Many of the approaches to the synthesis of 2-oxa­
bicyclo [3.3.1]nonanes involve the cyclisation of a 
suitably 1,3 disubstituted cyclohexane. The problem 
associated with this is that the groups involved in 
the formation of the final ring must be axial on the 
cyclohexane ring already present (Figure 1 ).
OTs
Figure 1
A route was required that did not involve this 
method of ring formation. Obviously, it is energetically 
more costly to bring two groups to a 1,3-diaxial orienta­
tion than to get a single group into an axial position. 
Therefore we envisaged using an internal enolate 
alkylation process, where only the alkylating group has 
to be in an axial orientation. We attempted to use a 
cyclisation analogous to that of Marvell et a l ^ ^  in 







In our case, we used an oxo-analogue of a 4- 
substituted cyclohexanone. In this approach it was 
envisaged that 4-ethoxy substituted cyclohexanones would 
afford the target system.
Base
OCHjCHjX















Ethylene glycol, benzene 
NaH
Allyl bromide, KI, DMF 
°3
(vi) NaBH . 4




3.2 Synthesis of 4-ethoxy substituted cyclohexanones
It was visualised that the 4-ethoxy substituted
cyclohexanones would be synthesised from 4-hydroxy
cyclohexanone (101) (Scheme 21).
This latter compound is not very stable thermally,
and is not available commercially. The method chosen
121was that of Haslanger and Lawton, which involved
the partial oxidation of cyclohexane-1,4-diol (100)
using 0.95 equivalent of Jones reagent to yield 4-hydroxy
cyclohexanone (101) as a pale green oil. Haslanger
and Lawton used this without purification. However,
unpurified 4-hydroxycyclohexanone (101) decomposed
significantly, even overnight, particularly in the
presence of oxygen. This occurs by dehydration, which
is effected by residual acid from the Jones reagent.
Consequently, it was purified by dry-column "flash"
chromatography and gave a 54% yield of a colourless oil.
Once purified it could be stored indefinitely. The
ethylene ketal of 4-hydroxycyclohexanone (102) was
prepared using crude alcohol by the method of Haslanger 
121and Lawton and was obtained in 57% yield. The 8- 
( 2-propenyloxy)-1,4 dioxaspiro[4.5]decane (103) was 
prepared by the reaction of the sodium alkoxide of 8- 
hydroxy 1,4 dioxaspiroT4.5]decane with allyl bromide. 
in D M F ; better yields are obtained (^10%) if 20% w/v 
of dry potassium iodide is present in the reaction mixture. 
This is probably due to a Finkelstein type reaction, 
i.e. halide exchange. The yield was approximately 70%.
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The i.r. spectrum gave the characteristic double bond
stretch at 1640cm The ^Hnmr spectrum showed the
typical peaks for the allyl group, a complex multiplet
at 66.16-5.74 (C^Cf^) and a triplet at <55.4-5.04
(CH=CH 2 ). The evidence for the ether linkage is seen 
13at 64.01. The Cnmr was in accord with the desired
compound. Also, using chemical ionization a molecular
ion was seen in the mass spectrum at m/e 199(M+^).
The allyl ether (103) was subjected to ozonylsis with
122a reductive work up using sodium borohydride. Sodium
borohydride was chosen as this decomposes the ozonide 
to give an alcohol, which was synthetically more useful 
in our case than the usual aldehyde. This reaction 
worked very well and gave yields of over 90% of 8 — (2 — 
hydroxyethoxy)-1,4 dioxaspirof4.5ldecane (104), which 
t.l.c. (PE/EA,5:1) and ^Hnmr indicated was pure enough 
to use without any purification. This was submitted 
to an acidic hydrolysis using either acetic acid/t^O 
or perchloric acid with both methods giving comparable 
yields of ^70% of 4-( 2-hydroxyethoxy)cyclohexanone (105), 
which were purified by vacuum distillation. Spectral 
data were in accord with the desired compound. The 
i.r. spectrum showing alcohol (3455cm ^) and ketone 
(1710cm ^) peaks. The alcohol (105) was converted to 
the tosylate (^90% yield), which showed no hydroxyl 
group in the infra red spectrum and was used without 
purification.
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3 . 3 Cyclisation attempts
3.3.1 With tosylate as leaving group
Cyclisation was attempted using the tosylate as 
a leaving group via an internal enolate alkylation process 
as mentioned before. A number of base/solvent systems 
were tried and these are summarised in Table 1.
Base Solvent
1. LDA THF
2 . KOtBu THF
3. KOtBu tBuOH
4 . NaH DME
Table 1
The LDA/THF reaction with 4-(2-tosyloxyethoxy) 
cyclohexanone (106) yielded mainly unreacted starting 
material. The KOtBu/THF and NaH/DME procedures yielded 
unidentifiable mixtures containing starting material. 
KO^Bu/THF reaction yielded 4-(2-hydroxyethoxy)cyclo­
hexanone (105) the hydrolysis product of the tosylate. 
Cyclisation attempts with tosylate as a leaving group 
had proved to be unpromising. Consequently an alternative 
leaving group was sought.
3.3.2 Bromide as leaving group
The modification chosen was to use bromide as the 
leaving group. This was achieved by modifying the
- 58 -
synthetic route slightly by utilizing the method of 
123Becker. This involved the formation of the tosylate
of 8-(2-hydroxyethoxy) -1, 4 dioxaspiroT4.5Idecane (104), 
which was refluxed in acetone with lithium bromide.
This was convenient because replacement of the oxytosyl 
group by the bromo function and deprotection of the 
carbonyl were achieved in one step. The product was 








Reagents: (i) TsCl,Py,0 (ii) LiBr, Acetone, reflux
Scheme 22
Cyclisation attempts were carried out on the bromo 
compound. Two base/solvent systems were tried:
1) LDA/THF and 2) KOtBu/benzene. The LDA reaction gave 
only unreacted starting material. The KOtBu/benzene 
gave no identifiable product.
A hypothesis concerning the difficulty encountered 
in cyclisation was whether we had chosen the appropriate 
leaving group and therefore it was decided to change 
the leaving group. This idea was supported by observations
- 59 -
124made by Schultz and Dittami. They found that
cyclisation yields were dramatically changed depending 
on the choice of leaving group, in their case going 
from chloride to iodide. Therefore it was decided to 
prepare the mesylate as the leaving group as this would 
be more reactive than the previous leaving groups.
3.3.3 Mesylate as leaving group
4-(2-hydroxyethoxy)cyclohexanone (105) was mesylated 
at room temperature, although the aqueous work-up was 
effected rapidly and at ice-bath temperature to avoid 
undue decomposition of the product. The mesylate was 





Reagents: (i) MsCl, DMAP, Py, RT
Scheme 23
Two base/solvent systems were tried: 1) LDA/THF;
2) KO^Bu/Benzene. However, the results were as before; 
there was no evidence to suggest that cyclisation had 
occurred, although absence of the mesylate was shown.
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This seemed to contradict the hypothesis that an 
unreactive leaving group was the cause of failure to 
cyclise, since such a description is hardly applicable 
to the oxymesyl group.
3.4 Rationale on failure of cyclisation attempts 
involving 4-ethoxy substituted cyclohexanones
It was difficult to account for the curious difficulty 
encountered in achieving this cyclisation. To recapitu­
late, one fact is known for certain; the situation 
has to be due to an effect of the ethoxy oxygen. This 
may be stated because: it is that function which 
represents the only difference between the failure of
the cyclisation encountered in this project and success
u 120,124of analogous carbon chain reactions.
There should be no problem in the formation of the 
enolate anion, the problem lies in why the resultant 
anion fails to undergo cyclisation by attack.
The first idea to be considered was that the conforma­
tion required to enable cyclisation to occur was in 
some way sterically or energetically unfavourable.
In considering the resonance stabilised enolate anion, 
figure (2)it was appreciated that effective overlap of p~ 
orbitals throughout its "^-system demands a more than 
usually rigid geometry of the carbonyl carbon, C(l).
This is enforced by the shortening of the bond between
2
C(l) and the Sp hybridised C(2), which also adopts 
a trigonal disposition. The result is appreciable 
flattening of the usual chair conformation of the ring,
-  61 -
in a manner similar to that of cyclohexene
© o
Figure 2
It would be anticipated that the most stable conforma 
tion would be the half-chair ring conformation in which 
the 4-substituent is equatorial (figure 3). In this 
conformation there is no way that C (2 * ) can get close 
enough to C(2) to undergo attack by the enolate anion.
As mentioned earlier, to enable cyclisation to 
occur, the 4-substituent must be axial to the ring 
(figure 1 ).
Therefore consideration of purely steric effects 
does not help to explain why cyclisation has not occurred. 
It is true that the conformation in figure 3(b) is 
unfavourable compared to that of figure 3(a). However, 
equilibrium amounts of the former would be expected.
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(a) half-chair, 4-ethoxy group eq
(b) half-chair, 4-ethoxy group ax 
Figure 3
Were these then to cyclise, the conformation equilibrium 
would be disturbed in favour of figure 3(b). Such a 
process would continue until cyclisation was complete. 
This is underlined by the fact that the analogous 
cyclisation, where the ethoxy oxygen is replaced by 
CH2 , does occur. This cannot be explained by purely 
steric considerations. The magnitude of the unfavourable 
interaction between H(6B) and Ch^ would be anticipated 
as greater, and not less, than between H(6 8) and 0.
The implication of this evidence is that there 
is, in the oxygen ring formation, an electronic effect 
which disfavours cyclisation. This would obviously 
not manifest itself in the analogous carbon chain 
cyclisation. It seems likely that straightforward
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repulsion between the ethoxy oxygen and the enolate 
anion can also be discounted.
In order to suggest a reason why cyclisation did 
not occur, the process of nucleophilic attack is 
reviewed. It has long been known that SN^ processes 
are considerably assisted by the presence of an electro­
negative group a- to the leaving group, the so-called 
"a-effect".^ (figure 4)
5Y CR
- r  , r \  ^ ©
R Y---CR2
Figure 4
As shown in figure 4, this has been ascribed to 
a delocalisation of electron density from a filled 
orbital on Y towards the CI^ group. The result is a 
stabilisation of the developing positive charge on CI^.
By this means, the expulsion of the leaving group X 
is facilitated. Alternatively, the effect can be regarded 
as classical resonance stabilisation of a carbonium ion 
by the adjacent Y group, as shown in figure 4.
Now we go on to consider the consequences of moving 
the Y group one carbon atom further away from CR2 •
There are two ways of regarding this as shown in figure 5. 
In figure 5(a), Y is considered to occupy a position 
6 to CR2 , where effective overlap of filled orbital 
on Y with one on CI^ is not possible. Figure 5(b) 
shows Y as a substituent of the a-carbon, which is capable 
of a type of internal attack which helps to expel X.
This is known as "anchimeric assistance". In the former 
case, the influence that is beneficial to nucleophilic 
substitution, the + R resonance stabilisation is not 
possible. However, the destabilising inductive influence 
may now become significant, assuming it can be exerted 
through two bonds. Evidence that OR groups have a 
significant inductive effect comes from the fact that 
2-alkoxyethyl halides undergo solvolysis much more slowly 
than ethyl halides. Gould c o m m e n t e d / ^  "Therefore
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such substituents, except for cases involving neighbouring 
group participation will retard unimolecular substitutions."
It must next be considered how these factors would 
influence bimolecular substitution. Initially one would 
think that an electron-withdrawing group as Y, by 
increasing the magnitude of 6+ on CI^, would assist
attack. However, there is no sharp dividing line 
between SN^ and reaction mechanisms. These two
cases are in effect, the extremes of a wide spectrum.
Now, considering the S ^ - t y p e  transition state, 
it is convenient to consider the two opposing situations 
(figure 6). The first case (a), where Z is a negatively 
charged, powerful nucleophile such as OH . Here n = l f 
the transition state is negatively charged, the initial 
product is neutral. In the transition state, Z supplies 
electron density to the centre under attack faster than 
X can extract it; this leads to the development of 
<5- at C. Any electron-withdrawing Y group will certainly 
assist the reaction.
However, for case (b) where Z is a neutral nucleo­
phile, supplying only a lone pair, for example ^ 0 ,  
the situation is different.
Where n=0, the transition state will progressively 
develop a positive charge at the carbon centre being 
attacked, and the initial product carries a full positive 
charge. In the transition state, X will withdraw electron 
density faster from the attacked centre than can be 








centre. Clearly, any electron withdrawal will merely 
exacerbate this situation and will retard the reaction 
in this case.
The question which one has to ask now is which 
case does nucleophilic attack by the enolate anion in 
these cyclisation attempts resemble? The answer to 
this will indicate whether or not the ethoxy oxygen 
can be expected to assist or retard cyclisation. 
Superficially it would appear to resemble case (a).
However, although the enolate is an anion, the electron 
is delocalised over three atoms (see figure 2). Therefore, 
the rate of donation of electron density by the anion, 
to the transition centre, will depend upon the 
magnitude of its resonance stabilisation. This will 
oppose such a donation of electron density. A consequence 
of the leaving group extracting its electron pair from
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the C (2' ) centre faster than the rate of donation of 
electron density by the attacking enolate would be a 
build up of positive charge at that atom. In such a 
circumstance it is appreciated that any inductive effect 
of a 6-oxygen atom would retard the reaction, possibly 
prohibitively. Furthermore, another look at figure 3(b) 
will indicate that the conformation required for cyclisa­
tion is closer to that depicted in figure 5(a) than 
in figure 5(b). That is anchimeric assistance by alkoxy 
oxygen during the reaction, in order to stabilise that 
positive centre is effectively ruled out. Consequently 
it is believed that failure of these cyclisations is 
due to a 6-oxygen effect caused by an inductive effect 
of the ether oxygen.
3.5 Cyclisation attempts using 4-chloroacetyl
cyclohexanone (110)
The internal alkylation process using 4-ethoxy 
substituted cyclohexanones seemed to suffer from a 
oxygen effect which proved prohibitive to the reaction.
It was decided to make use of the a-effect. That is 
to attempt cyclisation on a 4-ethoxy substituted cyclo­
hexanone, substituted suitably a to the leaving group 
with some function capable of donating electron density 
to the transition state. This would lead to
stabilisation of the transition state, by reversing 
the inductive effect of the ethoxy oxygen because of 
the resonance effect of the a-substituent.
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It was hoped that with a suitable a-substituent, 
there should be no reason to prevent the occurrence 
of cyclisation. It was this idea that gave rise to 
the second approach.
OH
(1 0 1 )
OCCHXI
O





Reagents: (i) C1CCH2C1, Py, Et20
Scheme 24
There were three excellent reasons for the choice 
of a 4-oxychloroacetyl substituent on cyclohexanone. 
Firstly, it replaces the CH2 a-to CH2X by a carbonyl 
group. This has a u-system perfectly disposed to 
stabilise the SN2 transition state as carbonyls are 
known to exhibit the a-effect.
Secondly it is easily and cheaply prepared in two 
steps from (100). For chloroacetylchloride, the much 
greater reactivity of the acetylchloromethyl function, 
compared to that substituted a-to the carbonyl, makes
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alkoxide attack almost exclusive at the former position.
Thirdly, (110) has the additional property necessary
to make this approach a feasible synthesis of (99).
That is, when cyclised to 2-oxabicycloC3.3.llnon-3,6-
dione (111), the 3-carbonyl function ought to be
selectively reducible due to the difference in reactivity
of ketone and lactone. 4-hydroxycyclohexanone (101)
127was chloroacetylated using pyridine as a base. The
spectroscopic data were in accord with the required
structure. ^Hnmr shows a first order quintet at 65.22
which integrates to 1 proton and is assigned H(4).
The expected 2-proton singlet for Ct^Cl is also clear
at 64.10. The remaining protons, on the ring, form
13a multiplet at 1.9 to 2.76. Cnmr were also as expected, 
indicating one signal for CH, two for quaternary carbons 
and three for ; all at shifts in close accord with 
those predicted by correlation tables. The most 
informative peaks in the Cl mass spectrum were 191/3(M+^) 
and 157(M+*-Cl).
A number of cyclisation attempts were carried out 
on 4-(chloroacetoxy)-cyclohexanone (110) and these are 
summarised in Table 2.
LDA/THF was tried as a base/solvent system, where 
t.l.c. indicated a complex mixture. No attempt was 
made at separation. Another base/solvent tried was 
KOBu^/THF, where a seven-component mixture was obtained. 
Apart from starting material which was one of the 
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NaH, DMF, RT Baseline
material
Table 2
identified. The two other components were unidentifiable. 
The three compounds identities are believed to be:
4-hydroxycyclohexanone, which was identified by comparison 
of the spectral data with that of known material. One 
of the components was believed to be 2-oxabicycloC3.3.l3 
non-3,6 dione (111). I.r. spectroscopy showed two
o
o
(1 0 1 ) (1 1 1 ) (1 1 2 )
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carbonyl stretches, one for the lactone (1740cm ^) and 
one for the cyclic ketone (1717cm-^ ). The ^Hnmr showed
a multiplet at <55.15, which integrated to 1 proton and 
was assigned as the hydrogen attached to the bridgehead 
nearest the ether oxygen. The rest of the ring protons 
were found between 52.6-1.8 as a complex multiplet, which 
integrates for nine protons. The fact that no 2-proton 
singlet for C ^ C l  is seen at 64.10 indicates that this 
grouping is no longer present. In the mass spectrum 
the molecular ion was seen at m/e 154 also with a peak 
at m/e 109 indicating the loss of CO^ from the molecular 










Figure 7 Figure 8
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a common peak for cycloalkanones.
The other compound believed to be isolated was 
the ring opened form of (111), the opened lactone (112). 
This probably was the result of ring-opening as shown 
in figure 9.
(Ill)
OH ^ C 0 2H
(112)
Figure 9 Mechanism for ring-opening of lactone (111)
The i.r. spectrum showing alcohol (3520), carboxylic 
acid (3150) and ketone (1710cm *) peaks. The ^Hnmr 
spectrum showed a multiplet at 65.1, which integrated 
for one hydrogen, a broad singlet at 63.4 an hydroxy 
peak, which disappeared on D^O exchange, a multiplet 
between 62.6-1.8, which integrated for ten hydrogens.
In the mass spectrum the molecular ion was seen at m/e 
172, a peak at m/e 115, resulting from 6-cleavage of 
the carboxylic acid and at m/e 97 due to C^H^O+. The 
result of the mass spectra agreed with the usual
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fragmentation patterns for a cyclohexanone.
Sodium hydride in DMF was used. However, these 
conditions completely decomposed the starting material 
and consequently no products were isolated. It was 
decided that conditions employed so far might be too 
harsh. Therefore we envisaged using a milder system.
The two systems tried, refluxing in pyridine, and DBU 
in DCM, resulted only in the formation of 4-hydroxycyclo- 
hexanone (101). We imagined this as a result of EclB 
mechanism as shown in figure 10.
Figure 10 Formation of 4-hydroxycyclohexanone from 





From our results it was becoming clear that a number 
of competing reactions were taking place. Also, a very 
important factor was the insignificant difference in 
acidity between the protons a to the carbonyl on the 
ring and those a to the carbonyl in the side chain.
The indications were that those a to the carbonyl on 
the side chain were probably more acidic, which is not 
what we wanted. The idea behind the synthesis of the 
2-oxabicyclo[3.3.1Inonanes was to use them as synthetic 
intermediates for more complex molecules, consequently 
a high yielding synthetic route was sought. It seemed 
unlikely that this approach would furnish such a route 
due to a number of competing reactions, which were not 
useful to us. Therefore it was decided to abandon this 
synthetic strategy.
3.6 Cyclisation via 2,4-disubstituted cyclohexanones
After our problems with the internal enolate 
alkylation approach it was decided to go back to the 
concept of cyclising a suitable 1,3 disubstituted cyclo- 
hexane even with all the inherent problems that this 
strategy imposed, which have been mentioned.
It was convenient to make use of a synthetic inter­
mediate that we already possessed for this approach.
We used 4-hydroxycyclohexanone (101), although in the 
protected form using t-butyldimethyl silyl as the protecting
group (see scheme 25). This was prepared by the method
128of Wilcox and Grantham. Attempts to alkylate this
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with 2-t-butyldimethylsiloxyethylchloride failed, another 
example of the g-oxygen effect. Consequently alkylation 
was performed using allyl bromide. The desired compound 
was obtained as a mixture of cis and trans isomers 
approximately in a 1:1 ratio. Small amounts of the 
dialkylated (113), trialkylated (114) and tetraalkylated 






The required monoalkylated product (117) was obtained 
in a yield of 70%. No attempts were made to separate 
the isomers. Spectral data were in accord with the 
desired structure. I.r. spectrum gave a carbonyl 
(1711cm ^ ) and a double bond (1639cm *) ^Hnmr spectrum 
showed multiplets at 65.65, 5.1 and 4.95 for the double 
bond part of the allyl group. A multiplet at 54.15 
for CHOTBDMS and a multiplet at 6 2.9-1.7 for the rest 
of the protons apart from the protecting group which 
came as two singlets, one at 60.95 for t-butyl and at 
50.15 for dimethyl. The ^Cnmr showed the presence 
of two isomers as every peak in the spectrum was mirrored 















Reagents: (i) TBDMsCl, DMF, Imidazole
(ii) LDA, THF, HMPT, -78°, Allyl bromide
(iii) 0s04 , NaI04 , Et20, H20
(iv) Formic acid, Et2N, RuCl2 (Pd3)3 
(v) Bu4NF, THF
Scheme 2 5
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the. isomers in approximately a 1:1 ratio. In the cis 
and trans 4-t-butyldimethylsiloxy 2-(21-propenyl)cyclo- 
hexanones, it would be expected that the OTBDMS group 
would prefer to be in an equatorial position due to 
its large steric requirement. Therefore the two most 
likely conformations for the cis and trans isomers 
are shown below with the OTBDMS group in an equatorial 
position in both cases.
TBDMS'
TRANS
R = c h 2c h =c h 2
Figure 11
In the mass spectrum (C.I.) the molecular ion was 
seen at m/e 269 (M+1). The next informative peak was 
at m/e 211 indicating the loss of t-butyl group. The 
base peak was at m/e 137 which is the result of the 
loss of the OTBDMS group.
The aldehyde (118) was prepared from the allyl 







sodium metaperiodate in a two phase system of ether 
and in a yield of 62%.
The ir spectrum showed two carbonyl stretches, 
one for ketone (1710cm *) and the other for the aldehyde 
(1695cm ^). ^Hnmr showed a multiplet for the aldehydic 
proton at 5 9.8. The mass spectrum (C.I.) gave a molecular 
ion at m/e 271 (M+ )^ and fragmentation of this was the 
same as the allyl compound (117) with loss of OTBDMS 
group giving the base peak at m/e 139.
The next step was the selective reduction of an 
aldehyde in the presence of a ketone. One equivalent 
of sodium borohydride was used but this gave some of 
the reduced ketone. The chosen method was that of 
Khai and Arcelli*^ who used the catalyst RuC^tPPh^)^ 
(0.4%) with triethylamine and formic acid. This 
gave the desired compound in a yield of 7 3%. The 
spectral data was in accord with the required structure. 
The mechanism of the reduction is not clear. The R u C ^  
(PPh^)^ complex decomposes formic acid into hydrogen
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and carbon dioxide. The hydrogenation of the aldehyde 
proceeds by the insertion of the carbonyl group into 
M-H that is generated by the oxidative addition of • 
The alkoxo-hydrido complex thus formed reacts with the 
and reductively eliminates the product alcohol^^ 
(see scheme 26). There is believed to be competition 
between the aldehyde and ketone to coordinate to the 
catalyst and in all cases cited the aldehyde is reduced 









0  =  CHR
Scheme 26 Mechanism of hydrogenation
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The silyl compound was deprotected using standard 
132conditions, to give the required dialcohol (120)
in 54% yield for cyclisation. As mentioned before the
compounds carried through this synthetic scheme are
a mixture of cis and trans isomers and it is only the
cis isomer that can obtain the 1,3-diaxial configuration
required for cyclisation. So only 50% of the starting
material would be expected to react. The method we tried
for cyclisation was an "oxidative-reduction" dehydrative
coupling using triphenylphosphine (TPP) and diethyl
133azodicarboxylate (DEAD). Unfortunately none of the
desired compound was obtained. It was at this point 
that we decided to abandon the attempted synthesis 
of 2-oxabicyclo[3.3.1Inonanes as more profitable work 
was being carried out in the other series, the 
3-oxabicyclo[3.3.1Inonanes.
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4. Synthesis of 3-oxabicyclor3.3.1Inonanes
4.1 Synthetic strategy
It was envisaged obtaining the bicyclic system 
3-oxabicyclo[3.3.1Inonane via the reaction of the enamine 






(1 21 ) 
Reagents:
Tetrahydro-4H-pyran-4-one (121) can be bought, but
is expensive. Consequently a synthetic route was required.
134The method chosen was that of Owen and Reese, and 
Arentzen, Yan Kui and R e e s e . T e t r a h y d r o - 4 H - p y r a n - 4 - 
one (121) can be obtained in a two step sequence from 
3-chloropropionylchloride (124) (Scheme 28). The first 
step is the aluminium chloride-catalysed Friedel-Crafts 
acylation of ethylene with 3-chloropropionyl chloride 
(124) yielding 1,5-dichloro-pentan-3-one (125), which 
is then acid hydrolysed to give tetrahydro-4H-pyran-4- 
one(121) in 45% overall yield (based on 3-chloropropionyl 
chloride (124) as starting material.)
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(124) (125) (121)
Reagents: (i) A1C13,CH2=CH2 (ii) H20/H+
Scheme 28
The first reported reaction between an enamine and
acrolein to yield a bicyclic compound was that of Stork 
136and Landesman (Scheme 29).
Reagents: (i) Pyrrolidine, PTSA, Benzene
(ii) Acrolein, Dioxan
Scheme 2 9
Variations including the isolation of the intermediate 
3-(21-oxycyclohexyl)propanal (130) from the enamine and 
acrolein have been reported.^ ^ T h e s e  could then 
be cyclised by Amberlite IR-120 resin in water to yield 





Reagents: (i) Acrolein, 0 (ii) Amberlite IR-120 Resin,
H?0
Scheme 30
4.2 Synthesis via morpholine enamine and acrolein
Our first approach utilized the morpholine enamine
(132), which was obtained in a 90% yield as a white solid
(Mp 42-3° ). This was reacted with acrolein (Scheme 31)
to give 6-morpholino 3-oxabicycloL3.3.1]nonan-9-one (133)
as a mixture of exo and endo isomers in a ratio of
approximately 70% to 30% as determined by g.l.c. This
compares with the results obtained in similar carbocyclic 
139
systems, 70-80% of the a-epimer (exo) and 30-20% 
of the 8-epimer (endo), which approximates to the likely 
thermodynamic equilibrium.
The exo and endo isomers of 6-morpholino 3-oxabicyclo 
C3.3.1]nonan-9-one (133) were not separated. However, 
the spectral data were in accord with the required 
structures. The i.r. spectrum showed one carbonyl stretch 
(1717cm-^). The ^Hnmr spectrum shows a complex multiplet 







Reagents: (i) Morpholine, PTSA, benzene
(ii) Acrolein, benzene
(iii) KOH, Hydrazine hydrate, Digol




oxygen. A multiplet at 62.85 was seen for the CH adjacent
to the nitrogen, also, multiplets at 5 2.5 for the 's
adjacent to the nitrogen and at 5 2.3-1.8 for the remaining
ring protons. In the mass spectrum the molecular ion
was seen at m/e 225 indicating that the desired compound
had been obtained. However, the base peak was at m/e
126. This will be discussed at a later stage in connection
with the mass spectrum of 6-morpholino 3-oxabicyclo
[3.3.1Jnonane (134). The ketone group of 6-morpholino-
3-oxabicyclo[3.3.1]nonan-9-one (133) was removed by a 
140Huang-Minlon modification of the Wolff-Kishner reduction 
and gave 6 -morpholino 3-oxabicyclo[3.3.1jnonane (134) 
in 72% yield as a mixture of exo and endo isomers in 
a ratio of 9:1 as determined by g.l.c. The i.r. spectrum 
showed the absence of any carbonyl stretch. The ^Hnmr 
spectrum was essentially the same as that for the oxo-
derivative. The mass spectrum showed the molecular ion
at m/e 211. As in the oxo-derivative the base peak was
at m/e 126. Figure 13 indicates the fragmentation process.
Figure 13
- 86 -
The N-oxide (135) was formed with 30% in methanol
and ethanol. However, pyrolysis of the N-oxide (135) 
to the alkene (28) was unsuccessful with no identifiable 
products being obtained. It was then decided to try
to effect the Cope elimination using THF with molecular
141 141sieves and also with DMSO as these were reported
to effect the elimination at lower temperatures, but
only starting materials were obtained. Unfortunately
the Cope elimination was unsuccessful in our case and
it was decided to abandon this approach and try an alternative
route, however, still involving the reaction of the enamine
of tetrahydro-4H-pyran-4-one with acrolein.
4.3 Mechanism of the enamine reaction with acrolein
The mechanism of formation of the morpholino products
(133), which have been regarded^** #139,142 expected
products between acrolein and a cyclohexanone-enamine 
has not been fully rationalised.
143The standard text book mechanism is illustrated
in Scheme 32. However, this mechanism does not fit
completely with some of the experimental observations.
It has been shown that reaction between the enamine and
acrolein at 0° initially leads to an intermediate lacking
144carbonyl group. It has been postulated that the reaction






1 * C H ,= C H C H O — ► |
CHjCHCHO
H2CH2CHO
h 2c h 2c h o
Scheme 32
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h n c 4h ,
( 128
Scheme 33
The subsequent conversion of the dihydropyran (136) 
was interpreted as an intermolecular process, since any 
intramolecular rearrangement would result in a single 
preferred configuration. As mentioned before a mixture 
of exo and endo isomers are obtained in agreement with
14 4the expected thermodynamic equilibrium. Appleton et al 
put forward the idea that a small amount of hydrolytic 
agent would hydrolyse the dihydropyran (136) to a mixture 
of amine and dicarbonyl compound (130), which would then 
recyclise to give the expected products (128) (See Scheme 
33) .
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Another interesting feature of this reaction is 
that the ketols (131) sometimes isolated from this type 
of reaction, when reacted with pyrrolidine, give the
14 5amine products (128) and not those one would expect.
OH
Reagents: (i) Pyrrolidine, benzene
Scheme 34
From these observations a mechanism has been 
14 5postulated which takes into account these experimental 
findings (see Scheme 35) and does not involve a dihydrogen 
intermediate. It follows known enamine reaction mechanisms 
and fits all the required criteria. The intermediates 
likely to be formed in the cold do not contain carbonyl 
groups. It involves an intermolecular rather than an 
intramolecular process (reaction intermediate (141) with 
another intermediate (139)). This mechanism also indicates 
a possible pathway for the conversion of ketols (131) 

























4.4 Synthesis via pyrrolidine enamine and acrolein in 
aq THF
145In a procedure developed at Organon in their 
synthesis of hexahydro-8-hydroxy-5,9-methobenzocycloocten- 
11-ones (146), it was shown that it was possible to go 
directly from the enamine to the ketol (146) without
prior isolation of the keto-aldehyde which had been the
_ , , , 137, 138method used previously.
(145) (146)
Reagents: (i) Acrolein, THF(aq)
Scheme 36
It was decided therefore to utilize this approach 
in the synthesis of the 6-hydroxy 3-oxabicyclo[3.3.1] 
nonan-9-ones (147) and (148). The pyrrolidine enamine 
of tetrahydro-4H-pyran-4-one (122) was prepared in 90% 
yield. In the literature method"^ ^ for the preparation 
of the enamine (122), p-toluene sulphonic acid (PTSA) 
was used. However, we found that the absence of PTSA 
made no difference to the yield or any appreciable 
difference in the rate of reaction and was beneficial 
as the enamine could be used without any purification. 
Generally it was used immediately, however, it can be
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stored in the fridge under ^  for several weeks.
The i.r. spectrum showed an absence of any carbonyl
-1stretch, and the required double bond stretch (1645cm )was 
present. The ^Hnmr spectrum showed a triplet at 6 4.6,
J=3Hz for H-3, multiplets at 64.2 and 3.8 for H-2 and 
H-5, a multiplet at 6 2.81 for pyrrolidine protons
and at 62.2-1.8 for the remaining protons. The enamine 
was reacted with acrolein in THF (aq) to give 6-hydroxy 
3-oxabicyclo[3.3.1]nonan-9-one as a mixture of exo (147) 
and endo (148) isomers in 60% yield in a 1:1 ratio as 
determined by g.I.c. These were separated using a
Chromatotron (centrifugally accelerated chromatography).
On basification of the acid aqueous layer, a small amount 
(approximately 5%) of exo and endo 6-pyrrolidinyl 3-oxa 














The exo (147) and endo (148) isomers were identified 
by their spectral data. The i.r. spectra were identical, 
with both showing hydroxyl (3460, 3450) and carbonyl 
(1720cm~^) functions. The mass spectra were also 
essentially the same with the fragmentations shown in 
the figure 14, the most important fragmentations being 
loss of the hydroxy function to give the base peak at 
m/e 138 and then loss of an oxygen containing fragment 
which is common in 3-oxabicyclo[3.3.1Inonanes and can 
be one or more of the following: CH^O, Cfr^OH, CH^O,
CH3OH and CH3OCH3.
OH
m/e 156 m/e 138












The real difference between the two isomers was apparent 
from their nmr data.
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4.5 ^Hnmr study of exo and endo 6-hydroxy 3-oxabicyclo 
[3.3.1]nonan-9-one (147) and (148)
At this point we carried out a detailed analysis 
of the 1Hnmr spectra of the two hydroxy isomers, in order 
to rigorously elucidate their structures. To achieve 
this a number of decoupling experiments were performed
The exo and endo isomers could readily be identified. 
This was achieved by comparison of the methine protons 
associated with the hydroxy groups. We assume that a 
low field methine indicates an equatorial hydrogen, and 
consequently an axial hydroxy and therefore the endo 
isomer. In the endo isomer the methine is seen at 
5 4.6 whereas in the exo isomer it is seen at 6 4.11.
The endo isomer also showed a less complicated CHjOCf^
4
system with no 'W' coupling present. 'W' coupling ( J) 
is observed in saturated compounds, where the C-H and 




The presence of 4j coupling is important in the 
assignment of stereochemistry in the exo and endo 
derivatives. Only the axial methine (exo isomer) can 
couple with H4 axial to give a 'W' coupling of the
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no 'W' Coupling 'W' Coupling between
between H^eq and H^ax H6ax anc* H4ax
Figure 16
The difference manifests itself in the spectra by 
giving for the H-4axial in the exo isomer a doublet of 
quartets whereas for the endo isomer only a doublet of 
doublets is seen (see spectra). The ^Hnmr data for the 
exo and endo isomers is shown in table 3. The spectra 
were assigned by using decoupling experiments. In both 
isomers irradiation was carried out on the methine proton 
by the hydroxy (H — 6) and on one of the bridgehead methines. 
In the case of the exo compound the C-l methine, and 
for the endo isomer the C-5 methine were irradiated.
In the exo isomer, irradiation at 64.11 caused 
simplification from a doublet of quartets to a doublet 
of doublets at 63.73 indicating the 'W* coupling and 
therefore the H-4ax proton. It simplifies at 6 2.53 
indicating the C-5 methine, and also at 62.02 going from 
a quintet to a quartet indicating the H-7ax proton.
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There is also a small change at 62.12 showing the presence 
of a 'W' coupling between H-6ax and H-8ax. Irradiation 
at 62.35 causes simplification at 54.18 and 3.92 going 
from a doublet of triplets to a doublet of doublets and 
from this it may be deduced that these two resonances 
are due to H-2eq and H-2ax. Simplification at 62.53 
indicates for the H-5 methine a 'W' coupling across the 
smallest bridge, and at 62.11 and 1.83 showing the H-8eq 
and H-8ax protons.
In the endo isomer decoupling at 64.55 causes 
simplification at 62.48 indicating the H-5 methine. 
Irradiation at 62.48 simplifies the spectrum at 64.18 
and 3.83 showing the H-4eq and H-4ax protons. The methine 
at 64.55 is sharpened. The methine at 62.38 is too close 
to the irradiated peak to see the 'W' coupling.
The protons next to the ether oxygen were also 
assigned via their geminal coupling constants (Table 
4) and these agreed with the assignments made from the 
decoupling experiments.
Jl_2ax anc* J4ax-5 are diagnostic for the conformation 
of the tetrahydropyran ring. As the values are small 
(<4Hz), this shows that the tetrahydropyran ring exists 
predominantly (>90%) in the chair conformation. J5-6ax 
and J 2 _gax give the conformation in the other ring. 
Unfortunately from the spectra we were unable to determine 
these.
Table 3 Hnmr chemical shifts for exo and endo 6-hydroxy 3-oxabicyclo[3.3.1]nonan-9-one
Compound
Chemical shift 6U (PPM)H
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C ' X .  ^ 0H
W Y
)0
2.38 4.27 3.88 4 .18 3.83 2.48 4.55 2.75 2.38 2.10 1.74 1.72
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Exo J~ = 11.32 2eq-ax
J. = 11.56 4eq-ax
Jl-2eq = 1 ‘6
J, = 2.1 l-2ax
J. _ = 1.48 4eq-5
j a c = 2.4 4ax-5
J. , 1.1 4ax-6ax
Endo J0 = 11.28 2eq-ax
J. = 11.72 4eq-ax
J.. n = 1 . 6  1 -2eq
J, 0 = 2.1 l-2ax
J. . = 1.48 4eq-5
J. , = 2.8 4ax-5

















4.6 Synthesis of 3-oxabicyclo[3.3.1 ]non-6-en-9-one(149 )
In our approach to the synthesis of 3-oxabicyclo
[3.3.1 ]non-6-ene ( 2 8 )  it was hoped to dehydrate the keto-
alcohols (147) and (148) followed by a Huang-Minlon
reduction of the resulting 3-oxabicyclo[3.3.1]non-6-en-
9-one (149). However, the dehydration of (147) and (148)
did not prove to be an easy matter. Simple acid dehydration
146using cH^SO^ in ether gave the desired compound in
a yield of only 15%. Using 85% phosphoric acid also gave
a messy reaction mixture and a correspondingly low yield.
An explanation for this is that these types of acid
dehydration go via cations, which may cause skeletal
rearrangements. No other identifiable products were
isolated from the reaction mixture. Reaction with
147phosphorus oxychlonde and pyridine gave a mixture 
of the exo and endo 6-chloro 3-oxabicyclo[3.3.1]nonan-9- 
ones (150) and (151) and the alkene (149). These were 
separated by medium pressure chromatography. The stereo­
chemistry was assigned by the fact that the endo isomer 
had a low field methine proton (CHC1, 64.82), whereas 
in the exo isomer the corresponding methine proton was 
at a higher field (CHC1, 64.35). The endo isomer also 
showed a less complicated CH 2 OCH 2  system. In the endo 
isomer H. axial is a doublet of doublets (63.86) whereas 
the exo isomer axial is a doublet of triplets (63.79).
There is evidence of 'W' coupling in the exo, but not
1 3the endo isomer. The Cnmr spectra agreed with these 
assignments (see section 4.11), the two important
(147) +  (148)
Reagents:
*  d-^ii) (1 4.)
(153) ddiiN
d( iv)
(a)(i) c H2S04 ,ether,0° or
(ii) 85% phosphoric acid
(b )(i ) POCl3 ,Py
(c ) (i ) HN03 ,Ac20,-25°
(ii) LiCl,Li2C03 ,N-methvl pyrrolidine
(d ) (i ) MsCl,E13N ,DCM (ii) Collidine.A




differences being the resonances at carbons 4 and 6.
This will be discussed in section 4.11. The mass spectra
of the two isomers were slightly different. They both
gave molecular ions at m/e 176/174. However, they had
different base peaks, that for the exo isomer being at
m/e 138 and for the endo isomer at m/e 55.
Mesylation of the ketoalcohols (147 and 148) afforded
the mesylates (153) in 86% yield as a mixture of exo
and endo isomers. These were not separated. The ^Hnmr
spectrum showed the equatorial methine (65.2) of the
endo isomer and the axial methine (64.3) of the exo isomer.
Elimination of the mesylates (153) in refluxing collidine
afforded the desired alkene (149) in 42% yield.
Elimination in glacial acetic acid-sodium acetate-acetic 
148anhydride gave the alkene (149) in 27% yield.
Conversely, bromination of the mesylate with LiBr in
acetone and elimination of the bromo compounds (154)
149with L ^ C o ^ - L i B r  in DMF gave the desired compound 
(149) in 67% yield.
By far the most successful method was by the 
elimination of exo and endo 6-nitrooxy 3-oxabicyclo[3.3.1] 
nonan-9-one (152), which was formed by the reaction of 
the ketol-alcohols (147) and (148) with fuming HNO^ and 
acetic anhydride. The ^Hnmr spectrum showed the 
equatorial proton (65.62) of the endo isomer and the 
axial methine proton (65.25) of the exo isomer. The 
elimination was performed using LiCl-Li 2 C0 3  and N- 
methylpyrrolidone^^^ and this gave the required alkene
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(149) in 70% yield. The success of this reaction in 
comparison with the others is that it probably goes via 
a cyclic transition state (figure 17) with syn elimination 
In this type of reaction there is no possibility to form 
potentially rearrangeable cations. Consequently formation 
of the nitrate ester (152) and subsequent elimination 
is our preferred method for the formation of 3-oxabicyclo
[3.3.1]non-6-en-9-one (149).
(0°





The i.r. spectrum showed the double bond (3031,=CHSt,
1648cm ^C=CSt) and the carbonyl (1728cm ^). The ^Hnmr
spectrum exhibits a doublet of triplets at 66.01 (J^=9.5Hz,
J2=3 .3Hz) (H-6 ) and a quartet of triplets at 65.7 (J^=9.5Hz
J2=6Hz and J^l.OHz) (H-7). A doublet of triplets at 64.15
and 6 3 . 94 appeared for and H. and a doublet of2eq 4eq
doublets at 63. 79 and 63.71 for H-, and H„ . A multiplet2ax 4ax
at 6 2.81 (3H) was assigned to H-8 and the bridgehead 
hydrogen nearest the double bond (H-5). The other bridge­
head hydrogen appeared at 6 2.54. The structure was 
confirmed by the ^Cnmr spectrum: 210.58 (s,C-9)f 131.01
(d ,C-6 ) , 125.08 (d ,C-7), 76.81(t ,C-4 ) , 72.25(t ,C-2 ) , 50.16 
(d,C-5 ), 4 8.4 5(d ,C-1), 36.58(1,0-8). The mass spectrum
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gave a molecular ion at m/e 138, which was also the base 
peak. The other fragmentations are those normally 
associated with this type of ring system.
4.7 Synthesis of 3-oxabicyclor3 .3.1]nonan-6-one (158)
The synthetic strategy was to take the keto-alcohols 
(147) and (148), remove the keto group and then oxidise the 
alcoholic function. For removal of the keto group the 
Huang-Minlon method was avoided due to the possibility 
of effecting a reverse aldol reaction due to the presence 
of the $-hydroxy carbonyl grouping. The method chosen was 
to form the dithiolane (155) and then subsequent desul- 




Reagents: (i) Ethanediol, BF^.Et20,DCM




The dithiolane (155) was formed using a modification
152
of the existing method. It was found that using a
non-aqueous work up, increased yields could be obtained 
by as much as 30%. Normally, the reaction is worked up 
with 5% NaOH (Aq), which is used to remove the excess 
ethanedithiol. In our case the reaction mixture was 
concentrated and then chromatographed directly to give 
the dithiolane (155) in 86% yield. When an aqueous work 
up was used, yields of around 50% were obtained. This 
is due to high water solubility of these 3-oxabicycloC3.3.1] 
nonan-6-ols, and in reactions involving these types of 
compounds we tried as much as possible to keep to non- 
aqueous work u p s .
The dithiolane (155) was obtained as a mixture of 
exo and endo isomers clearly seen in the ^ C n m r  spectrum 
with the peak of one isomer being mirrored by the peak 
of the other isomer. However, they appeared as only one 
spot on t.l.c. (PE/EA,5:1) and consequently no attempt 
was made to separate the isomers. The i.r. spectrum showed 
the absence of any carbonyl stretch. The dithiolane was 
shown in the ^Hnmr spectrum by a multiplet between 63. 35- 
3.13 integrating to four protons. The mass spectrum gave a 
molecular ion at m/e 232. The base peak was at m/e 214, 
due to loss of water from the molecular ion.
Desulphurisation was effected using hydrazine hydrate
(98%) and KOH in trigol at 135° ,153 but this gave
154extremely low yields (^30%). Liquid NH^/Na only gave 
marginally better yields (^40%) and Raney Nickel in absolute
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155ethanol gave by far the best yield (^70%). The problem 
associated with the first two methods is the high water 
solubility of the products, whereas the third method is 
a non-aqueous method and consequently gives a greater 
yield. However, since a large excess of Raney Nickel 
is required (7g/g of substrate), it is difficult to use 
in large-scale preparations. This was primarily the reason 
for trying the other methods. Although they are easier 
to perform on a larger scale, the yields are considerably 
reduced.
Exo and endo 3-oxabicyclo[3.3.1]nonan-6-ols (156) and
(157) were obtained in an approximately 1:1 ratio and were
separated by flash chromatography. These were identified
13using ^Hnmr and Cnmr spectroscopy. In the iHnmr spectra,
the methine associated with the hydroxy group was at
64.09 in the endo isomer whereas in the exo isomer it
was at higher field (63.98). The endo isomer also showed
13a less complicated CH 2 OCH 2  system. In the Cnmr spectrum
the carbon associated with the hydroxy group was at lower
field for the exo isomer (672.91), the endo isomer being
at 670.58. The other main difference was at C-4, the
exo isomer being at a lower field (666.48) than the endo
isomer (669.56). The mass spectra were essentially the
same, each having molecular ions at m/e 142 and base peaks
at m/e 79. The main fragmentations in the spectra being
the loss of water and other oxygen containing fragments.
The exo and endo alcohols (156) and (157) were oxidised
156by pyridinium chlorochromate (P C C ) to give 3-oxabicyclo
-  I l l  -
[3.3.1]nonan-6-one (158) in a 70% yield. The oxidation 
product had an M +  ^ peak at m/e 141 and a ^ C n m r  resonance 
at 6213.86 together with a strong absorption at vmax 
1705cm  ^ in the i.r. showing it to be the desired 
compound.
4.8 Synthesis of 3-oxabicyclo[3.3.1]non-6-ene (28)
The synthesis of 3-oxabicycloC3.3.1]non-6-ene (28)
was achieved in a number of ways (scheme 40) all involving
different starting materials. The first approach involved
140the Huang-Minlon reduction of 3-oxabicyclo[3.3.llnon-
6-en-9-one (149). This gave the desired compound in
a very low yield ^10%. A possible reason for the low
yield is that these types of compounds are too sensitive
to be able to withstand such harsh conditions.
The second approach involved mesylation of 3-oxabicyclo
[3 . 3 .1]nonan-6-ols (156) and (157) and elimination of the
mesylates (161) with 1,8-diazobicyclo[5.4.0 lundec-7-ene 
157 o
(DBU) at 70 with no solvent present to give the desired
compound in 39% yield.
The third approach involved 3-oxabicyclo[3.3.1]nonan-
6-one (158) which was directly reduced to the cycloalkene
158
by treatment with chlorotrimethyl silane and zinc, 
and gave the desired compound in a 41% yield. The mechanism 
postulated is via an ylide - stabilised organozinc carbenoid 









(ii) MsCl,DMAP,P y ,DCM
(iii) DBU, 70 °
(iv) TMSC1,Zn
(v) HSCH2CH2SH,BF3 .Et20
(vi) Acetone, Raney Nickel, 
abs ethanol
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The fourth approach involved the attempt to 
selectively remove the thioacetal of 3-oxabicyclo[3.3.1] 
non-6-en-9-one (159) without reducing the double bond.
It was hoped to achieve this by refluxing the Raney nickel 
in acetone prior to use and hence deactivating it. 
Unfortunately, on reduction a mixture of 3-oxabicyclo 
[3.3.1 ]non-6-ene (28) and 3-oxabicyclo[3.3.1Inonane (160) 
was obtained. The i.r. spectrum of 3-oxabicyclo[3.3 .13 
non-6-ene (28) showed the double bond at 1640cm The
^Hnmr spectrum showed multiplets at 65.9 and 5.6 (H-6 
and H-7 respectively). The mass spectrum gave a molecular 
ion peak at m/e 124.
4.9 Synthesis of enol ethers of 3-oxabicyclo[3.3.1Inonan-
6-one (158)
The idea behind the synthesis of the enol ethers 
was that they would provide, once ozonolysed, a way of 
differentiating between the C-3 and C-5 side chains in 
the tetrahydropyran as they would be in different oxidation 
states, one as the aldehyde, the other as the carboxylic 
acid or ester (figure 18).
X =  TMS, TBDMS or Me
Figure 18
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The TMS enol ether (162) was synthesised using the
159method of House et al and was obtained in a yield of 
56%. The i.r. spectrum showed the double bond stretch 
at 1650cm ^ . The ^Hnmr showed a triplet at 64.8 (J=3Hz) 
for the proton associated with the double bond and a singlet 
at 60.15 for the trimethyl silyl group. The mass spectrum 














The TBDMS enol ether (163) was synthesised using a
method of Clark and Heathcock^^ using LDA, HMPT and
TBDMSC1 and was obtained in a yield of 58%. However,
it was obtained in much higher yield (95%) using the method
of Mander and S e t h i , w h i c h  uses TBDMS triflate and 2,6-
lutidine. One limiting factor for this reaction is the
expense of TBDMS triflate,which requires the use of two
equivalents. The i.r. spectrum showed the required double
bond stretch at 1660cm The ^Hnmr spectrum showed a
triplet at 65(J=3Hz) for the proton associated with the
double bond. Doublets were seen at 63.81 (H^e^),3.75
(H- ), 3.65(H. ) and doublet of doublets at 63.45(H0 )zeq 4 ax zax
which were assigned by comparison of their geminal coupling
constants. The H-5 bridgehead proton resonates as a
doublet of doublets. Multiplets were seen at 62.10-2.0
for the C-8 hydrogens and at 61.9 for the remaining ring
protons. The two singlets at 60.95 and 6 0.15 were
13attributed to (CH^)^CSi and (CH^^Si. The Cnmr spectrum
agreed with the required structure and all the resonances
were assigned (see experimental). The mass spectrum has
a molecular ion peak at m/e 254. Major fragamentation
peaks were at m/e 197 (M-C(CH^)^), and m/e 105.
Attempts to synthesise the methyl enol ether of 3-
oxabicyclo[3.3.1]nonan-6-one (165) were less successful.
Reaction of 3-oxabicycloC3.3.1]nonan-6-one (158) with 2,2-
162dimethoxypropane-PTSA-MeOH in DMF gave mainly the acetal 
(164) with a small amount of the methyl enol ether (165). 
These could be separated by column chromatography. The
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ketal (164) showed no carbonyl absorption in the i.r.
spectrum. The ^Hnmr spectrum showed the two methoxy groups
13of the acetal as singlets at 63.19 and 3.15. The Cnmr
spectrum was in accord with this structure. The mass
spectrum had a base peak at m/e 185(M *). Main
fragmentations were losses of the methoxy groups at m/e
153 and m/e 123. The acetal was converted to the methyl
enol ether (165) by refluxing with PTSA in trimethylortho 
163
formate. The i.r. spectrum gave the required double
bond stretch at 1640cm The ^Hnmr spectrum showed a
triplet at 64.7 attributable to the resonance of H-7, 
and a singlet at 63.45 for the methoxy group confirming 
the presence of the methyl enol ether. The mass spectrum 
gave a molecular ion at m/e 154.
4.10 Summary
The idea behind the synthesis of the 3-oxabicyclo 
[3.3.1 Inonanes was to use them as synthetic intermediates 
which could then be ozonylsed and further elaborated. 
Consequently high yielding reactions were required. The 
route chosen was that shown in Scheme 42. The TBDMS enol 
ether (163) was synthesised in an overall yield of 24% 
starting from tetrahydro-pyran-4-one (121). The TBDMS 
enol ether (163) had the advantages that once ozonylsed 
it would yield a bifunctional product and it could be 







(i) Pyrrolidine, benzene (ii) Acrolein,THF(aq) 
(iii) Ethanedithiol,BF3Et20,DCM
(iv) Raney Nickel, Absolute ethanol (v) PCC,DCM




4.11 Cnmr of 3-oxabicyclo[3.3.1]nonanes
13It has been shown that the Cnmr chemical shifts
are sensitive to stereochemical factors. Moreover, the
13effects of substituents on C shieldings are often
. . 164
additive within a class of compounds. These features
13
make Cnmr a powerful method for conformational analysis.
13
The conformational influences on C chemical shifts
for bicycloC3.3.1 Inonanes and 3-oxabicyclo 1 3 .3.1Inonanes
X 6 5are reported to be about the same. Apparently the
steric effects of the ether oxygen atom on the chemical
shifts are about the same as those of the Ct^ group.
1 f\ f\
Empirical force field calculations show that the tetra
hydropyran ring in 3-oxabicyclo[3.3.1Inonane is much less
flattened than the corresponding ring in the carbocyclic
system. This explains the strong preference of 3-oxabicyclo
[3.3.1Jnonane for the C-C conformation.
It has been found that after correcting for
13substituent effects, the C chemical shifts of bicyclo
[3.3.1 Inonane derivatives are characteristic for their
conformation.'*"^ Consequently ^ C n m r  data is useful in
estimating the conformational preferences of bicyclo^3.3.1]
nonane derivatives.
13The C chemical shift data of various 3-oxabicyclo 
[ 3.3.1]nonanes are collected in Table 5. The assignments 
of the chemical shifts were based on standard methods, 
i.e. off resonance decoupling, and by comparison of 
chemical shifts between related compounds. Methylene, 




13Table 5 Cnmr chemical shifts (ppm)
Compound C-l
3-oxabicycloC3.3.1]nonane 30.0
Exo 6-hydroxy 3-oxabicyclo 49.87
L3.3.1]nonan-9-one(147)
Endo 6-hydroxy 3-oxabicyclo 48.46
[3.3.1]nonan-9-one(148)
Exo 6-chloro 3-oxabicyclo 49.49
[3.3.1]nonan-9-one(150)
Endo 6-chloro 3-oxabicyclo 49.44
[3.3.1]nonan-9-one(151)
Exo 6-hydroxy 3-oxabicyclo 28.55
[3 . 3.1]nonane (156)
Endo 6-hydroxy 3-oxabicyclo 29.34



































and 90 Distortionless Enhancement by Polarisation transfer 
(DEPT) technique. This involves employing a 0y pulse 
of 90°, when and CH^ carbons cancel and only C H 's
remain. When the pulse is 135° then CH's and C H ^ 's 
give a positive intensity whereas the 1s give a negative 
reading.
It is well known that the magnitude of substituent
effects depend on the nature and the orientation of the
functional group. Upon replacement of a functional group,
the carbon bearing the functionality (the a carbon) and
the carbon immediately adjacent to the carbon containing
the substituent (the 8 carbon) usually experience down-
field shifts. On the other hand, the carbons y to the
substituent usually exhibit upfield shifts. In the
epimeric 2-substituted bicyclo[3.3.1lnonan-9-ones (Figure
19) it was shown that there was more pronounced deshielding
of a-carbons in the exo isomers compared to the endo 
168isomers. It is unsure whether this effect was
electronic in origin or was caused by slight differences 
in molecular geometry, since endo groupings may introduce 
steric interactions which could be partially relieved 
by some distortion of the carbon skeleton.
This type of effect is seen in the 6-substituted 
3-oxabicyclo[3.3.llnonanes with greater deshielding in 
the exo isomers (3.02-1.57 ppm). Considering the 8-effect 
at the bridgehead carbons (C-5) only small differences 
are noticeable, while the 8C-7 methylene carbons are 









Y-effect is evident in carbon C-4 and this is used to 
differentiate between carbons 2 and 4 as carbon 4 has 
a shielding effect.
In order to reveal conformational preferences in 
the substituted 3-oxabicyclo[3.3.1Jnonanes, it is primarily 
necessary to correct for substituent influences. As 
mentioned before substituent influences in bicyclo [3.3.1] 
nonanes are independent of ring conformation. Therefore, 
it is assumed that the same substituent effects can be 
applied for the 3-oxabicyclo[3.3.1Inonanes.
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Table 6 Substituent effects in 2-substituted bicyclo 
[3.3.1]nonan-9-onesa '^
a B( C - 5 ) B( C - 7 ) Y(C-4 ) Y ( C — 8 ) Y (C-9
Exo - OH 42.6 8.2 8.0 -3.6 -5.1 -1.6
Endo - OH 39.2 7.9 9.0 -7.0 -6.5 -2.4
Exo - Cl 31.3 8.1 7.9 -1.5 -4.3 -5.5
Endo - Cl 27.5 7.4 11.0 -5.4 -4.4 -5.9
a) Substituent effects are in ppm relative to bicyclo
[3.3.1]nonan-9-one; a minus sign denotes a high field 
shift on substitution. b) Ref.168
Table 7 Substitution effect of 9-oxo function5
a 8 Y <5
185.6 18.6 2.6 -2.0
a) Relative to bicycloC3.3.1!nonane in ppm
It was anticipated that using the above substituent 
effects it would be possible to determine conformation 
preferences assuming that the parent 3-oxabicyclo[3.3.1] 
nonane is in the double chair conformation.
After correcting for the 6-substituent (only a,
3 and Y effects taken into account) and for the 9-oxo 
function (a, 6, Y and 6 effects), the chemical shifts
of corresponding carbon atoms within the series agree 
closely and the values are shown in table 8. For





















oxabicyclo [3.3.1] nonanes (substituent corrected)
2 4 5 6 7 8 9
73.4 73.4 30.0 31.2 22.5 31.2 33.3
73.1 72.0 30.5 30.5 23.2 31.7 30.1
71.9 73.1 30.9 33.0 23.4 31.2 30.0
74.0 73.3 31.1 31.6 24.7 31.3 31.0
74.1 74.1 30.9 31.8 22.5 29.8 30.5
73.0 73.1 28.0 30.3 22.3 31.5 33.4
73.4 73.5 28.4 31.3 21.9 31 .8 33.5
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Table 9 chemical shifts (ppm) of the conformations of bicyclo[ 3 .3 .1 Inonane^ ^
CONFORMATION 
Bicyclof 3.3.1Jnonanes
13C chemical shifts (ppm)
C C C C C C C C C  ^1 2 3 4 5 6 7 8 9
cc 28.1 31.5 22.3 31.5 28.1 31.5 22.3 31.5 34.4
cb
bb
25.9 33.3 16.4 33.3 25.9 26.7 19.0 26.7 28.6
26.3 31.4 20.7 31.4 26.3 31.4 20.7 31.4 23.7
124
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comparison the average for the various established
conformations of the carbocyclic system are included 
165for reference. (table 9)
13The C chemical shifts clearly indicate that the 
various 3-oxabicyclo[3.3.1Inonane derivatives occur 
predominantly in the CC conformation. In particular 
the chemical shifts agree very well with those of the 
parent system. The C-7 chemical shift has often been 
used as a conformational probe and in our case the 
C-7 chemical shifts clearly indicate that they are in 
the CC conformation. Obviously, the shifts of the other 
carbon atoms are subject to the influence of the hetero­
atom, but the conformational influences on their shifts 
observed in the carbocyclic compounds can still be 
recognized here.
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5. Ozonolysis of silyl enol ethers and elaboration 
of side chains
5.1 Synthetic strategy
Ozonolysis has been widely used both in degradative 
work and in synthesis for the preparation of aldehydes, 
ketones and carboxylic acids. A way of achieving 
bifunctionality has been with the use of silyl enol 
ethers. (figure 20)
R = SiMe3 R=H
R= SiMe2t- Bu R;SiMe2t-Bu
Figure 20
As can be seen from figure 20 the terminii are in 
different oxidation states and consequently it should 
be possible to perform selective reactions on either 
end. With this concept in mind we envisaged utilizing 
the silyl enol ethers of 3-oxabicyclo[3.3.1]nonan-6-one.
It was anticipated that these would be ozonolysed and 
then selective Wittig reactions would be attempted.
5.2 Ozonolysis of silyl enol ethers of 3-oxabicyclo
[3.3.1]nonan-6-one (158)
The trimethylsilyl enol ether (162) and t-butyldimethyl 
silyl enol ether (163) were ozonolysed as shown in Scheme 43.
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l)0 3,-78°





(166) R = H
(167) R=SiMe2t-Bu
Scheme 4 3
It was important to monitor the reaction closely. 
Normally in ozonolysis the reaction is complete when the 
blue coloration persists. However, this was not a 
sufficient criterion to show that the reaction had gone 
to completion. The reaction had been stopped when a 
blue colour had appeared and there was still starting 
material present. Starch-iodine paper was used to 
indicate the presence of excess oxidant. It was 
important to do this frequently, time depending on the 
size of reaction, as if it was left too long over­
oxidation occurred. The trimethylsilyl enol ether (162) 
gave the desired aldehyde-carboxylic acid (166) in over 
90% yield and this was purified by column chromatography 
(PE/EtOAC, 1:1 + 1% formic acid). The t-butyldimethylsily 
enol ether (163) gave the desired aldehyde-siloxy ester 
(167) in approximately 90% yield. However, all methods 
of purification of this compound failed. Distillation, 
chromatography using triethylamine-treated silica and
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chromatography using neutral alumina failed to produce 
the desired compound. Spectral data were recorded on 
the crude compound and indicated relatively high purity 
(>90%). The ir spectrum showed a broad carbonyl stretch 
at 1 7 0 0 c m I n  the nmr spectrum there was a multiplet 
for the aldehydic proton at 69.75. Multiplets were seen 
at 64.15, 3.85, 3.36 and 2.95 for the methylene hydrogens 
adjacent to the ether oxygen and a multiplet at 62.7 
for the bridgehead hydrogen adjacent to the siloxy ester 
grouping. A multiplet was seen at 52.35 for the other 
bridgehead hydrogen and the hydrogens nearest the aldehyde, 
and a multiplet at 61.7 for the remaining ring hydrogens. 
The two singlets attributable to the resonances of the 
hydrogens of (CH^^CSi and occur at 60.95 and
0.15 respectively. The mass spectrum gave a molecular 
ion (C.I.) at m/e 285. The base peak was at m/e 127.





m/e ss m/e 127
Figure 21
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The difficulties encountered in purification led
us to deprotect the siloxy ester (167) to give the
carboxylic acid (166) (Scheme 44). This was achieved
132
using a mixture of acetic acid, and THF (3:1:1)
and gave the desired compound in 81% yield. It is worth
1 "3 o
noting that tetra n-butylammonium fluoride in THF 
gave none of the desired compound. 5-(2-formylmethyl)- 
3-tetrahydropyran carboxylic acid (166) was obtained 
as a white solid (m.p. 127-128°). The ir spectrum showed 
a carboxylic acid stretch (3500-3000cm ^) and a carbonyl 
stretch at 1700cm The ^Hnmr spectrum was assigned
by decoupling experiments and by use of a COSY spectrum 
(page 130). The aldehydic proton was seen as a multiplet 
at 6 9.9 and the carboxylic acid proton as a broad singlet 
at 6 9.0. There are four resonances centred at 64.19,
3.94, 3.35 and 3.05 attributable to C-2(Heq), C-4(Heq), 
C-2(Hax) and C-4(Hax) respectively, the protons of the 
methylenes adjacent to the ether oxygen. Multiplets 
were seen at <52 .75 for the bridgehead nearest the 
carboxylic acid and at 62.35 for the other bridgehead 
proton. The methylene adjacent to the aldehyde appeared 
as a multiplet at 62.31 and the methylene at C-6 appeared 
as a quartet at 61.4. The COSY spectrum indicated 
retention of stereochemical integrity from the ozonolysis 
reaction as there was evidence of coupling between the 
two bridgehead hydrogens and therefore a cis arrangement.
The mass spectrum gave a M  ^ peak at m/e 171, which 
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was at m/e 129 corresponding to the loss of the aldehyde 
side chain.
The aldehyde-carboxylic acid (166) was also converted
119into its methyl ester (168) using diazomethane and 












-1The ir spectrum showed one carbonyl band at 1720cm 
In the ^Hnmr spectrum the aldehydic proton was seen as 
a multiplet at 69.9. Multiplets were seen at 54.14,
3.92, 3.33 and 3.01 for C-2Heq, C-4Heq, C-2Hax and C-4Hax 
respectively (the protons of the methylenes adjacent 
to the ether oxygen). The methyl ester appeared as a 
singlet at 63.7. The two bridgehead protons, and 
H,_ were seen as multiplets at 62.7 and 2.28 respectively. 
Multiplets were seen at 62.16 for the methylene next 
to the aldehyde and at 61.4 for the methylene at C-6.
The mass spectrum gave a peak at m/e 185. The base
peak was at m/e 143 corresponding to the loss of the 









5.3 Synthesis of 5-(2-formylmethyl)-3-tetrahydropyran
carbanal (170)
5-(2-formylmethyl)-3-tetrahydropyrancarbanal (170) 
was synthesised starting from the aldehyde-carboxylic 
acid (166), which was converted to the dialcohol (169) 
by diborane.1^  The ir spectrum showed the absence of 
the carboxylic acid and carbonyl stretches and gave a 
stretch for the hydroxyl group at 3650 and 3450cm ^ .
The dialcohol (169) was then oxidised using pyridinium 
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Reagents: (i) Diborane, 0° (ii) PCC,DCM
Scheme 4 5
The structure of the dialdehyde was confirmed by 
the ir spectrum showing a carbonyl stretch at 1710cm  ^
and the ^Hnmr spectrum, where two multiplets were seen 
at 69.85 and 9.65 corresponding to the two aldehydic 
protons.
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5.4 The Wittig reaction
The Wittig reaction has proved to be synthetically 
a very useful reaction, involving the reaction of a 
phosphonium ylid with an aldehyde (or ketone) to give 
an olefin and phosphine oxide. An important aspect of 
this reaction has been the control of stereochemistry 
to give either cis or trans olefins. A phosphonium ylid 
and an aldehyde can react to give two diastereomeric 
betaines (171 and 172). The relative rates of formation 
and decomposition of these betaines control the stereo­
chemistry of the olefin mixture produced by the Wittig 
reaction. The trans betaine is favoured thermodynamically, 
as being in the eclipsed form it has a minimum of steric 
interactions. However, the cis-betaine is the kinetic 
product (i.e. formed first). If formation of the betaine 
is the rate determining step, the betaine will decompose 
rapidly to the olefin and consequently give the cis-olefin. 
If however the rate of decomposition of the betaine 
becomes comparable to the rate of formation, then betaine 
reversibility becomes important, and the proportions 
of betaines present depends on their thermodynamic 
stability rather than their rate of formation, and so 
the proportion of trans-olefin increases. The factors 
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Low temperatures Elevated temperatures
Polar, aprotic solvents Apolar, protic solvents
Lewis base Betaine stabilizing salts
Salt free solutions Carbanion stabilization
No carbanion stabilization R^=CN, COOR, COR, Aryl,Vinyl
(R^= alkyl, alkoxy) Electron rich phosphorus atom
Electrophilic phosphorus
atom
Pph3 + Excess base
Table 10
Therefore by choosing the correct conditions it 
should be possible to perform a stereospecific synthesis. 




Having successfully ozonolysed the 3-oxabicyclo
C3.3.1]nonane ring system the next step was to perform
selective Wittig reactions on the respective side chains
(see Scheme 46).
The Wittig reagent (173) can be bought as can the
methyl ester of (176). The Wittig reagent (174) has
171 172
been synthesised by two groups ' both involving 
eight step sequences. It was envisaged synthesising
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xoc cox
27 ) X=H or OR
♦C6H13PPh3Br"
(173)












the Wittig reagent (175) by our own route, which will 
be discussed at a later stage.
5.5.2 Attempted Wittig reactions on 5-(2-formylmethyl)-
3-tetrahydropyranmethyl t-butyldimethylsiloxy 
carbonyl (167)
Originally it was anticipated performing the Wittig
reactions on the aldehyde-siloxy ester. Unfortunately
attempted Wittig reactions were unsuccessful. The
23conditions chosen were those of Corey et al, who had
used them in a synthesis of LTB^. They involved the
use of nBuLi as the base in THF, the important factor
being the addition of 15 equivalents of HMPA (based
on the phosphonium salt). These conditions were reported
to give exclusively cis-olefins.
In the case of the aldehyde-siloxy ester none of
the desired compound was obtained, although starting
material disappeared. This may be due to lability of
the siloxy-ester grouping, as it is known that the siloxy
ester grouping reacts with nBuLi and that the original
173functionality (i.e. carboxylic acid) is not restored. 
Consequently, any excess base present would have an 
adverse effect on the reaction. The lability of the 
siloxy-ester grouping led us to deprotect and attempt 
the Wittig rection on the free carboxylic acid.
5.5.3 Synthesis of 5-(cis-2-octenyl)-3-tetrahydropyran 
carboxylic acid (178)
It was decided, because of the failure of (167) 
to react with Wittig reagents, to use the aldehyde-
138
carboxylic acid (166). Obviously in this case we would 
have to use 2 equivalents of the phosphonium salt as 
one equivalent would be consumed by the carboxylic acid. 
The reaction of the aldehyde-carboxylic acid (166) with 
n-hexyltriphenylphosphonium bromide (173) gave the desired 
compound in a yield of 73%.




The ir spectrum indicated the presence of the 
carboxylic acid group (3500-3000cm *) and a carbonyl 
stretch at 1700cm-1. The double bond was shown by the 
presence of =CH stretch at 3020cnrl. The lHnmr spectrum 
was in accord with the desired compound. The aldehydic 
peak had disappeared. The carboxylic acid proton was 
seen as a broad singlet at 6 10.64. The resonances of 
the double bond protons were seen as multiplets centred 
at 65.44 and 5.34. The resonances of the methylenes 
adjacent to the ether oxygen appeared as two multiplets
(166) (178)
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at 64.15 and 3.93 and two triplets at 3.35 and 2.96.
A multiplet was seen at 62.66 for the methine nearest 
the carboxylic acid group. There were multiplets at 
62.2, 1.97, 1.69 and 1.26 and a triplet at 60.88 (J=6.5Hz) 
for the terminal CH^ group.
It was important to introduce the double bond in 
entirely the cis configuration and consequently we hoped 
that the conditions used would achieve the required 
stereochemical control of the Wittig reaction. By analogy 
from previous reactions where these conditions have been 
used we should obtain a purely cis-olefin. It is well 
known that the vicinal coupling for Jtrans is greater 
than Jcis. The value for Jtrans is ll-19Hz and Jcis 
is 5-14Hz. The vicinal coupling constant of (178) was 
calculated to be 10.99Hz and therefore the evidence points 
to (178) possessing a cis-olefin as we had anticipated.
The mass spectrum gave a molecular ion at m/e 240 
and a base peak at m/e 141. This compound was sent for 
biological testing.
5.5.4 Attempted Wittig reaction on 5-(2-formylmethyl)-3- 
tetrahydropyrancarbanal (170)
It was hoped to be able to perform selective Wittig 
reactions on the dialdehyde (170) envisaging that the 
two aldehydes would be different in reactivity.
It was anticipated that the acetaldehyde group 
at C-5 would be more reactive due to its greater 
flexibility and therefore would react selectively. 







to be no appreciable difference between the two aldehydes. 
Using similar conditions that had been successful for 
the aldehyde-carboxylic acid (166) but only using one 
equivalent of the phosphonium salt and employing inverse 
addition in order to keep the concentration of the 
phosphonium salt low. Unfortunately a complex mixture 
was obtained.
5.6 Approach to the synthesis of Wittig reagent (175)
The starting point for the synthesis of (175) was 
from hexanal (179), and it was envisaged elaborating 
this to (175) by two three-carbon extensions (Scheme 
48) .
Hexanal (179) was reacted with the Wittig reagent,
174
2-(1,3-dioxan-2-yl)-ethylidenetriphenylphosphorane 
to give 2-cis-(2-octenyl)-1,3-dioxane (180) in an 86% 
yield. The 1,3-propanediol was trans acetalised with 
acidic methanol as the six-membered ring acetal has a 
high equilibrium stability, such that simple acid
(i) Q_  (ii)
CcH, , CHO  ►C^H1 , CH = CHCH^CH" \   ►C^H, , CH=CHCH-,CH( OMe ).
)— /5 11--  5 11 2 \  _ S  5 11 2 2u
(179) (180) (181)
(iii) (iv)
h =c h c h 2c h o  ------
(182) (183
C5HllCH  CHCH CHO - - - - - ------- ►C5 H 1 1 CH = CHCH2 CH = CHCH2 CH2 0 ^ ><^ 0 M e
v) (vi)
;=c h c h 2c h =c h c h 2c h 2o h -----
184) (185)
C.H._CH=CHCH_CH CHCH~CH~OH --►CcH1 .CH = CHCHnCH = CHCH-CH_OTs5 1 1  2 2 2  5 1 1  2 2 2
(vii) (viii) +
---------► C5H llCH=CHCH2CH=CHCH2CH2Br  ►C 5H 11CH=CHCH2CH=CHCH2CH2PPh3Br
(186) (175)
Reagents: (i) tBuOk, Hexane, 2-(1,3-Dioxan-2yl)-ethylidenetriphenyl
phosphorane, RT, (ii) PTSA, MeOH, (iii) AcOH, H20
(iv) MeO><b(CH2 )3PPh3Br”, ‘78° (v) THF/MeOH/H20
THF, nBuLi, HMPA 1:1:1
pH 4.0(HOAc),0 °




hydrolysis is unfavourable, to give (181). The dimethyl
acetal (181) was then hydrolysed at room temperature
in aqueous acetic acid to give the aldehyde (182). The
ir spectrum showed a carbonyl stretch (1730cm ^). The
^Hnmr spectrum indicated the presence of the aldehyde,
a triplet (J=2Hz) at 69.65. The double bond appeared
as two multiplets centred at 65.68 and 5.56. It was
assumed that we had the cis isomer by analogy with similar 
174examples. Unfortunately, it was at this point that 
the work had to be terminated.
5.7 Conclusion
From the work previously described it is clear that 
the work done has laid a firm foundation to the synthesis 
of a number of lipoxygenase inhibitors. The ozonylsis 
products of the TMS (162) and TBDMS (163) enol ethers 
are potentially versatile synthetic relay compounds for 
a large number of possible products and have laid the 
basis for future studies.
EXPERIMENTAL
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INSTRUMENTATION AND EXPERIMENTAL TECHNIQUES
Infrared (ir) spectra were recorded in the range 
4000-600cm  ^ using Perkin Elmer 197 and 1310 grating 
spectrophotometers, with 0.05mm polystyrene film as 
a calibration reference (1601.4cm  ^ absorption) and 
in the range 4000-400cm  ^ using Perkin-Elmer 983 Fourier 
transform spectrophotometer. Peaks are separated 
in wave numbers. Spectra of liquid samples were taken 
as thin films, or as solutions in CHCl^ or 
Spectra of solid samples were taken in CHCl^ solution.
Routine mass spectra from both electron ionization 
(E.I.) and chemical ionization (C.I. reagent gas 
isobutane), and high resolution accurate mass determina­
tions were recorded with a VG Analytical 7070E instrument 
with a VG2000 data system at an ionizing potential of 
70eV where possible. The molecular ion peak (M+ ) and 
base peak are indicated, as are all sizeable fragmenta­
tions .
Proton magnetic resonance (^Hnmr) spectra were
recorded at 60MHz on Hitachi Perkin-Elmer high resolution
R24B and Varian Anaspect EM360 spectrometers, on Jeol
13100MHz, 270MHz and 400MHz. Cnmr spectra were
determined with a Jeol FX90Q or GMNGXFT 270 spectrometer. 
1 13
H and Cnmr spectra were recorded, unless otherwise 
noted, in CDCl^, and are expressed in parts per million 
(6) downfield from internal tetramethylsilane. 
Multiplicities are given as follows: singlet (s),
doublet (d), triplet (t), quartet (q), and multiplet (m).
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Melting points (m.p.) were determined on commercially 
available apparatus (Gallenkamp) and are uncorrected. 
Elemental microanalyses were carried out using the Carlo 
Erba 1106 Elemental Analyser.
Thin layer chromatography (t.l.c.) was used 
extensively as a qualitative guide during reactions and 
for assessing purity of compounds. Art 5554 Merck DC- 
alufolien Kieselgel 60 ^ 2 5 4  an<  ^ 5550 Merck DC-
alufolien aluminiumoxide 60 neutral (Type E) sheets
containing fluorescent indicator were used for this 
purpose. Visualisation of reaction components was 
achieved by illumination under short wavelength (254nm) 
ultraviolet light, and developing with a 7% (W/V) methanol 
solution of dodeca-molybdophosphoric acid (PMA) followed 
by warming the t.l.c. plate.
Medium pressure flash column chromatography was 
routinely employed using Kieselgel 60 and 60H silica 
gel (Merck) for reaction component separations. Pressure 
was applied using commercially available hand bellows 
(Gallenkamp). In most cases, columns were prepared 
in petroleum ether (60-80°) and eluted with ethyl acetate 
petroleum ether mixtures of steadily increasing polarity. 
Material to be chromatographed was pre-adsorbed onto 
the column support and applied as a thin layer to the 
top of the column.
Dry column "flash" chromatography was carried out 
as follows: such columns were packed in a sintered
funnel, dry, and under suction of a water pump. They 
were pre-eluted with the least polar component of the
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eluent. During this procedure, constant coverage of 
the stationary phase with this solvent was maintained, 
until collection of solvent in the receiver vessel was 
seen. The column was then allowed to be sucked dry.
Sample mixture was loaded by either dissolving in a 
small amount of a suitable non polar solvent, preferably 
that used during pre-elution or by pre-adsorption.
The column was sucked dry, and the mixture eluted using 
appropriate constant volumes of eluent, and the fraction 
in the receiver isolated.
In those cases where reduced pressure distillation 
was difficult, if not destructive of the heavier compounds, 
or when column chromatography was particularly difficult, 
very pure samples were obtained by employing preparative, 
centrifugally accelerated thin-layer chromatography 
(Model 7924 Chromatotron) 2mm absorbent layer (silica 
gel PF254 *-YPe ^0 TLC from Merck) coated on circular 
plates was used for sample loadings of up to 300mg total 
sample.
Solvents were of SLR grade, unless otherwise stated.
Where water was used, this had been glass distilled
once. Anhydrous solvents had been distilled under dry
nitrogen and were stored over activated molecular sieves.
Other dry solvents were stirred with a drying agent
under reflux prior to distillation, as follows: DMF
(P 0 ), benzene (LAH). Tetrahydrofuran (THF) was pre- 
2 5
dried over sodium wire, then refluxed over sodium 
benzophenoneketyl under dry nitrogen until anhydrous.
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This was re-distilled immediately prior to use.
All other general reagents and solvents were purified
when required using the methods described by Perrin
. , 118 , .. , 119et al, and those m  Vogel.
Glassware used for reactions under anhydrous
conditions was baked in an oven at 120° for ca 12 hours
and allowed to cool in a dessicator over silica gel.
Flasks and stirring bars were, however, additionally
flame dried under dry nitrogen.
In all experiments, the excess solvent was evaporated
with a Buchi rotary evaporator by using water aspirator
reduced pressure. Residual traces of solvent were removed
on a manifold connected to an oil pump.
All temperatures are recorded in °C.
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1214-hydroxycyclohexanone (101)
A stirred solution of 1,4 cyclohexanediol (29g,
0.25mol) dissolved in acetone (1250ml) was cooled in
an ice bath. To this was added ice-cold, freshly prepared
Jones Reagent (30mls, 0.95 equivalent) over a 50 minute
period. Jones Reagent prepared as follows: to CrO^
(26.7g ) at ice-bath temperature, cF^SO^(23mls) was added
slowly and allowed to cool. The resultant solution was
made up to lOOmls with water, added slowly with stirring.
After addition of Jones Reagent, the green suspension
was allowed to warm to room temperature, with stirring
over a 20 minute period. The chromium salts were allowed
to settle and the acetone solution was decanted and twice
suction filtered through a bed of celite. Acetone was
removed on the rotary evaporator to yield a light green
oil (containing approx. 20% of diketone). Columned using
dry column "flash" chromatography with chloroform as
elutant gradually increasing methanol content from 0-5%.
This yielded a colourless oil (15.6g, 54%); v (thinJ max
film) 3380(-OH), 1690cm"1 (C=0); 6„(CDC1,) 4.08 (m,H *5
1H, CHOH) , 3.62 (br.s, 1H, CHOH), 2.82-1.76 (m, 8H‘, 
ring); 212.15 (s, C-l), 65.82 (d, C - 4 ) , 37.17 (t,
C - 2 , C - 6 ) , 33.64 (t, C-3, C-5); M/Z (70ev E.I.); 114
(M + , 100%), 73, 68, 60, 55, 54, 41, 39.
1218-hydroxy-1,4-dioxaspiro[4.5Idecane (102 )
To a magnetically stirred solution of crude (101) 
(27g, 0.24mol) in benzene (550mls) was added ethane-1,2-
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diol (14.9g, 0.24mol). The flask was equipped with a
Dean and Stark water separation apparatus and the reaction
mixture was refluxed for 14-22 hours until no more water
separated. The cooled reaction mixture was washed with
saturated KHCO^ (1 x 30ml) and the benzene layer separated
and dried (MgSO^). Benzene was evaporated to yield a
pale yellow oil (21.6g, 57%), which was used without
further purification. v (thin film) 3400 (-OH),
*  max ' '
1100 and 1030cm"1 (C-O-C); 5 (CDC1.,) 4.08 (1H, br.m,H J
CHOH), 3.9 (s, 4H, 0CH2CH20), 3.6 (br.m, 1H, CHOH),
2.0-1.7 (m, 8H, ring).
8-(2-propenyloxy) 1,4-dioxaspiro[4.5 ]decane (103)
A magnetically stirred slurry of sodium hydride 
(2.2g, 0.09) in dry DMF (lOOmls) was prepared as follows: 
sodium hydride, stabilised in mineral oil (3.7g) was 
added to a flame dried flask, which was stoppered with 
a septum and flushed with dry N2 . The mineral oil was 
next removed by washing with pentane (3 x 20mls) when 
the pentane had evaporated, the DMF was added. To this 
stirred slurry was added (102) (12.7g, 0.08mol), dissolved 
in dry DMF (lOmls), dropwise. After evolution of gas 
had ceased, dry potassium iodide (lOg) was added followed 
by the dropwise addition of allyl bromide (freshly distilled) 
(13.9g, 0.12mol) dissolved in dry DMF (lOmls). The 
reaction mixture was then stirred at room temperature 
for 10-15 hours. The mixture was then poured into water 
(500mls) and sodium chloride (50g) added. The mixture
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was extracted with ether (3 x 200mls) and dried (MgSO^).
Removal of the solvent yielded a yellow oil (ll.lg).
This was purified by dry column "flash" chromatography
(PE/EA, 5:1) to yield a colourless oil (10.6g, 67%)
Found: C,66.5; H,9.4 calc, for c n H i 8 ° 3 ' C,66.7; H,9.1%;
v (thin film) 1640vw (C=C), 1100 and 1030cm  ^ (C-O-C); max '
^^(CDCl^) 6.16-5.74 (m, 1H, ^ ,trans = 17Hz,
cis = 10Hz, a2 * _i * = 5Hz' = CH 2 )' 5.40-5.04 (t, 2 H #
CH = CH2 ), 4.01 ( s , 2H, OCH2CH), 3.92 (s, 4H, 0CH2CH20), 
3.46 (br.m, 1H, CHO), 2.00-1.40 (m, 8H, ring). 6C (CDC13 ) 
135.65 (d, C - 2 '), 116.04 (t, C - 3 ' ), 108.51 (s, C-4 ) ,
74.16 (d, C - 8 ), 68.96 (t, C-l'), 64.25 (t, C-2, C-3)
31.42 (t, C-6, C-10), 28.66 (t, C-7, C-9); M/Z (C.I. 
iBuH) 199 (M+1 , 100%), 141, 69, (70ev E.I.) 99, 86 ( 100%), 
41.
1228-(2-hydroxyethoxy) 1,4-dioxaspiro[4,5Idecane (104)
A magnetically stirred solution of (103) (7.7g, 
0.039mol), dissolved in chloroform (75ml) was cooled 
to -72 °C (IMS/CC>2 bath). Ozone was passed through the 
solution until the latter changed colour, from clear 
to pale blue, whereupon the solution was degassed with 
nitrogen and allowed to warm up to room temperature.
After a reflux condenser and a thermometer had been fitted 
to the reaction flask, a solution of sodium borohydride 
(11.8g, 0.31mol) in aqueous ethanol (50% V/V; 75mls) 
was slowly added to the stirred ozonide. The solution 
throughout was maintained at room temperature. Then
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the reaction mixture was warmed on a water bath (50°C)
for 2 h  hours with continued stirring, before being left
to stand, unstirred for 10-15 hours. The mixture was
neutralised with H2SO^ (10% w/v), the chloroform layer
separated, and the aqueous layer further extracted with
chloroform (3 x 75ml). The extracts were combined and
dried (MgSO^) and solvent was removed to yield a pale
yellow oil (7.1g, 93%). T.L.C. (EtOAC) indicated that
this was pure enough for next stage. However, a small
sample was columned ("flash" chromatography) for analysis
purposes; Found: C,59.38; H,8.99, calc, for c iqH 1 8 0 4 :
C ,59.41; H ,8.91%; v (thin film) 3460 (-OH), 1095,max ' '
and 1030cm-1 (O-C-O); 6H (CDC13 ) 3.93 (s, 4H, 0CH2CH20),
3.56 (m, 5 H , CHOCH2CH2 ), 2.46 (br.s, 1H, OH), 1.76 (m,
8 H , ring); 6C (CDC13 ) 108.46 (s, C-5), 75.25 (d, C - 8 ), 
69.45 (t, C-l'), 64.20 (t, C-2, C-3), 61.81 (t, C-2'),
31.37 (t, C - 6 , C-10), 28.55 (t, C-7, C - 9 ).
4-(2-hydroxyethoxy)-cyclohexanone (105)
Method A :
A solution of (104) (l.lg, 5.5mmol) dissolved in 
aqueous acetic acid (AcOH:H20 3:1 v/v; 30ml) was stirred 
magnetically for 18 hours at room temperature. The 
reaction mixture was then neutralised with aqueous sodium 
hydroxide (4M) before being extracted with ethyl acetate 
(2 x 30ml) and dried (MgSO^). Removal of solvent afforded 
a yellow oil (0.74g). This was vacuum distilled on a 




To a magnetically stirred solution of (104) (l.lg,
5.5mmol) dissolved in methanol (lOmls) at room temperature
was added perchloric acid solution (10%; 0.4ml). The
solution was left to stir for 1^ hours, after which it
was neutralised with sat. NaHCO^(aq) and freed of methanol
on a rotary evaporator. The residue was extracted with
DCM (3 x 20mls), the combined extracts were dried (MgSO^).
Removal of the solvent afforded a pale yellow oil (0.79g).
Vacuum distillation as in method A yielded a colourless
oil (0.61g, 70%); Found: C,60.6; H,9.0; calc, for
CqH. a O ~ ; C ,60.74, H ,8.92%, v (thin film), 3455 (- O H ), 8 14 3 max
1710cm"1 (C = 0 ); 5H (CDC13 ) 3.68 (m, 5H, CHOCH2CH2O H ),
2 .78-1 .55 (m, 9H, OH; ring); 6C (CDC13 ) 211.50 (s, C-l ) , 
73. 30 (d, C-4 ) , 69.78 (t, C-l'), 61.92 (t, C-2'), 37.11 
(t, C-2, C-6) , 30.50 (t, C-3, C-5); M/_Z (C.I., iBuH)
159 (M +1 ), 97 (100), 29.
4-(2-tosyloxyethoxy) cyclohexanone (106)
2g, (13mmol) of (105) inamhydrous pyridine (5ml) 
was added to p-toluenesulphonylchloride (2.56g, 13mol) 
in anhydrous pyridine (12ml). The solution was left 
stirring for 24 hours at 0° . Then H20(lml) was added 
and stirring continued for 30 minutes. The reaction 
mixture was diluted with ether (100ml) and the solution 
was washed with H20, dil H2SO^(aq) and NaHC03 (aq) and 
dried (MgS0 4 ). Removal of solvent gave a viscous yellow
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oil (3.64g, 95%), which solidified on standing for two
weeks. v (thin film) 1355, 1170, 940cm ^-sulphonate
max *
group. 6 (CDC1.,) 7.4 (q, 4H aromatics), 4.15 (m, 2H,H J
CH2O T s ), 3.5 (m, 3H, CHOCH2CH2O T s ), 2.1-1.3 (m, 8H, 
aliphatic ring).
8-(2-tosyloxyethoxy)-1,4-dioxaspiro[4.5]decane (107)
The ketal alcohol (104) (5.3g, 26mmol), dissolved
in anhydrous pyridine (lOmls), was added to a solution
in anhydrous pyridine (25mls) of p-toluenesulphonylchloride
(5.0g, 26mmol) which was magnetically stirred in a
temperature controlled IMS bath (0° ) for 24 hours.
The reaction mixture was diluted with ether (50ml), washed
with saturated CuSO^(aq) (3 x 100ml), water (2 x 100ml),
dried (Na2 SO^) and evaporated to yield a yellow oil
(7.4g, 91%) which was used for the next stage without
further purification. v (thin film) 1350, 1170 and 
*  max
920cm  ^ (S O ^ ) ; fi^CDCl^) 7.4 (q, 4H, aromatics), 4.1 
(m, 2 H , CH2OT s ), 3.9 (s, 4H, 0CH2CH20), 3.5 (m, 3H, 
CHOCH2CH2O T s ), 1.85-1.0 (m, 8 H , aliphatic ring).
1234-(2-bromoethoxy)-cyclohexanone ( 108)
A magnetically stirred solution of (107) (2.4g, 
6.7mmol) and LiBr (11.4g, 0.13mol) dissolved in Analar 
acetone (40mls) was refluxed for 48 hours. The cooled 
suspension was concentrated down on a rotary evaporator, 
diluted with ether (50mls), washed with water (50mls) 
and dried (MgSO^). Removal of solvent afforded a yellow
- 153 -
oil (1.6g). This was purified by chromatography (medium
pressure) to yield a colourless oil (0.98g, 66%); Found:
C,43.1; H,5.8 calc, for CgH^3BrC>2 : C,43.4, H f5.9;
v (CHCl^), 1710cm"1 (C=0); 6„(CDC1^) 3.84, (m, 3H,max j H j
CHO-CH2 ) 3.52 (t, 2 H , J ^6Hz, CH2B r ) , 2 .82-1 .64 (m, 8H, 
ring); 6 (CDClg) 210.68 (s, C-l), 73.14 (d, C - 4 ) , 68.42 
(t, C-l'), 37.00 (t, C-2'), 30.99 (t, C-2 C-6), 30.45
(t, C-3, C — 5); M/z (low ev E.I.) 220/2 (M+ , 39%), 141 
(100, M-Br), 113.
4-(2-mesyloxyethoxy)-cyclohexanone (109)
In a flame-dried flask continuously purged with 
dry nitrogen, a solution of (105) (175mg, l.lmmol) and 
DMAP (220mg, 2.2mmol) dissolved in dry DCM (10ml) was 
magnetically stirred. Methanesulphonyl chloride (320mg, 
2.8mmol) was added, followed by pyridine (440mg, 5.5mmol), 
whereupon the solution became cloudy. The reaction 
mixture was stirred for 2 hours before being diluted 
with DCM, washed with ice cold dil HC1 (0.1M, 2 x 15ml)
and ice cold H20 (2 x 15ml), and dried (MgSO^). Removal
of solvent afforded a pale yellow oil (280mg), which 
was purified by "flash" chromatography (PE/EA 1:1).
This yielded a colourless oil (234mg, 90%); S^(CDClg)
4.37 (br.m, 2H, CH2OMs), 3.78 (m, 3H, CHOCH2CH2O M s ),
3.04 (s, 3 H , CH3 ), 2.76-1.70 (m, 8H, ring). 6C (CDC13 ) 
210.41 (s, C-l), 73.62 (d, C-4), 69.34 (t, C-l'), 66.26
(t, C - 2 ' ) ,  37.54 (q, OMs), 36.95 (t, C-2, C-6), 30.34
(t, C-3, C - 5 ); M/Z (70ev E.I.) 236 (M + , 4%), 159,
141, 123, 96, 79, 68, 54, 41.
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Reaction of 4-(2-tosylethoxy) cyclohexanone (106) with 
KOBu*1 in THF120
Using flame dried equipment in an atmosphere of 
dry ^  , a slurry of KOBu*' (0.58g, 0.6mmol) was prepared 
in dry THF (10ml). To this was added slowly a solution 
of (106) (150mg, 0.5mmol) in THF (2ml). The mixture 
was stirred at 43-45° for 22 hours. The reaction was 
filtered, 10ml H 2 O added to the filtrate and the solvent 
removed. The residue was extracted several times with 
pentane, the extracts washed with sat. Na 2 SO^(aq) and 
dried (MgSO^). The solvent was then removed to yield 
40mg of an oil containing 4-(2-hydroxyethoxy)-cyclohexanone 
(105) and other unidentifiable products.
Reaction of 4-(2-tosylethoxy) cyclohexanone (106) with LDA
(106) (0.25g, 0.85mmol) in dry THF (2ml) was added 
dropwise to a solution of LDA (l.leq) at -78°C in an 
N 2  atm. The reaction mixture was stirred for h hr 
and then allowed to warm to room temperature. Quenched 
with NH^Cl(aq) (5ml) and freed of THF. The residue was 
dissolved in ethyl acetate, washed with water, brine, 
dried (MgSO^) and solvent evaporated to yield 90mg of 
a yellow oil of mainly starting material.
Reaction of 4-(2-tosylethoxy) cyclohexanone (106) with 
NaH in DME
To a stirred suspension under ^  at room temperature 
of NaH (40mg, 1.7mmol), freed from mineral oil by washing 
with pentane (3 x 10ml) in dry dimethoxyethane (10ml)
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was added dropwise over a period of 20 minutes a solution 
of (106) (200mg, 0.55mmol) in DME (5ml). The resulting 
mixture was heated under reflux for 20 hours. Upon cooling 
excess NaH was destroyed with ethanol, the reaction mixture 
was poured into ^ 0  (50ml), and extracted with ether 
(3 x 30ml). Combined ether extracts washed with H 2 O, 
brine, dried (MgSO^) and freed of solvent to give 30mg 
of an orange oil, which contained no identifiable product.
Reaction of 4-(2-tosylethoxy) cyclohexanone (106) with 
KOBu11 in But0H
To a stirred solution at room temperature in a 
N 2  atmosphere, (106) (250mg, 0.8mmol) in dry t-butyl- 
alcohol (10ml) was added dropwise over a period of 5 
minutes to a solution of KOBu*^(93mg, 0.83mmol) in dry 
t-butylalcohol (5ml). The resulting mixture was refluxed 
for 2 \ hours, cooled and poured into sat. brine (30ml).
The organic material was extracted with ether (3 x 20ml), 
washed with brine, dried (MgSO^) and solvent removed 
to yield 60mg of an orange oil. No identifiable product.
Reaction of 4-(2-bromoethoxyl)-cyclohexanone (108) with 
LDA
A solution of (108) (lOOmg, 0.45mmol) dissolved 
in dry THF (2ml) was added dropwise to a solution of 
LDA (l.leq) at -78°C. The reaction mixture was left 
to stir for an hour at -78°C and was then allowed to 
warm to room temperature and left stirring overnight. 
Reaction quenched with NH^Cl(aq) (2ml) followed by the
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removal of THF. The residue was taken up in ether (20ml) 
washed with water (5ml), brine (2 x 5ml) and dried 
(Na 2 SO^). Removal of solvent afforded a yellow oil (80mg), 
which was found to be mainly starting material.
Reaction of 4-(2-bromoethoxy)-cyclohexanone (108) with 
KOBu*1
In a flame dried flask continuously purged with
dry N 2  and fitted with a reflux condenser, ^BuOK (115mg,
lmmol) in dry benzene (10ml) was stirred magnetically.
A solution of (108) (150mg, 0.7mmol) in dry benzene (2ml) 
was added dropwise, leading to a change of colour of 
the reaction mixture, from clear to pale yellow. The 
stirred solution was refluxed for 2hours after which 
TLC (PE/EA 5:1) indicated the absence of any starting 
material. The reaction mixture was washed with brine 
(5ml) and dried (Na2 SO^). Removal of solvent afforded 
a yellow oil (60mg), which was found to be a complex 
mixture containing starting material.
Reaction of 4-(2-mesyloxyethoxy)-cyclohexanone (109) 
with KOBu*'
In a flame dried flask continuously purged with
dry N 2  and fitted with a reflux condenser, ^BuOK (90mg,
0.8mmol) and dry THF (10ml) was stirred magnetically.
A solution of (109) (lOOmg, 0.4mmol) in dry THF (2ml) 
was added dropwise. The solution remained clear for 
several seconds, then rapidly became yellow. The reaction 
mixture was refluxed for 10-15 hours. TLC (EA) indicated
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no remaining starting material. The reaction mixture 
was freed of THF and taken up in ether (20ml), washed 
with H 2 O (20ml) and dried (Na 2 SO^). Removal of solvent 
afforded a pale yellow solid (14mg), for which TLC 
indicated several components. Small scale column chroma­
tography (PE/EA 5:1) largely succeeded in the separation 
of these. However, no identifiable material was isolated.
1274-(chloroacetyloxy)-cyclohexanone (110)
A solution of (101) (3.7g, 33mmol) dissolved in
sodium dried ether (75ml) was stirred magnetically and
pyridine (2.9ml, 36mmol) was added, followed by chloro-
acetylchloride (3.1ml, 39mmol) dropwise. The solution
became cloudy on addition of chloroacetylchloride, then
yellow shortly afterwards. The reaction mixture was
left to stir for 4 hours. TLC (EA) indicated no starting
material. The reaction mixture was washed with dil.
HC1 (0.1M, 2 x 25ml) and brine (2 x 25ml) and dried (MgSO^).
Removal of solvent afforded a yellow solid (5.6g) which
was purified by flash chromatography (PE/EA, 5:1). This
yielded a white crystalline solid, 4.9g, 77%); mp. 58-
60°; Found: C, 50.10, H,5.79. C g H ^ O ^ C l  requires:
C , 50 . 39 ; H , 5 . 77% ; v (CHC1-J 1705cm"1 (C=0); <5 (CDC1,)' max 3 H 3
5.22 (m, 1H, CH) 4.10 (s, 2H, O^Cl ) ,  2.76-1.90 (m, 8H, 
ring). 6C (CDC13 ) 209.22 (s, C-l), 166.48 (s, C-l'),
70.48 (d, C-4), 40.85 (t, C - 2 ’) 36.73 (t, C-2, C-6),
29.90 (t, C-3, C-5); M/Z (C.I. iBuH) 191/3 (M+ 1 , 21%),
157, 97 (100).
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Reaction of 4-(chloroacetyloxy)-cyclohexanone (110) with 
LDA
A solution of (110) (770mg, 4mmol) in dry THF (5ml) 
was added dropwise to a solution of LDA (l.leq) in an 
N 2  atmosphere. The solution was stirred for 1 hour and 
then allowed to warm to room temperature. Reaction 
quenched with sat. NH^Cl(aq), evaporated, dissolved in 
ethyl acetate, washed with ^ O ,  brine, dried (Na 2 SO^) 
and evaporated to yield 310mg of a brown oil, which 
consisted of a complex mixture of which no useful data 
could be extracted.
Reaction of 4-(chloroacetyloxy)-cyclohexanone (110) with 
NaH
Sodium hydride (60% suspension in mineral oil)
(270mg, 12mmol) was washed three times with pentane (5ml). 
Dry DMF (4ml) was added to make a suspension. The reaction 
was conducted in an inert atmosphere (^ ). (110) (200mg,
llmmol) was dissolved in DMF (1ml) and added dropwise 
to the suspension. The reaction was stirred at room 
temperature and followed by TLC. Complex mixture obtained.
Reaction of 4-(chloroacetyloxy)-cyclohexanone (110) 
with DBU
(110) (lOOmg, 0.53mmol) was dissolved in dry DCM 
(5ml) in an atmosphere of dry ^ . DBU (0.16ml, 0.0106mol) 
was added dropwise and then stirred for 1 hour. Directly 
columned (silica) using ether as the elutant to yield
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^50mg of a colourless oil, which was 4-hydroxycyclo- 
hexanone (101).
Reaction of 4-(chloroacetyloxy)-cyclohexanone (110) 
with pyridine
(110) (lOOmg, 0.53mmol) was dissolved in dry pyridine 
(2ml) and refluxed for 1 hour. It was then partitioned 
between ethyl acetate and dil. HC1, washed with brine, 
dried and evaporated to yield ^20mg of a pale yellow 
oil, which was found to be 4-hydroxycyclohexanone (101).
Reaction of 4-(chloroacetyloxy)-cyclohexanone (110) with 
KOtBu
In a flame dried flask continuously purged with 
dry ^  and fitted with a reflux condenser, KO^Bu (496mg, 
4.42mmol) in anhydrous THF (50ml) was stirred magnetically. 
To this was added a solution of (110) (765mg, 4.02mmol).
The stirred solution was refluxed for 2 hours after which 
the reaction was quenched with H 2 O (5ml). The reaction 
mixture was freed of THF and taken up in Et20 (30ml), 
washed with *^0, brine and dried (Na 2 SC>4 ). Removal of 
ether gave a viscous, deep orange-red oil (450mg).
T.L.C. (PE/EA, 5:1) indicated seven components. These 
were separated using gradient elution "flash" chromato­
graphy (PE/EA from 5:1 to 1:1), producing six yellow 
oils and a pale yellow solid, which was shown to be starting 
material. Component 1, (first off column) 43mg, 
unidentifiable. Component 2, 57mg, starting material.
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Component 3, 29mgf unidentifiable. Component 4, 23mg
2-oxabicyclo[3.3.1]non-3,6 dione (111), v (CHC10 )---------------------------------------------  max j
1740, 1710 (C=0), 1280 (C-O-C); 6„(CDC1.J 5.15 (m, 1H),
2.6-1.8 (m, 9H ). M/Z (70ev, E.I.) 154(M+ ), 109 (M-C02 ),
97 (100), 96, 83, 80, 69, 57, 41. Component 5, 120mg
unidentifiable. Component 6, 35mg 4-hydroxycyclohexanone
(mainly). Component 7, 15mg v (CHC1Q ) 3520(-OH), 3150max o
(acid-OH), 2240, 1710 (C=0), 1420, 1280cm'1 , 6h (CDC13 )
5.1 (m, 1H), 3.4 (br.s, 1H, -OH), 2.6-1.8 (m, 10H).
M/Z (70 ev. E.I.) 172 (M+ ), 115, 97 (100), 96, 83, 69,
55, 41.
12 84-tertbutyldimethylsiloxycyclohexanone (116)
A solution of (101) (3.37g, 0.03mol), t-butyldimethyl- 
chlorosilane (5.47g, 0.036mol) and imidazole (5.1g,
0.075mol) in dry DMF (10ml) was stirred for 48 hours 
at room temperature under a silica gel drying tube.
The mixture was then poured into H 20 and extracted several 
times with ether. The ether extracts were back extracted 
with H20, dried (Na2SO^), and evaporated to yield 6.6g 
(96%), columned using dry column "flash" chromatography: 
PE/EA 10:1 to yield 6.15g (90%) vmax (thin film); 1710 
(C=0), 1260, 1110, 1050cm'1 ; 5 H (CDC13 ) 4.15 (q, 1H,
CHOTBDMS), 3.0-1.7 (m, 8H), 0.95 (S, 9H, Si-C(CH3 )3 ,
0.15 (s, 6H, Si-(CH3 )2 ; 6C (CDC13 ) 216.26 (s, C-l), 70.86
(d, C-4), 41.77 (t, C-2, C-6), 39.06 (t, C-3, C - 5 ) , 30.66 
(q, (CH3 )3 ), 22.92 (s, C(CH3 )3 ), -4.6 (q, Si-(CH3 )2 );
M/Z (C.I. iBuH) 229 (M+ 1 ), 171, 97.
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2 -t-butyldimethylsiloxyethylchloride
A solution of 2-chloroethanol (5g, 0.062mol), 
t-butyldimethylchlorosilane (9.35g, 0.074mol) and imidazole 
(10.57g, 0.16mol) in dry DMF (15ml) was stirred for 48 
hours at room temperature under a silica gel drying tube. 
The mixture was then poured into water and extracted 
several times with ether. The ether extracts were back 
extracted with H 2 0 , dried (Na2 SO^), and evaporated to 
yield a pale yellow oil, which was columned using dry 
column "flash" chromatography (PE/EA, 5:1) to yield 10.46g 
(87%) of a colourless oil. 6 (CDCl..) 3.88 (t, 1H, J, =
H J
7Hz, CH 2 C1), 3.52 (t, 1H, J, = 6 Hz, CH 2 OTBDMS), 0.95 
(s, 9 H , SiC(CH3 )3 ), 0.15 (s, 6 H, Si(CH3 )2 ); SC (CDC13 )
69.02 (t, C-2), 50.33 (t, C-l), 31.01 (q, C(CH3 )3 ), 23.62 
(s, C(CH3 )3 ), -4. 6 (q , Si-(CH3 )2 . M/Z (C.I. iBuH) 197/195 
(M + ), 137, 91, 83.
Reaction of 4-tertbutyldimethylsiloxycyclohexanone (116) 
with 2-tertbutyldimethylsiloxyethylchloride with LDA
A solution of (116) (500mg, 2.2mmol) in dry THF 
(2 ml) was added dropwise via a canula to a solution of 
LDA (l.leq) at -78°C, stirred for % hr, 2-t-butyl- 
dimethylsiloxyethylchloride (430mg, 2.2mmol) in THF (2ml) 
was added dropwise via a canula. The solution was allowed 
to warm to room temperature, quenched with H 2 0, THF 
evaporated off, partitioned between H 2 0  and ethyl acetate, 
washed with brine, dried (Na2 S0 ^) and evaporated to 
yield 710mg of a slightly yellow oil, which was fov^ d 
to be only starting material.
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Reaction of 4-t-butyldimethylsiloxycyclohexanone (116) 
and 2-t-butyldimethylsiloxyethylchloride with KOBu 1  in THF
Under a N 2  atmosphere using flame dried apparatus 
a slurry of KOBu 1  (300mg, 2.7mmol) was prepared in dry 
THF (10ml). To this was added dropwise a solution of 
(116) (500mg, 2.2mmol) in dry THF (2ml). The solution 
was stirred for 1 0  minutes and then 2 -t-butyldimethyl- 
siloxyethylchloride (430mg, 2.2mmol) in dry THF (2ml) 
was added dropwise. The mixture was stirred at 40-45° 
for 24 hours. Only starting materials were recovered.
4-t-butyldimethylsiloxy 2-(2 1 -propenyl)cyclohexanone (117)
A solution of LDA (l.leq) was made and cooled to 
-78°C, where HMPT (0.6ml) was added and allowed to stir 
for 15 minutes. A solution of (116) (500mg, 2.2mmol) 
in dry THF (3mls), which had been azeotroped (x 3) with 
CCI 4  was added to the LDA solution and allowed to stir 
for 30 minutes. Allylbromide (distilled) (0.2ml,
2.2mmol) in THF (2ml) was added dropwise. The solution 
was allowed to warm up to room temperature and stirred 
overnight. Quenched with water THF evaporated and residue 
dissolved in ethyl acetate, washed with brine, dried 
(NA 2 SO^) and evaporated to yield 520mg. "Flash" chromato­
graphy using PE/EA (20:1) to yield 420mg (71%) as a mixture 
of cis and trans isomers. Found: C,67.1, H,10.5, calc.
for C.. (-H^O-Si: C,67.4, H,10.2; (thin film) 1711
1 j z o z max
(C=0), 1639cm"1 (C=C); 6H (CDC13 ) 5.65 (m, 1H, -CH = CH2 ) ,
5.1 (m, 1H, CH=CH2 ), 4.95 (m, 1H, CH=CH2 ), 4.15 (m, 1H,
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CHOTBDMS), 2.9-1.7 (m, 9 H ), 0.95 (s, 9H, Si-C(CH3 )3 ), 
0.15 (s, 6 H , Si-(CH3 )2 ); 6C (CDC13 ) 212.61 (s),
210.94 (s), 136.33 (d), 136.04 (d), 116.55 (t)f
116.20 (t), 69.32 (d), 65.60 (d), 46.76 (d), 43.87 (d),
40.84 (t)f 40.44 (t), 38.34 (t), 36.77 (t), 35.47 (t),
35.02 (t), 33.77 (t ), 33.04 (t), 25.76 (q), 18.09 (s),
18.04 (s), -4.87 (q), -4.68 (q); M/52 (iso-BuH C.I.)
269 (M+ 1 ), 211, 177, 137, (100%) 133.
4-t-butyldimethylsiloxy 2 — (2 * ethanal) cyclohexanone 
129(118)
Osmium tetraoxide (^20mg in 1.5ml ^BuOH solution) 
was added to a mixture of (117) (250mg, 9.5mmol), ether 
(8 ml) and H 2 0  (8 ml) and the mixture was stirred at room 
temperature for 10 minutes. Then powdered sodium meta­
periodate (450mg, 21mmol) was added over a 30 minute 
period and stirring was continued for 2.5 hours at R.T.
The mixture was poured into H20 (50ml) and extracted 
with ether (3 x 30ml). The organic extract was dried 
(Na 2 SO^) and evaporated to yield 470mg of a dark brown 
oil. Columned (medium pressure) PE/EA, 20:1 to yield
160mg (62%) of a colourless oil. Found: C,62.29; H,9.74.
calc, for C. „ H_ ,.0-Si : C,62.18, H,9.69%. v 1710,14 z. o J max
1695cm"1 (C=0), 6„(CDC1^) 9.8 (m, 1H, CHO), 4.15 (m,H o —
1H, CHOTBDMS), 3.0-1 . 8  (m, 9 H ), 0.95 (s, 9H, Si-C(CH3 )3 )
0.15 (s, 6 H , Si(CH3 )2 ); M/Z (C.I., iBuH) 271 (M+ 1 ),




Sodium borohydride (lOmg, 0.18mmol) in absolute
ethanol (5ml) was added to (118) (200mg, 0.74mmol) in
THF (10ml). Solution stirred for 1 hour at R.T. and
then poured into 2NHC1 (5ml) and extracted with ether
(3 x 10ml), washed with H 2 O (1 x 10ml), brine (1 x 10ml),
dried (MgSO^) and evaporated to yield 153mg. Columned
(medium pressure) PE/EA, 1:1 to yield 108mg (53%) of
4-t-butyldimethylsiloxy 2-(2'-hydroxy ethyl) cyclohexanone
and 33mg (16%) of 4-t-butyldimethylsiloxy 2-( 2 1-hydroxy
ethyl) cyclohexanol as a colourless oil. Found: C,61.38,
H,11.31. calc, for C^H^gO^Si: C,61.26; H,11.02%.
v (film) 3450 (-OH). 6U (CDC1-,) 4.15 (m, 1H) , 3.6max H
(m, 3H, CH 2 OH), 3.4 (br.s, 1H, OH), 2.3-1 . 6  (m, 10H),
0.95 (s, 9 H , Si-C(Me)3 ), 0.15 (s, 6 H, Si-(CH3 )2 ).
4-t-butyldimethylsiloxy 2-(2'-hydroxyethyl)
130cyclohexanone (119)
Et^N (0.55mmol, 0.08ml) in dry THF (5ml) under 
N 2  was added to formic acid (0.83mmol, 0.031ml), solution 
cooled at room temperature, RuCl^Ph^)^ (0.03mmol, 0.4%) 
added and allowed to evolve gas. 3 minutes later (118) 
(0.55mmol, 150mg) was added and stirred for approx. 30 
minutes. Solution was then neutralised with 2NHC1, THF 
evaporated and residue dissolved in ether, washed with 
H 2 <D, dried (Na 2 SO^) and evaporated to give 155mg of a 
colourless oil. Columned (medium pressure) PE/EA 5:1
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to give H O m g  (73%) of a colourless oil. Found: C,61.82;
H, 10.43. calc, for C 1 ylHnoO_Si: 0,61.72; H,10.36%. v14 28 3 ' max
(film) 3450 (-OH)f 1705cm"1 (C=0), 6 (CDC1,) 4.15(m, 1H,H J
CHOTBDMS), 3.7 (m, 3H, CH 2 O H ) , 2.5-1 . 6  (m, 9H), 0.95 
(s, 9 H , Si-C(Me)3 ), 0.15 (s, 6 H, Si-(CH3 )2 ). M/Z (C.I. 
iBu H ) 273 (M+1 ), 215, 141.
1324-hydroxy 2-(2 1 -hydroxyethyl) cyclohexanone (120)
(119) (150mg, 0.55mmol) was dissolved in anhydrous
THF (5ml) and tetrabutylammonium fluoride (0.16ml, 1. 6 m m o l )
was added and the solution stirred for 1 hour. THF
evaporated off and the residue dissolved in ether and
washed with brine, dried (Na 2 SO^) and evaporated to yield
8 6 mg. Columned (medium pressure) PE/EA, 1:3 to yield
54mg (54%) of a colourless oil. Found: C,60.61, H,9.02.
calc, for C QH . . ;  C,60.74, H,8.92%? v (CHC1,) 3455 
8  14 3 ' max 3
( - O H ) , 1710 (C=0), 6 (CDC1-3) , 4.05 (m, 1H, CHOH) , 3.7
a  j —
(m, 3 H , CH 2 OH), 3.5 (br.s, 1H, OH), 2.5-1 . 6  (m, 9H);
M/Z (C.I. iBuH) 159 (M+ 1 ), 97.
4-hydroxy 2-(2 1 hydroxyethyl) cyclohexanone (120) with
133triphenyl phosphine and diethyl azodicarboxylate (DEAD)
To a cooled solution of (120) (40mg, 0.25mmol), 
and triphenylphosphine (67mg, 0.25mmol) in anhydrous 
CDC 1 3  ( 1 ml) was added dropwise with stirring diethyl- 
azodicarboxylate (60mg, 0.34mmol) under an atmosphere 
of dry N2 . ' Hnmr of reaction mixture gave no indication
of product.
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1, 5-Dichloropentan-3-one (12 5 )
3-chloropropionylchloride (124) (500g, 3.94mol) 
was added slowly to a stirred suspension of powdered 
anhydrous aluminium chloride (735g, 5.5mol) in DCM 
(550ml), contained in a cooled (ice-water bath) three­
necked flask (31). Ethylene gas (dried over KOH and 
anhydrous CaSO^) was bubbled into the reaction mixture, 
which was allowed to warm to 20°. The reaction was 
monitored by i.r. to ascertain completion. (A small 
quantity [y 0 .1 ml) of the mixture was treated with water 
(0.1ml), organic layer separated, dried (MgSO^) and i.r. 
spectrum run, comparison of carbonyl stretching; starting 
material 1790cm product 1718cm 1 ). The products were 
then slowly added to a cooled (ice-salt bath) mixture 
of dichloromethane (500ml), HC1 and ice (21 of aqueous 
layer; ca 1M with respect to HC1), so that the temperature 
did not rise above 20° . The organic layer was separated,
washed with water (3 x 21) and dried (MgSO^). The solvent 
was then evaporated under reduced pressure to yield crude
1.5 dichloropentan-3-one (540g, 8 8 %) as a dark brown 
o i l .
v = 1718cm"1 ; 6 „(CDC10 ) 3.73 (t, J=6.5Hz, 4H),max h j
3.5 (t, J= 6 .5Hz, 4 H ).
135Tetrahydro-4H-pyran-4-one (121)
A 31 three-necked round-bottomed flask, fitted with 
an efficient mechanical stirrer, a reflux condenser and
- 167 -
a 250ml dropping funnel was charged with sodiumdihydrogen 
phosphate dihydrate (624g, 4mol), 8 8 % orthophosphoric 
acid (196g, 1.76mol) and water (1.251). The reaction 
vessel was immersed in a water bath and heated until 
the temperature of its contents reached 100°. Crude 
1,5-dichloropentan-3-one (125) (310g, 2mol) was placed 
in the dropping funnel and added dropwise over a period 
of 75min to the vigorously stirred aqueous solution, 
which was maintained at 100° ± 3°. The temperature of 
the reactants was maintained at 1 0 0 ° for a further 1 2 0 min 
and was then cooled to 0°. 10M sodium hydroxide (aq)
(o,650ml) was then added slowly to the cooled products 
(ice/water bath) until the pH had risen to 5-6. The 
neutralised products were decanted from the tarry residue 
and extracted with dichloromethane (500ml + 2x250ml).
The combined extracts were dried (MgSO^) concentrated 
under reduced pressure (rotary evaporator) and the 
pale brown residual liquid rapidly distilled under reduced 
pressure to yield a colourless liquid. Tetrahydro-4H- 
pyran-4-one (91g, 45%); b.p. 58 /12mm ( l i t , ^ ^  59-60 , 
13mmHg).
v (thin film) 1719cm  ^ (C=0). <5 (CDC1-,) 3.98max /  H o
(t, 3H , J= 6 H z . CH 2 -0-CH2 ), 2.51 (t, 3H, J= 6 Hz-CH 2 ~C-
c h 2 ).
G.L.C. (CPSIL-5, 80°) 98.5% pure.
2 , 3-Dihydro-4-morpholino-2H-pyran (129 )
Under a N 2  atmosphere, a mixture of tetrahydro-4H- 
pyran-4-one (121) (3g, 0.03mol), morpholine (2.55g,
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0.06mol) and benzene (30ml) were refluxed. Water was 
separated by means of a Dean and Stark apparatus (%4hrs). 
Solvent removed on rotary evaporator. Residue distilled 
on Kugelrohr to yield 4.65g (92%) of a white crystalline
o 1 6 9  ° k
solid (mp 42-43 ) (lit, b.p. 62-64 at 0.1mm Hg ) .
v (thin film) 1650 (NC = C), 1450cm"1 (C-O-C); 5„(CDC1,)max \ n j
4.58 (t, 1H, J=3Hz, C=CH), 4.20 (m, 2H, C=CCH 2 0), 3.73 
(m, 6 H , CH 2 OCH 2  and CH 2 0), 2.81 (m, 4H, CH 2 NCH2 ), 2.13 
(m, 2 H , CH 2 C=C).
142
6 -morpholino 3-oxabicyclo[ 3.3.l]nonan-9-one (133)
Acrolein (0.54g, 0.65ml) was added over 30min to 
a solution of (129) (1.64g, 9.8mmol) in benzene (30ml),
o
maintained at 0 . Stirring of the cold solution was
continued for an additional lhr, after which the mixture
was heated at reflux for 3 h r s . The benzene was evaporated
and the product collected by distillation on the Kugelrohr
(b.p. 120 , 0.15mm Hg) to yield 1.62g (74%) of a pale
yellow oil as a mixture of exo and endo isomers [G.C.
(71.29) OV column 175 ]. Found: C r64.12f H,8.43
N,6.32, ^ 1 2 ^ 1 9 ^ 3  requires: C,63.98, H,8.50, N,6.22%.
. \
v a (thin film) 1717cm"1 (C=0), 5U (CDC1,) 4.2-3 . 6max y  h j
(m, 8 H , CH 2 OCH2 , CH 2 OCH2 ), 2.85 (m, 1H, CH-N), 2.5 (m,
4 H , CH 2 NCH2 ), 2.3-1 . 8  (m, 6 H). M/Z (70ev. E.I.) 225 
(M + ), 126 (1 0 0 %), 28.
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6-morpholino 3-oxabicyclo[3.3.1]nonane (134)
(133) (0.5g, 2.2mmol) was refluxed with 0.36ml 
hydrazine (99-100%) and potassium hydroxide (0.42g) in 
triethylene glycol (5ml) for 1.5hrs. Then the mixture
o
was distilled until a bottom temperature of 190 was 
reached. The residue was then refluxed for 3 h r s . The 
residue and distillate were combined and diluted with 
(10ml), extracted with ether (3x20ml), washed with 
brine (2x30ml), dried (MgSC>4 ), solvent evaporated
o
and product distilled on the Kugelrohr (120 , 0.3mmHg)
to yield 0.33g (72%) of a pale green oil, which was a 
mixture of exo and endo isomers. CG.C.(91.9) OV column 
175°]. Found: C,67.90, H,10.01, N,6.59, C 1 2 h 2 iN 0 2
requires C,68.21, H,10.02, N,6.63%. ^(CD C l ^ )  4.2-3 . 6  
(m, 8 H , CH 2 OCH2 , CH 2 OCH2 ), 2.85 (m, 1H, CH-N), 2.5 (m,
4 H , CH 2 -N-CH2 ), 2.3-1 . 6  (m, 8 H ). M/Z (70ev E.I.) 211 
(M + ), 126 (100%), 100,87.
142N-oxide of 6 -morpholino 3-oxabicyclo [3.3.1]nonane (135)
To a solution of (134) (150mg, 0.7mmol), ethanol 
(1.5ml), methanol (1.5ml) was added 30% H 2 0 2  (1ml).
o
The resulting solution was heated at 70-72 for 36 hours. 
The excess H 2 0 2  was decomposed by stirring the solution 
for 8  hours in the presence of platinum black, filtered 
and evaporated to give a colourless viscous syrup. This
o
was dried at 80 (1 mm) to give a colourless crystalline
solid.
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Pyrrolysis of the N-oxide of 6-morpholino 3-oxabicyclo
[ 3 . 3 .11 nonane (135)^ ^
Apparatus was set up for simple distillation, flushed 
with nitrogen, and heated slowly. At 115° liquification 
occurred. After lhr at 115° the flask was heated at 
150° for 3 h r s . However, examination of the distillate 
and residue showed no traces of the desired product.
N-oxide of 6 -morpholino 3-oxabicyclo[3.3.1]nonane (135)
o . 1 4 1with 4A molecular sieves m  THF
Hydrated (135) (lOOmg) was dissolved in dry THF 
(10ml), 4A molecular sieves were added and the H 2 O was
removed at 80 . The solution was left at this temperature
for 24hrs. It was then diluted with ether, filtered 
evaporated to yield 60mg of a yellow oil, which contained 
none of the desired compound.
N-oxide of 6 -morpholino 3-oxabicyclo[3.3.1]nonane (135)
0 141with 4A molecular sieves in DMSO
Hydrated (135) (140mg) was dissolved in dry DMSO
o
(10ml), 4A molecular sieves were added and the solution
stirred at room temperature for 24hr. It was then diluted
with ether, filtered, washed with water, dried (MgSO^) 
and evaporated to yield 80mg of a yellow oil, which 
contained none of the desired compound.
- 171 -
2,3-Dihydro-4-pyrrolidinyl-2H-pyran (122)
In an N 2  atmosphere, a mixture of (121) (120g, 1.2mol),
pyrrolidine (272ml) was refluxed in benzene (800mls).
Water was separated by means of a Dean-Stark trap. After
water had ceased to separate, the benzene was evaporated
off and the residue azeotroped twice with benzene to
remove excess pyrrolidine to yield 172g (94%), which
was used without purification.
v (CHCIt) 1645 (C=C), 1450cm-1 (C-O-C); 5U (CDC1,J max o y  H j
4.6 (t, 1H, J=3Hz, C=CH), 4.2 (m, 2H), 3.8 (m, 2H), 2.81
(m, 4 H , CH 2 NCH2 ), 2.2-1 . 8  (m, 5H).
Exo and endo 6 -hydroxy 3-oxabicycloT3.3.1]nonan-9-one 
(147) and (148)
(122) (4.39g, 0.029mol) was dissolved in THF (75ml)
and purged with N2 . The solution was stirred in an N 2
o
atmosphere and cooled to below 1 0  , H 2 0  (0 .8 ml) was added, 
followed immediately by acrolein (2.9ml, 0.044mol) dropwise. 
The reaction was stirred at room temperature for 2hr, 
after which dilute HC1 was added until pHl-2 had been 
reached. The reaction was then stirred for 30min, after 
which ether was added and stirring continued for lOmin.
The batch was allowed to settle for 10-15min, after which 
the aqueous layer was run off. The aqueous layer was 
extracted with ether (3x50ml). The organic layer was 
washed with H20 (1x50ml), brine (1x50ml). Each of these 
washes was back extracted with the ether extracts used 
for the main aqueous. Ether extracts were combined,
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dried (MgS04), the solvent evaporated to yield 2.6g
(57%) of 6 -hydroxy 3-oxabicyclo [3.3.1]nonan-9-one as a
mixture of exo and endo isomers. [G.C. (1:1) OV column
175°C.] Isomers separated on the Chromatotron (PE/EA, 2:1)
Endo isomer (148) eluted first as a colourless oil
Endo isomer: v (CHC10 ) 3460, 3450 (-OH) , 1720 (XC=0),----------------  max j /
1080cm'1 . 6 (CDCl-j) 4.6 (septet, 1H, CHOH) , 4.27 (dt,
H J —
1 H ' J2e-2a = n -28Hz' J 2  = !- 6 Hz), 4.18 (dt, 1H, J4e_4a 
= 11.72Hz, J 2  = 1.5Hz), 3.88 (dt, 1H, J 2 a-2e = 13-*28Hz'
J 2  = 2.1Hz), 3.83 (dd, 1H, J4a_4e = 11.72Hz, J 2  = 2.8Hz), 
2.75 (m, 1H), 2.48 (octet, 1H), 2.375 (m, 2H), 2.10 (m, 1H), 
1.74 (m, 1H), 1.72 (m, 1H, -OH). 6C (CDC13 ) 212.65 (s,
C-9 ), 74 .96 (d, C- 6 ), 74 .48 (t, C-2 ), 68.70 (t, C-4 ) ,
57.41 (d, C-5), 48.46 (d, C-l), 30.44 (t, C - 7 ), 27.246
(t, C- 8 ). M/Z (70ev. E.I.) 156 (M+ ), 138, 111, 97, 83,
71, 55, 54, 41, 28, 27. M/Z 156.0781 (M, 44%, calculated
for CgH 1 2 0 3  156.0786).
Exo isomer (147) after further elution as colourless
crystals, m.p. 184.5-185 ° . Exo isomer: v (CHC1-,)■ max *3
3460, 3450 (-OH), 1720 fc=0), 1080cm'1 . 6U (CDC1^) 4.6
/ H j
(dt, 1H, J4e_4a = 11.56Hz, J 2  = 1.48Hz), 4.2 (dt, 1H,
J2e-2a = 1]--32Hz' J 2  = 1.6Hz), 4.. 11 (m, 1H, CHOH), 3.91
(dt, 1H, 32a_2e = 11.32Hz), 3.73 (dq, 1H, J4a_4e = 11.56Hz,
J 2  = 2.4Hz, J3  = 1.1Hz), 2.57-2.45 (m, 2H), 2.35 (septet,
1H), 2.11 (m, 1H), 2.02 (m, 1H), 1.83-1.79 (m, 2H).
5c (CDC13 ) 214.11 (s, C-9), 76.53 (d, C- 6 ), 75.67 (t, C-2),
70.94 (t, C-4), 57.38 (d, C-5), 49.87 (d, C-l), 29.22
(t, C-7 and 8 ). M/Z (70ev.E.I.) 156 (M+), 138, 111,
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97, 83, 71, 55, 54, 41, 28, 27 M/Z (E.I.) 156.0785 (M, 
32%, calculated for ^gH ^2 ° 3  156.0786).
The acidic aqueous layer was basified, extracted 
with ether (3x30ml), washed with H20 (30ml), brine (30ml) 
to yield 0.84g of a gum which was filtered through silica 
gel to yield 0.15g of 6 -pyrrolidinyl 3-oxabicyclo[3.3.1]
nonan-9-one (123) as a mixture of exo and endo isomers.
v (thin film) 1726cm-  ^ (C=0), S^tCDCl,,) 4.2-3.7 (m, max /  rl j
4 H , CH 2 -0-CH2 ), 2.9 (m, 1H), 2.5 (m, 4H, CH 2 -N-CH2 ) 2.3-
1.6 (m, 10H). M/Z (70ev.E.I.) 209 (M+ ), 126 (100%).
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14 6
6-oxo 3-oxabicycloC3.3.1]non-6-ene (Method A) (149)
(147) and ( 148) (200mg/ 1.3minol) in ether (3ml) 
was cooled in an ice/salt bath and added dropwise via 
a cannula to a cooled (ice/salt bath) solution of ct^SO^ 
(1.2ml) over a period of 30 minutes. Then stirred for 
1 hour, solution poured into ice (6 g) extracted with 
ether (3x20ml), washed with (10ml), brine (10ml),
dried (Na2 S0 ^) and filtered through a column of Florisil 
to yield 26mg (16%) of a colourless waxy solid.
6 -oxo 3-oxabicycloC3.3.1lnon- 6 -ene (Method B) (149)
(147) and (148) (lOOmg, 0.65mmol) was dissolved 
in 85% phosphoric acid (2ml) and heated at 150° for l^hr. 
The cooled reaction mixture was diluted with 1^0 and 
extracted with pentane, washed with sodium carbonate 
(a q ), brine (2x15ml) and dried (Na 2 S0 ^) and evaporated 
to give a yellow oil (30mg), which contained product 
with several other components.
14 8
6 -oxo 3-oxabicyclo[3.3.1]non- 6 -ene (Method C) (149)
A solution of (153) (lOOmg, 0.42mmol) in glacial 
acetic acid (10ml of 0.5M sodium acetate to which 1% 
acetic anhydride had been added) was placed in a stoppered 
flask and thermostatted at 50° for 24hr. The cooled 
mixture was poured onto ice-water (30ml), extracted with 
pentane (3x30ml), and the combined extracts washed once 
with H^O, then with sat sodium hydrogen carbonate solution
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until no further carbon dioxide evolution was observed. 
The pentane solution was then dried (Na^SO^) and pentane 
evaporated to yield a yellow oil (20mg), columned (PE/EA, 
5:1) to yield 16mg (27%).
6-oxo 3-oxabicyclo[3.3.1]non-6-ene (Method D) (149)
(153) (200mg, 0.84mmol) was dissolved in collidine 
(4ml) and refluxed for 20 hr. The cooled solution was 
acidified with cHCl (congo red), extracted with ether 
(3x20ml), dried (MgSO^) and evaporated to yield a yellow 
oil (70mg), columned ( PE/EA, 5:1) to yield 49mg (42%).
6-ox o 3-oxabicyclo [3 . 3 .1] non-6-ene (Method E) (149)^ ^
(154) (700mg, 4mmol), LiBr (1.04g, 12mmol), Li^CO^ 
(890mg, 12mmol) were dissolved in dry DMF (10ml) under
o
an atmosphere. The solution was stirred at 150 for
5hr, then poured into H^O (30ml), extracted with 
ether (3x20ml), washed with brine and dried (Na^SO^) 
and evaporated to yield 600mgs of a yellow oil. Flash 
chromatography (PE/EA, 5:1) yielded 370mg (67%) of a 
waxy colourless solid.
150
6-oxo 3-oxabicyclo[3.3.1]non-6-ene (Method F) (149)
(152) (lg, 5mmol), LiCl (0.55g, 13mmol) and Li^CO^ 
(0.5g, 6.8mmol) were dissolved in N-methyl pyrrolidone 
(5ml) under an atmosphere. Using an oil bath, the 
temperature was slowly raised to 85° and then heated 
at this temperature for 2 hr, then cooled, poured into
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H 20» and extracted with ether (3x20ml), washed with brine,
dried (Na2SO^) and azeotroped with CCl^ (3x25ml) to yield
1.2g of a brown oil. Flash chromatography (PE/EA, 5:1)
to yield 480mg (70%). v (CH-C1-) 3031 (=CHSt), 1728max z z
(C=0), 1648cm”1 (C = CSt) <5H (CDC13 ) 6.01 (dt, 1H, J1 = 9.5Hz,
J2=3.3Hz , = CH (C-6)), 5.7 (qt , 1H, J 1=9.5Hz, J2=6Hz,
J3=1.9Hz , =CH (C-7)), 4.15 (dt, 1H , J4e_4a=11•2Hz,
J0 = 1.8 H z ), 3.94 (dt, 1H, J- _ =10.8Hz, J_ = 1.83Hz), 3.79 
z z e — z a z
(dd, 1H, J„ „ =11.2Hz, J~ = l.46Hz), 3.71 (dd, 1H, J_ . =  4a-4e 2 2a-2e
10.8Hz, J2=1.83H z ), 2.81 (m, 3H, CH2~CH=CH and =CH-CH 
(bridgehead)), 2.54 (m, 1H, bridgehead). <5^(CDC13 )
210.58 (s, C-9), 131.01 (d, C-6), 125.08 (d, C-7), 76.81 
(t, C-4), 72.25 (t, C-2), 50.16 (d, C-5), 48.45 (d, C-l),
36.58 (t, C - 8 ) . M/Z (70ev. E.I.) 138 (M+ , 100%), 108,
79. M/Z 138.0673 (M, 100%, calculated for CgH1()02
138.0679 ) .
Reaction of exo and endo 6-hydroxy 3-oxabicycloC3.3.1]
nonan-9-one (147) and (148) with phosphorus oxychloride
^ 147and pyridine
A solution of (147) and (148) (200mg, 1.3mmol) in 
dry benzene (2ml) was added to a stirred solution of 
phosphorus oxychloride (0.18ml, 1.9mmol) and pyridine 
(1.54ml, 1.9mmol) in dry benzene under N2 at room 
temperature overnight. The reaction quenched with H20 
(10ml), washed with sat CuS04 (aq), brine and dried 
(MgSO^) and evaporated to yield 180mg of a yellow oil. 
Columned (PE/EA, 5:1) to yield 40mg of a waxy solid, 
3-oxabicyclo [3.3.1]non-6-en~9-one (149); 60mg of endo
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6-chloro 3-oxabicyclo[ 3.3.1]nonan-9-one(151); v -------------------- i-------------------------  max
(CHC1-) 1720cm"1 (C=0), 6U (CDC1^) 4.82 (sextet, 1H,j s  H j
C H C 1 ), 4.28 (dt, 1H, JGEM=11.5Hz, J2=1.5Hz), 4.24 (dt,
1H , Jg e m =12Hz , J2=1.5Hz ), 3.90 (dt, 1H, JGEM=11.5Hz, 
J2=2.2H z ), 3.86 (dd, 1H, Jg e m =12Hz , J2=2.75Hz ), 3.08 
(m, 1H), 2.7 (m, 1H), 2.44 (m, 1H), 2.15 (m, 2H), 2.0
(m, 1H). 6c (CDC13 ) 210.12 (s, C-9), 76.69 (t, C-2),
74.42 (t, C-4), 61.92 (d, C-6), 56.87 (d, C-5), 49.44
(d, C-l), 28.56 (t, C-7), 27.73 (t, C-8). M/Z (70 ev.
E.I.) 176/174 (M + ), 139, 109, 81, 67, 55 (100).
Found: C,54.91; H,6.42. C g H ^ C l C ^  requires C,55.02;
H,6.35%; 60mg of exo 6-chloro 3-oxabicyclo [3.3.1]nonan-
9-one (150). v__ (CHC1.,) 1720cm'1 (NC=0), 6tf(CDCln )------ max j / H j
4.73 (dt, 1H, JGEM=12Hz, J2=1.5H z ), 4.35 (m, 1H, CHC1), 
4.23 (dt, 1H, Jg e m =11.36Hz , J2=1.6Hz ), 3.92 (dt, 1H,
JGEM = 12Hz' J2= 2 *2Hz)/ 3 , 7 9  (dt' 1 H ' JGEM = il-SHz),
2.88 (m, 1H),2.64 (m, 1H) , 2.4 (m, 1H) , 2.2 (m, 2H) ,
I.9 (m, 1H). 6 c (CDCI3 ) 210.16 (s, C-9), 76.65 (t, C-2),
72.76 (t, C-4), 64.92 (d, C- 6 ), 57.88 (d, C-5), 48.81
(d, C-l), 32.15 (t, C-7), 29.77 (t, C- 8 ). M/Z (70ev. E.I.)
176/174 (M+ ) , 138 (100), 109, 81, 55. Found: C, 55.12;
H, 6 . 29 , C8H h C102 rec3u:i-res C,55.02; H,6.35%.
6-nitrooxy 3-oxabicyclo[3 . 3 .1 ]nonan-9-one (152) 1')^ >
Fuming HNO^ (19.1ml) was added to acetic anhydride 
(39ml) whilst cooling in an IMS/CO^ bath, keeping the 
temperature below -25°. Stirred for lOmin, after which 
(147) and (148) (2.3g, 14.7mmol) in acetic anhydride
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(2ml) was added dropwise, stirred for l-2hr (followed
by T L C ) and then poured into and stirred overnight
(to decompose acetic anhydride), extracted with ether
(3x30ml), washed with brine, dried (Na2S0^) and evaporated
to yield an orange oil. Columned (PE/EA, 4:1) to yield
2.8g (78%) of colourless crystals as a mixture of exo
and endo isomers. (Recrystallised PE/EA) M.P. 65.9-67.0 ,
v (CH-Cl- ) 1735 (SC=0), 1629 (NO- st as), 1219cm"1max A A /  A
(NO 2  st sy). S ^ C D C l ^ )  5.62 (m, 1H, CHONO 2 , equatorial), 
5.25 (m, 1H, CH0N02 , axial), 4.28 (m, 4H, O ^ O O ^ ) , 3.94 
(m, 4 H , CH2OCH2 ), 2.8 (m, 4H), 2.5-1.8 (m, 8 H ) . Found: 
C,47.71, H,5.55, N,6.82. C8H 11N<^ 5 re(3ulres C,47.76,
H , 5 . 51, N ,6.96%.
3-oxabicyclo[3.3.1]nonan-6-yl methane sulphonate-9-one(153)
To a stirred solution of (147) and (148) (200mg,
I.3mmol), Et^N (0.26ml, 1.8mmol) in dry DCM (5ml) at
0° was added dropwise over 15min a solution of methane 
sulphonylchloride (0.12ml, 1.6mmol) in dry DCM (2ml).
The resulting solution was stirred for 2hr at 0° . The
reaction was quenched with H^O. The organic phase was 
separated, washed with 2MHCL, brine and dried (MgSO^). 
Evaporation of solvent gave 310mg of a yellow oil.
Columned (PE/EA, 3:1 ) to give the mesylate as a waxy 
solid (260mg, 86%) as a mixture of exo and endo isomers 
(1 :1 ).
v (CHC1-) 1720cm-1 6„(CDC1-) 5.2 (m, 1H, CHOMsmax 3 H 3 —
(E q H )), 4.3 (m, 1H, CHOMs (A x H )), 4.1-3.6 (m, 4H, C ^ -
- 179 -
0-CH2 ), 3.0 (s , 3H, -S02CH3 )/ 2.7 (m, 1H)# 2.4 (m, 2H),
2.2-1.8 (m, 4 H ). M/Z (70ev. E.I.) 234 (M+ ), 138 (100%),
109, 79, 55 (100%). M/Z (E.I.) 234.0556 (M, 7.5%
calculated for C n H ,  .Or- S 234 .0561 ).9 14 5
6-bromo 3-oxabicyclo[3.3.1lnonan-9-one (154)
(153) (1.9g, 8.1mmol) and lithium bromide (1.7g,
19.4mmol) were heated under reflux in analar acetone
(30ml) for 48hr. The suspension was concentrated, then
diluted with ether, washed with H20, brine and dried
(MgSO^) and evaporated to give 1.28g of a brown oil,
passed through a column of Florisil to yield 1.14g (64%)
of a yellow oil as a mixture of exo and endo isomers.
v (thin film) 1710cm“l (C=0); 5„(CDC1^) 4.91 (sextet,max /  H j
1H, CHBr, equatorial), 4.75 (dt, 1H, CH20), 4.45 (m,
1H, CHBr, axial), 4.31-4.22 (m, 3H, CH20) 4.0-3.8 (m,
4 H , CH20), 3.21-2.95 (m, 2H), 2.8 ( m, 1H), 2.7 (m, 1H), 
2.45 (m, 3 H ), 2.3-1.9 (m, 3 H ). M/Z (70ev. E.I.) 221/
219 (M + ), 139 (100), 109, 81, 55. Found: C,43.95;
H,5.13, CgH^BrC>2 requires C,43.86; H, 5.06%.
Ethylenethioketal of 6-hydroxy 3-oxabicyclo[3.3.1]nonan- 
9-one (155)
To a 0° solution of (147) and (148) (9.5g, 0.061mol) 
and ethanedithiol (9.5ml, 0.09mol) in N2 atmosphere in 
dry DCM (20ml) was added BFg.Et20 (1.9ml, 0.012mol) 
dropwise. The reaction mixture was stirred for 20min, 
warmed to room temperature and stirred an additional
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2hr. The solvent evaporated and the residue columned 
(Dry column "flash" chromatography, PE/EA, 10:1) directly 
to yield 12.2g (86%) of a colourless oil as a mixture 
of exo and endo isomers. 6„(CDC10 ) 4.18 (m, 1H), 4.17-
4.06 (m, 2 H ), 3.95 (m, 1H), 3.87 (m, 1H), 3.88 (dd, 1H),
3.35-3.13 (m, 4H, -S-CH2-CH2~ S ) , 2.47 (m, 1H), 2.31 
(m, 1H), 2.05 (m, 1H), 1.91 (m, 2H), 1.72 (m, 1H). M/Z 
(70ev. E.I.) 232 (M+ ), 214 (100%), 131, 105. Found: 
C,51.74, H,6.91. ^ioH 18°2^2 re<3u i-res C,51.69, H,6.94%.
Exo and endo 6-hydroxy 3-oxabicyclo[3.3.1Jnonane (156) 
and (157 ) Method A.153
(155) (700mg, 3mmol), hydrazine hydrate (98%) (3ml), 
potassium hydroxide (1.4g, 2 parts by weight) dissolved 
in Trigol (10ml). These were heated in a simple 
distillation apparatus, when the internal temperature 
reached the range 90-135° , evolution of gas occurred.
o
Heating was continued until the temperature reached 190 
and maintained at that temperature until final completion. 
Reaction followed by t.l.c. Reaction cooled, diluted 
with brine, extracted with ether (6x30ml), washed with 
brine, dried (Na2SO^) and evaporated to yield 230mg of 
a yellow oil. Columned (medium pressure) PE/EA. 2:1 
to give 120mg (28%) of a colourless oil as a mixture 
of exo and endo isomers (1:1).
- 181 -
Exo and endo 6-hydroxy 3-oxabicycloC3.3.1]nonane (156) 
and (157) Method
Liquid NH^ (50ml) was introduced into a 100ml three 
necked flask equipped with dry ice condenser. With 
stirring under ^ , sodium metal (50mg) was added giving 
the solution a dark blue colour. After 15 min, the colour 
remained indicating the liq NH^ and the apparatus to 
be dry. So with cooling in a dry ice/IMS bath, the sodium 
(1.47, 0.064mol) was added over a period of 5min, then 
stirring continued for 30min. (155) (1.65g, 0.0071mol) 
was added in anhydrous THF (5ml) over lOmin, keeping 
internal temp at approximately -40° . Stirring was 
continued at this temperature for l^hr. Then dry aceto- 
nitrile (4ml) was introduced (care-effervescence) 
over lOmin, the cooling bath was removed and the liq 
NH^ allowed to evaporate. H 2 O (20ml) added and then 
residue extracted with ether (3x50ml), dried (Na 2 SO^) 
and evaporated to give 430mg (43%) of a colourless oil 
as a mixture of exo and endo isomers.
Exo and endo 6-hydroxy 3-oxabicyclo[3.3.1 Inonane (156) 
and (157 ) Method C155
Raney nickel (W-2), (50% slurry in (pH-10))
was washed with until neutral, then 95% ethanol
(3x50ml), absolute ethanol (3x50ml). Approx. 7g Raney 
nickel was suspended in absolute ethanol (30ml), (155)
(lg, 4.3mmol) in absolute ethanol (5ml) was added and 
the resulting solution refluxed for 30min. The solution
- 182 -
was filtered and passed through a small plug of Florisil 
to yield 460mg (76%) as a colourless oil, which was a 
mixture of exo and endo isomers in an approximately 1:1 
ratio. Separated by flash chromatography (PE/EA, 4:1). 
Endo isomer eluted first as a colourless oil.
Endo isomer: v (CHC1-,) 3460, 3450 (-OH) , 1080cm ^--------------  max 3
6h (CDC13 ) 4.09 (m, 1H, CHOH), 3.88 (dt, 1H, JG£M=11Hz ), 
J2=2Hz ), 3.83 (dt, 1H, JGEM=11.5Hz, J2=2Hz), 3.74 (dt,
1 H ' JGEM=11Hz' J2 = 2Hz )• 3 -71 <d d ' 1H ' JGEM=11 * 5 H z 1 2 *6Hz>' 
2.49 (m, 1H), 2.13 (m, 1H), 1.8 (m, 1H), 1.7 (m, 2H),
1.6 (m, 3 H ) , 1.4 (m, 1H, CHOH). <5C (CDC13 ) 73.38 (t,
C-2), 70.58 (d, C-6), 69.56 (t, C-4), 36.33 (d, C-5)
31.14 (t, C-9) 30.91 (t, C-7), 29.34 (d, C-l) 28.33
(t, C-8). M/Z (70ev. E.I.) 142 (M+ ), 124, 92, 79, 67,
55, 41. Found: C,67.72 ; H,9.89. C8H 14°2 re<3uires
C,67.67%, H ,9.93%.
Exo isomer: v (CHC1-,) 3460, 3450 (-OH) , 1080cm ^-------------  max 3
6h (CDC13 ) 4.19 (dt, 1H, JGEM=11.8Hz, J2=1.5Hz), 3.98 
(m, 1H, CHOH), 3.85 (dt, 1H, JG£M=11Hz , J2=2Hz), 3.71 
(dt, 1H, Jg e m =11Hz , J2=2.15Hz ), 3.6(dq, 1H, JGEM=11.8Hz, 
J2=2.3Hz , J3=1.15Hz ), 2.45 (m, 1H), 2.18 (m, 1H), 1.9 
(m, 2 H ), 1.7 (m, 1H), 1.6 (m, 2H), 1.5 (bs, 1H, CHOH).
6c (CDC13 ) 73.04 (t, C-2), 72.91 (d, C-6), 66.48 (t, C-4),
36.14 (d, C-5), 31.76 (t, C-9), 30.32 (t, C-7), 29.39
(t, C-8), 28.55 (d, C-l). M/Z (70ev. E.I.) 142 (M+ ),
124, 92, 79, 67, 55, 41. Found: C,67.73; H,9.91.




Pyridiniumchlorochromate (910mg, 4.2mmol) was suspended
in DCM (5ml) and (156) and (157) (400mg, 2.8mmol) in
DCM (2ml) was rapidly added at R.T. The solution became
briefly homogeneous before depositing the black insoluble
reduced reagent. After l-2hr the oxidation followed
by t.l.c. was complete. The black reaction mixture was
diluted with 5 volumes of anhydrous ether, the solvent
decanted and the black solid washed twice with ether.
Product was isolated simply by filtration of the organic
extracts through Florisil and evaporation of the solvent
at reduced pressure to yield 310mg (79%) of a colourless
_1 \ .
waxy oil/solid. v (CHC1-,) 1705cm (C=0), <5 (CDCl^)max si ^ n o
4.03 (d, 1H, JGEM= H  .2Hz) , 3.91 (dt, 1H, JGEM=11.4Hz, 
J2=2.2H z ), 3.84 (dt, 1H, J =11.4Hz, J2=2.2Hz), 3.72 
(dd, 1H, J__=11.4Hz, J_ = 2.2Hz), 2.85 (m, 1H), 2.55 
(m, 2 H ), 2.2-1.95 (m, 5H). 6C (CDC13 ) 213.86 (s, C-6),
73.84 (t, C-2), 69.40 (t, C-4), 47.18 (d, C-5), 40.57
(t, C-7), 31.76 (t, C-9), 29.72 (t, C-8), 28.63 (d, C-l).
M/Z (iBuH. C.I.) 141 (M +1 ), 95, 81. Found: C,68.16;
H,8.72. ^8^12^2 re<3u ^res: C,68.55; H,8.63%.
Ethylene thioketal of 3-oxabicycloE3.3.1 ]non-6-en-9- 
one (159 )
To a 0° solution of (149) (200mg, 1.45mmol) and 
ethanedithiol (0.2ml, 1.9mmol) in N2 atmosphere in dry 
DCM (5ml) was added B F ^ . E ^ O  (0.08ml, 0.5mmol) dropwise. 
The reaction mixture was stirred for 20min, warmed to
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room temperature and stirred an additional 2hr. The
solvent was evaporated and the residue columned (PE/EA,
10:1) directly to yield 240mg (77%) of a colourless oil.
v ( CHC1-,) 3030 ( =CHs t ) , 1650cm-1 (C = Cst) 6„(CDC1-,)max 3 H 3
6.0-5.7 (m, 2H, CH=CH), 4.05 (m, 2H, CH20), 3.8 (m, 2H, 
CH20), 3.4 (m, 4 H , -SCH2CH2S-), 2.85 (m, 3H, CH2 
-CH=CH and =CH-CH (bridgehead), 2.5 (m, 1H, bridgehead). 
M/Z (70ev. E.I.) 214(M+ ), 131, 105, 91. Found: C,55.79,
H,6.43. ^10^14^^2 rec5u -^res C,56.04, H,6.58%.
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3-oxabicycloC 3 . 3 .1 ]non-6-ene (28) Method
To a solution of (149) (200mg, 1.5mmol), KOH (200mg) 
in diethylene glycol (5ml) was added 0.2ml of 98% hydrazine 
hydrate. After refluxing for lhr, the apparatus was 
set up for a distillation, and distilled until the
O o
temperature had reached 195 -200 . Then refluxing was 
continued for 3hrs. Distillate and residue combined 
and poured into ice/F^O, acidified and then extracted 
with ether, washed with brine, dried (MgSO^) and evaporated 
to yield 130mg of a yellow oil. Columned (medium pressure) 
PE/EA 5:1 to yield 23mg (12%) of a colourless oil.
15 7
3-oxabicycloC3.3.1Jnon-6-ene (28) Method B
(161) (llOmg, 0.5mmol) was dissolved in freshly 
distilled DBU (0.25ml, 1.6mmol) in an N2 atmosphere. 
Solution heated at 70° for 2hr. The solution was cooled 
and diluted with DCM (10ml), washed with 1^0 ( 10ml),
MH2S04 (10ml) and H20 (10ml), dried (Na2SC>4 ) and 
evaporated. Residue dissolved in ether and passed down 
a column of Florisil to yield 24mg (39%) of a colourless 
o i l .
158
3-oxabicyclo[3.3.1]non-6-ene (28) Method C
(158) (lOOmg, 0.72mmol) in anhydrous ether (1ml) 
was added to a rapidly stirred suspension of zinc (dust) 
(480mg, 7.2mmol) and chlorotrimethylsilane (400mg, 3.6mmol) 
in anhydrous ether (10ml). Then placed in a temperature 
controlled oil bath (40°) for 72hr. Solution cooled, 
mixture filtered and the etheral solution washed with
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NaHCO-j (aq) and dried (Na^SO^) to yield 60mg of a slightly
yellow oil. Columned (medium pressure) PE/EA, 5:1 to
yield 37mg (41%) of a colourless oil. v (CHCl^) 3030max
(=CHSt) , 1640cm"1 (C=CSt), 6„ (CDC1-) 5.9 (m, 1H, = CH),H o  —
5.6 (m, 1H, =CH), 4.05-3.6 (m, 4H, CH2OCH2 ), 2.45 
(m, 1H), 2.3 (m, 2H), 1.95 (m# 3H). M/Z (70ev E.I.)
124 (M + ), 93, 92, 67. M/Z 124.0879 (M, 100%, 
calculated for C g H ^ O  124 .0887).
Attempted desulphurisation of the ethylene thioketal 
of 3-oxabicyclo[3.3.1]non-6-en-9-one (159)
Raney nickel (W-2), (50% slurry in H20 (pH-10))
was washed with H2<D until neutral, then 95% ethanol (3x 
20ml), and then refluxed in analar acetone for 3hrs. 
Solvent exchanged with absolute ethanol. Approx 1.5g 
Raney nickel was suspended in absolute ethanol (10ml),
(159) (140mg, 0.65mmol) in absolute ethanol (1ml) was 
added and the resulting solution refluxed for 30min.
The solution was filtered and passed through a small 
plug of Florisil to yield 40mg of a mixture of 3- 
oxabicyclo[3.3.1 Inonane (160) and 3-oxabicyclo[3.3.1 ] 
non-6-ene (28).
3-oxabicyclo[3.3.1 ]nonan-6-yl methane sulphonate (161)
A solution of (156) and (157) (180mg, 1.3mmol),
MsCl (0.25mls, 3.2mmol) and dimethylaminopyridine (25mg, 
2.0mmol) in dry DCM (lOmls) was stirred under N 2 and 
pyridine (0.53mls, 6.5mmol) was added dropwise. The 
solution was left stirring for 3 hours, then diluted
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with DCM (20mls), washed with cold 0.1M HC1 (2x30ml), 
cold (2x30ml), dried (Na 2 S0 ^) and solvent evaporated
to yield 300mg of a brown/yellow oil. Columned (medium 
pressure chromatography) PE/EA, 4:1 to yield 230mg (80%) 
of a colourless oil.
6 h (CDC13 ) 5.01 (m, 1H, CHOMs (Eq H)), 4.22 (m,
1H, CHOMs (Ax H ) ) , 3.91-3.62 (m, 4H, a^-O-C}^), 3.03 
(s , 3H, -S02CH3 ), 2.6 (m, 1H), 2.2-1.9 (m, 5H), 1.8-1.6 
(m, 3 H ). M/Z (70ev E.I.) 124, 79 (100) M/Z (iBuH 
C.I.) 219 (M-l), 125 ( 100) .
1596-(Trimethyl siloxy)-3-oxabicyclo[3.3.1]non-7-ene (162)
A solution of (158) (540mg, 3.9mmol) in dry DMF
(6ml) and triethylamine (1.3ml, 9.4mmol) was treated
with chlorotrimethylsilane (0.6ml, 4.7mmol) and the
resulting slurry refluxed for 20hr. The cooled mixture
was diluted with pentane and washed with cold 5% sodium
bicarbonate and ^ O .  The pentane was dried and evaporated
to yield 550mgs of a yellow oil. Distilled on the
Kugelrohr (0.1mm/90°) to give 460mg (56%) of a colourless
oil. v (CHC1-,) 1650cm*1 (C = CSt). 6U ( CDC1-, ) 4.8 max o n o
(t, 1H, =CH, J = 3Hz), 3.8-3.4 (m, 4H), 2.5 (m, 1H) 2.1 
(m, 2 H ), 1.8 (m, 3H), 0.15 (s, 9H, SiMe3 ), M/Z (70ev 
E.I.) 212 (M+ ), 105, 75, 73, 59. M/Z (E.I.) 212.1245 




A solution of (158) (400mg, 2.8mmol) in dry THF 
(5ml) was added dropwise using a canula to a solution 
of LDA (l.leq) at -78° in a dry ^  atmosphere. The 
solution was stirred at -78° for 30min and then HMPA 
(0.8ml) and TBDMSC1 (484mg, 3.2mmol) in THF (5ml) were 
added dropwise. The yellow solution was then left to 
warm to room temperature (cooling bath removed) and pentane 
(50ml) was added after 15min. The solution was washed 
with H 2 O, brine and dried (MgSO^), solvent evaporated, 
azeotroped with CCl^ (3x30ml) to give 870mg of a yellow 
oil. Columned on neutral alumina (10.1) to give 410mg 
(58%) of a colourless oil.
6-(t-butyldimethylsiloxy)-3-oxabicyclo[3.3.l]non-7-ene 
(163) (Method B)161
TBDMS triflate (1.3mls, 7.4mmol) was added to
a solution of (158) 0.5g, 3.7mmol) and 2,6-lutidine
(0.63mls, 0.056moles) in DCM (5mls) in a atmosphere.
The reaction was monitored by t.l.c. (alumina) and when
complete, diluted with DCM (lOmls), washed with cold
sodium bicarbonate (1x10ml), CuSO^ (aq) (1x10ml). Organic
layer dried (Na SO,) and concentrated on rotary evaporator, 
2 4
the residue was taken up in dry ether, separated from
any insoluble material and evaporated to yield l.lg.
Columned on neutral alumina using 5% ether in Pet ether
(30-40°) containing 1 drop of pyridine as elutant to
give 890mgs (95%) of a colourless oil. v (thin film)
max
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1660cm"1 (C=CSt) (CDC13 ) 5(t, 1H, = CH, J=3Hz), 3.81,
(d , 1H, Jg e m =10.8Hz ) 3.75 (d, 1H, JGEM=10.6Hz), 3.65
(d, 1H, Jg e m =11Hz ), 3.45 (d d , 1H, JGEM=10.6Hzf J2=1.84Hz).
2.4 (d d , 1H), 2.10-2.00 (m, H) 1.9 (m, 3H), 0.95 (s,
9 H , Si(tBu)), 0.15 (s, 6H, Si(Me2 )) 6C (CDC13 ) 155.01 
(s, C-6), 108.96 (d# C-7 ) , 79.69 (t, C-4 ) 72.52 (t, C - 2 ) ,
41.42 (d, C-5), 34.36 (t, C-8), 34.23 (t, C-9), 34.21
(s, -C(CH3 )3 ), 32.77 (d , C-l), 30.24 (q, (CH3 )3 ), -4.67 
(q, Si-(CH3 )2 ). M/Z (70ev E.I.) 254 (M+ ), 197, 105,
75, 73, 59. M/Z (E.I.) 254.1697 (M, 28%, calculated
for c 14H26°2Si 254-1700)-
3-oxabicyclo[3.3.1]nonan-6-one (158) with 2,2-dimethoxy
162propane and p-toluene sulphonic acid
(158) (170mg, 1.2mmol) was dissolved in dry DMF (1ml)
and 2,2-dimethoxypropane (1ml). PTSA (5mg) in dry methanol
(0.05ml) were added and the resulting solution refluxed
for 3ishrs. Columned (PE/EA, 8:1) to yield 15mg of a
colourless oil, which was the methyl enol ether of 3-
oxabicyclo[ 3 . 3 .1 ]non-6-one (165). v (CHCl-.) 1640cm 1max j
(C=CSt). 6h (CDC13 ) 4.7 (t, 1H, =CH, J=3Hz), 3.9 (d,
1H, Jg e m =11Hz ), 3.77 (d, 1H, JGEM=10.7Hz), 3.64 (d, 1H,
JGEM=11Hz)' 3,5 (dd' 1H' JGEM=1° •7Hz)» 3 *45 3H  ^ c H 3 ),
2.5 (m, 1H), 2.3-2.15 (m, 3H ), 2.0 (m, 3H). M/Z (70ev
E.I.) 154 (M + ) 124, 95, 71, 55, 41. M/Z (E.I.) 154.0998
(M, 23% , calculated for C g H ^ 0 2 154.0994 ). Further 
elution gave 6,6-dimethoxy 3-oxabicyclo[3.3.1Dnonane 
( 164 ) 105mg as a colourless oil. <$G (CDC13 ) 4.0 (d,
1H, JGEM = 11 • 4Hz) , 3.86 (d, 1H, JGEj4=11Hz ), 3.69 (d, 3q e M =
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11Hz), 3.57 (dd, 1H, JGEM=11.4Hz, J2=2.4Hz) 3.19 (s,
3 H , CH3 ), 3.15 (s, 3 H , CH3 ) , 2.26 (m, 1H), 1.85 (m, 3H),
1.73 (m, 3 H ), 1.61 (m, 1H). 6C (CDC13 ) 101.57 (s, C-6),
73 .27 (t, C-2 ), 67.86 (t, C-4 ) , 47 .26 (q, OCH3 ), 47.15 
(d, C-5), 47.10 (q, OCH3 ), 34.80 (d, C-l), 30.46 (t,
C-9) 28.97 (t, C-7), 27.77 (t, C-8). M/Z (70ev E.I.)
185 (M-l), 153, 123, 95, 71, 55, 41.
5-(2-formylmethyl)-3-tetrahydropyranmethyl t-butyldimethyl 
siloxy carbonyl (167)1*^
(163) (500mg, 20mmol) was dissolved in analar methanol 
(10ml) and analar DCM (8ml) and was cooled to -78°.
Ozone was passed through until starch-iodine paper 
indicated the presence of excess oxidant as the blue 
colouration was not sufficient to show that the reaction 
had gone to completion. On completion the reaction mixture 
was treated with dimethyl sulphide (0.5ml) and allowed 
to warm to room temperature. Evaporation and then 
extraction with PE (30-40°) and H20. PE extracts washed 
with H20, dried (MgSO^) and evaporated to yield 540mg 
of a colourless oil. All attempts at purification proved 
unsuccessful. Spectral data on crude compound. max
(CHC1-,) 1700cm-1 (C=0) , 6„(CDC1,) 9.75 (m, 1H, CHO,j / H O  —
aldehyde), 4.15 (m, 1H, CH20), 3.85 (m, 1H, CH20), 3.36 
(m, 1H, CH20), 2.95 (m, 1H, CH20), 2.7 (m, 1H, CH COOTBDMS),
2.35-2.00 (m, 3H, CH2CHO and CHCH2CHO (bridgehead), 1.7-
1.6 (m, 2 H ), 0.95 (s, 9H, Si(tBu)), 0.15 (s, 6H, Si(Me2 )). 
M/Z (iBuH C.I.) 285 (M+ ), 255, 227, 211, 171, 155, 143,
127 (100) 113.
- 191 -
Attempted preparation of 5-(2-formylmethyl)-3-tetrahydro 
pyrancarboxylic acid (166)
(167) (lOOmg, 0.35mmol) was dissolved in anhydrous 
THF (5ml) and tetrabutylammoniumfluoride (0.1ml, lmmol) 
was added and the solution stirred for lhr. THF evaporated 
off and the residue dissolved in ether and washed with 
brine, dried (Na 2 SO^) and evaporated to yield none of 
the desired product.
5-(2-formylmethyl)-3-tetrahydropyran carboxylic acid 
(166) Method A ~^^
(162) (450mg, 21mmol) was dissolved in analar methanol 
(15ml), and analar DCM (12ml) and was cooled to -78°.
Ozone was passed through until starch-iodine paper 
indicated the presence of excess oxidant. On completion 
the reaction mixture was treated with dimethyl sulphide 
(0.5ml) and allowed to warm to room temperature. Solvent 
evaporated to yield 340mg (94%) of a colourless oil. 
Columned (medium pressure) (PE/EA, 1:1 + 1% formic acid) 
to give a white solid (290mg, 81%).
5-(2-formylmethyl)-3-tetrahydropyran carboxylic acid 
(166) Method B 132
(167) (440mg, 15mmol) was stirred in acetic acid 
(3ml), H 2 O (1ml) and THF (1ml) for 20hr at 25°. The 
THF was evaporated and the residue dissolved in ether 
and stirred vigorously for an hour. Washed with brine 
and then brine back extracted with ether. Organic extracts
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dried (Na2SO^) and evaporated to yield 280mg of a slightly
yellow oil. Columned (medium pressure) (PE/EA, 1:1 +
1% formic acid) to give a white solid (210mg, 81%) m.p.
127-128°. v (CHCl.,) 3500-3000 (broad) (COOH St), max 3
1700cm~l (NC=0). 6 (CDC1-J 9.9 (m, 1H, CHO, aldehyde),
^  H  j
9.0 (br. s, 1H, COOH), 4.19 (m, 1H, C-2, Heq), 3.94 (m,
1H, C - 6 , Heq), 3.35 (m, 1H, C-2, H a x ), 3.05 (m, 1H, C-6, 
Hax), 2.75 (m, 1H, CH-COOH (bridgehead), 2.35 (m, 1H, 
CHCH2CHO (bridgehead) 2.31 (m, 2H, CHCH2CHO), 1.4 (q,
2 H , CHCH2CH). M/Z (iBuH C.I.) 171 (M-iflOO), 153, 129, 
111. Found C, 55.76, H,7.12. C8H 12°4 re(3u ires 0,55.81,
H ,7 .02 %.
5-( 2-formylmethyl)-3-tetrahydropyran methylmethoxy 
carbonyl (168)^ ^
Diazomethane was prepared in the following way. 
N-methyl-N-nitrosotoluene-p-sulphonamide (4.18g) was 
dissolved in anhydrous ether (60ml), cooled in ice and 
a solution of potassium hydroxide (0.8g) in 95% ethanol 
(20ml) was added dropwise and was left standing for 5min, 
after which the etheral diazomethane solution was 
distilled until the ether distilling over was colourless.
(166) (500mg, 29mmol) was dissolved in the minimum 
amount of absolute methanol, cooled in ice, and an etheral 
solution of diazomethane was added in small portions 
until gas evolution had ceased and the solution had 
acquired a pale yellow colour. This was left until the 
excess diazomethane had evaporated. The solvent was
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then removed to yield 520mg (97%) of a colourless oil.
-1 n
v (CHC1,) 1720cm (C=0), 5„(CDC1,), 9.9 (m, 1H, CHO,max j /  h j —
aldehyde), 4.14, (m, 1H, C-2, Heq), 3.92 (m, 1H, C-6,
Heq), 3.7 (s, 3H, OCH3 ), 3.33 (m, 1H, C-2, Hax), 3.01 
(m, 1H, C-6, Hax), 2.7 (m, 1H, CH-COOCH^ (bridgehead),
2.28 (m, 1H), 2.16 (m, 2H), 1.4-1.2 (m, 2H). M/Z (70ev.
E.I.) 185 (M-l), 153, 143 (100), 142, 111, 82, 74, 55,
43, 41, 27.
1705-(hydroxymethyl)-3-tetrahydropyran ethanol (169)
(166) (lOOmg, 0.58mmol) was dissolved in anhydrous
O
THF (5ml) under a ^  atmosphere and cooled to 0 . A 
solution of diborane in THF (1M) (2ml) was added dropwise 
and the resulting solution was stirred for 2hr at 0°.
(5ml) was added to hydrolyse the reaction mixture. 
Extracted with Et20 (3x25ml), dried (MgSO^) and was 
evaporated to yield 60mg (66%) of a colourless oil.
Vmax (chc1 3 > 3650' 3450cm-1 (-0H), 6H (CDC13 ) 3.9-3.1
(m, 8H, CH2OCH2 , CH2OH), 2.05-1.1 (m, 10H).
5-(2-formylmethyl)-3-tetrahydropyran carbanal (170)
Pyridinium chlorochromate (410mg, 1.9mmol) was suspended 
in DCM (3ml) and (169) (lOOmg, 0.61mmol) in DCM (1ml) 
was rapidly added at R.T. After l-2hr the oxidation 
followed by t.l.c. was complete. The black reaction 
mixture was diluted with anhydrous ether (20ml), the
i
solvent decanted and the black solid washed twice with
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ether. Product was isolated simply by filtration of
the organic extracts through Florisil and evaporation
of solvent at reduced pressure to yield 54mg (57%) of
-1 ^
a colourless oil. v (CHCl^) 1710cm (C=0),max j /
6„ (CDC10 ) 9.85 (m, 1H, CHO, aldehyde), 9.65 (m, 1H,H J —
CHO, aldehyde), 4.2 (m, 1H, Ct^O), 3.9 (m, 1H, CH20),
3.4 (m, 1H, CH20), 3.0 (m, 1H, CH20), 2.7 (m, 1H, CHCHO 
(bridgehead), 2.2 (m, 3H, CH2CHO and CHCH2CHO (bridgehead)), 
1.8 (m, 2 H ).
Reaction of 5-(2-formylmethyl)-3-tetrahydropyranmethyl 
t-butyldimethylsiloxy carbonyl (167) with n-hexyltriphenyl 
phosphonium bromide
n-Hexyltriphenyl phosphonium bromide (330mg, 0.75mmol) 
was suspended in anhydrous THF (10ml) under N2 and cooled 
to -78°. nBuLi (0.5ml, 0.75mmol, 1.6m) was added dropwise 
and the resulting orange solution stirred for 30 minutes. 
After this time HMPA (1.74ml, O.Olmol, 15 equivalents 
based on phosphonium salt) was added followed immediately 
by a precooled (-78°) solution of (167) (200mg, 0.7mmol) 
in anhydrous THF (2ml) via a canula with the transfer 
completed by washing with THF (2x2ml). The reaction 
was stirred for 30 minutes at -78° and pentane/Et^N (10:1, 
9ml) was added and the mixture slowly warmed to 20°. 
Extraction with hexane/ether/Et^N (70/20/10) (4x30ml) 
followed by drying of the combined organic phase (Na^O^) 
and removal of solvent in vacuo yielded 80mg of a yellow 
oil containing none of the desired product.
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Reaction of 5-(2-formylmethyl)-3-tetrahydropyran carbanal 
(170) with n-hexyltriphenyl phosphonium bromide
n-Hexyltriphenyl phosphonium bromide (llOmg, 0.26mmol) 
was dissolved in anhydrous THF (5ml) under ^  and cooled 
to -78°. nBuLi (0.18ml, 1.64M, 0.26mmol) was added 
dropwise and the resulting orange solution stirred for 
30 minutes. At the same time a solution of (170) (40mg, 
0.26mmol) was dissolved in anhydrous THF (5ml) and was 
cooled to -78 . After 30min, HMPA (0.6ml# 3.8mmolf 15 
equivalents based on the phosphonium salt) was added, 
followed immediately by the phosphonium salt via a canula 
dropwise (inverse addition). The mixture was stirred 
at -78° for 30min and then warmed to 0° over lhr. It 
was then diluted with ether/pentane (10ml, 1:5) and washed 
with aqueous lithium chloride solution (2x5ml) and brine 
(1x10ml), dried (Na2 SO^) and evaporated to yield 60mg 
of a pale yellow oil, which was found to be a complex 
mixture.
5-(cis-2-octenyl)-3-tetrahydropyran carboxylic acid (178)
n-Hexyltriphenyl phosphonium bromide (220mg, 0.5mmol) 
was suspended in anhydrous THF (5ml) under ^  and cooled 
to -78°. nBuLi (0.36ml, 0.5mmol, 1.6M) was added dropwise
o
and the resulting orange solution was warmed to -20 
and stirred for 30mins. The suspension was recooled 
to -78° and anhydrous HMPA (1.2ml, 15 equivalents based 
on phosphonium salt) was added followed by (166) (40mg,
0.23mmol) in anhydrous THF (2ml) via a canula and stirred
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for lhr then allowed to warm to 0°. Quenched with ether,
evaporated and residue dissolved in ether, acidified
with dil HC1 (aq) and extracted with ether (3x20ml),
dried (Na2S0^) and evaporated. Residue dissolved in
pentane and solid filtered off. Pentane evaporated to
yield a colourless oil. Columned (medium pressure)
(PE/EA, 1:1 + 1% formic acid) to yield 41mg (73%) of
a colourless oil/solid. v (CHCl-,) 3500-3150 (-COOHmax j
St.), 3020 (=CHSt), 1700cm’1 (C=0). 6 (CDC1.J 10.54/ H o
(br. s, 1H, COOH), 5.44 (m, 1H, CH=), 5.34 (m, 1H, C H = ), 
4.15 (m, 1H, CH20), 3.93 (m, 1H, CH20), 3.35 (t, 1H, 
J 1=11.2Hz CH20), 2.96 (t, 1H, J1=11.2Hz, CH20), 2.66 
(m, 1H, CHCOOH), 2,2 (m, 1H), 1.97 (m, 3H), 1.69 (m,
1H), 1.26 (m, 8 H ), 0.88 (t, 3H, J1=6.5Hz, CH3 ). M/Z 
70ev. E.I.) 240 (M+ ), 150, 141, 128, 107, 94, 81, 79,




A 0. 5M solution of potassium-t-butoxide in anhydrous 
THF (10ml, 5mmol) was added via a canula to a stirred 
solution of 2-(1,3-dioxan-2-yl)-ethyltriphenylphosphorane 
(2.28g, 5mmol) in anhydrous THF (5ml) in a dry N 2 
atmosphere to give the orange phosphorane. Stirring 
was continued at room temperature for 30min and hexanal 
(lOmmol) was added dropwise. The mixture was stirred 
for 2hr and then poured into H 20 (50ml). Extracted with 
ether (3x50ml), dried (Na2SO^) and evaporated.
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Residue columned (PE/EA, 10:1) to yield 870mg (86%) of
a colourless oil. 6^ (CDCl^) 5.54 (m, 1H, =CH), 5.44
(m , 1H, = C H ) , 4.54 (t, 1H, J=5.2Hz, C H ^ ° ~ “^ ) ,  4.14 (dd,
^  O —
2 H , J1=8.12Hz, J2=4.95H z , CH20), 3.76 (t d , 2H, CH20)
2.37 (m, 2 H , CH2CH=CH), 2.12 (m, 3H ), 1.32 (m, 7H) 0.88 
(t, 3 H , CH3 ) 6c (CDC13 ) 132.76 (d), 122.86 (d), 102.04 
(d, C-l'). 66.98 (t, C-2' and C-4'), 33.47 (t), 31.50 
(t), 29.22 (t), 27.41 (t), 25.75 (t), 22.58 (t), 14.08 
(q, C - 8 ) . M/Z (70ev E.I.) 197(M"1), 122, 87 ( 100).
Found: C,72 .49, H,11.39, C ^2H22°2 re<3u:*-res C,72.68,
H,11.18%.
174Cis-3-nonenal dimethyl acetal (181)
A solution of (180) (870mg, 4.4mmol) and p-toluene 
sulphonic acid (3mg, 0.16mmol) in methanol (40ml) was 
heated at reflux for 2hr, cooled, and neutralised with 
anhydrous sodium carbonate. After evaporation of the 
methanol, the product was taken up in DCM, washed with 
H20, dried (Na2SO^) and evaporated to yield 620mg.
Residue columned (PE/EA, 10:1) to yield 580mg, 71% of 
a colourless oil. 6^(CDC13 ) 5.49 (m, 1H, =CH), 5.38 
(m, 1H, =CH), 4.37 (t, 1H, J=5.9Hz, CH(OMe)2 ), 3.33 
(s, 6H , (O M e )2 ), 2.37 (t, 2H, J=6Hz), 2.03 (m, 2H), 1.29 
(m, 8 H ), 0.89 (t, 3H, CH3 ). M/Z (70ev E.I.) 155 (M-OCH3 ), 
122, 114, 87, 75 ( 100). Found: C,70.96, H,11.84, C n H22
02 requires C,70.92, H,11.90%.
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Cis-3-nonenal (182)^ ^
A solution of (181) (520mg, 2.8mmol) in acetic acid
(12ml) and (6ml) was stirred at room temperature
for 4hr, neutralised with cold saturated sodium hydrogen
carbonate, taken up in DCM and dried (I^CO^). Solvent
evaporated to give 330mg. Residue columned (PE/EA, 10:1)
to yield 290mg, 74% of a colourless oil. v (CHC1-.)max j
_ i \
1730cm (C=0) 6 (CDC10 ) 9.65 (t, 1H, J=2Hz, CHO,/ H o  —
aldehyde), 5.68 (m, 1H, =CH), 5.56 (m, 1H, =CH), 3.18 
(m, 2 H , =CHCH2CHO), 2.03 (m, 2H, CH2CH=CH), 1.29 (m,
6H), 0.88 (t, 3H, CH3 ). M/Z (iBuH C.I.) 141 (M+ 1 ), 112, 
87 ( 100), 75. Found: C,76.87 H,11.61, C ^ H ^ O  requires
C ,77 . 09 H,11.50%.
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